{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "f17335faf0dde921e8213aefe834c911",
    "title": "Jefferies",
    "source_uri": "2025-08-29/1Q Review Resilient Earnings Given External Environment1Q Review Resilient Earnings Given External Environment_2025-08-29",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-27T00:37:55.165622",
      "extracted_at": "2025-10-27T00:37:55.165629"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 32,
        "successful_pages": 32,
        "date": "2025-08-29",
        "publication": "2025-08-29",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 3,
          "removed_paragraphs": 5,
          "reduction_ratio": 0.05356353710844419
        },
        "input_relative_path": "2025-08-29"
      }
    }
  },
  "passages": [
    {
      "passage_id": "9423d302f3279b94",
      "text": "Japan | Precision Equipment",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "6d318c1cec446df6",
      "text": "Equity ResearchAugust 29,2025",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "74ee7c9198d89250",
      "text": "1Q Review: Resilient Earnings Given External Environment",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "278faed7a62ebc31",
      "text": "Fujifilm announced 1Q FY3/26 results on Aug 6. It reported &#36;75.3bn in OP (up 21.1% YoY), exceeding the market view and delivering healthy progress toward the internal outlook. It also steadily acquired orders for bio-CDMO facilities being added in 2026-28. We think the company posted resilient results amid uncertainty in the external environment. We adjust our estimates. Reiterate our PT &#36;4,300 and Buy rating.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "d2fc484f1a64dea8",
      "text": "**1Q** **results:** Fujifilm reported &#36;749.5bn in sales (up 0.1% YoY, up 4.5% ex. forex) and &#36;75.3bn in OP (up 21.1% (up &#36;13.1bn) YoY, up &#36;21.8bn ex. forex), setting all-time sales and OP highs for 1Q. Compared to the internal outlook, the Imaging business beat sales and OP guidance.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "c492df2ceee60940",
      "text": "**Healthcare:** 1Q sales were &#36;228.5bn (down 2.9% YoY, up 1.6% ex. forex) with medical systems at &#36;144.0bn (down 2.9%, up 1.6% ex. forex). Medical materials for China declined on inventory adjustments. Bio CDMO booked &#36;53.2bn in 1Q sales (up 12.8%, up 18.9% ex. forex) with contributions from the first-phase investments in Denmark and recovery in operations at the Texas site following the shift to commercial facilities conducted last year. Scheduled halt of existing facilities in Denmark had a negative impact (as expected). This business started the fiscal year on track with full-year guidance for &#36;260.0bn in sales (up 18% YoY). Segment OP was &#36;4.3bn in 1Q (up &#36;700mn YoY). Decline in one-time items added &#36;3.8bn, and forex removed &#36;2.2bn. Real income had a &#36;500mn loss. Bio-CDMO business recorded an EBITDA margin in the low teens in 1Q, a modest decline from the mid-teen level in 1Q FY3/25 due to higher depreciation costs. In FY3/26, Fujifilm expects a mid-teen margin (unchanged from the previous view). Fujifilm gave an update on business discussions related to CDMO facilities it is adding. It newly concluded a contract for one system under the Denmark second-phase covering FY3/27-29 and will also finalize contracts for three of four systems in FY3/27. For the US second-phase from FY3/29, it concluded long-term contracts and basic agreements with multiple major drug firms for four of eight systems this time. Fujifilm is steadily acquiring orders for the additional facilities.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "2c22278471e58b6c",
      "text": "**FY3/26 guidance:** Fujifilm retained existing FY3/26 targets of &#36;3,280.0bn in sales (up 2.6% YoY) and &#36;331.0bn in OP (up 0.3%). It also targets a &#36;70 dividend (up by &#36;5), raising the dividend in a 16th straight year. This works out to a 32.2% dividend payout ratio. Forex assumptions are &#36;145/US$ and &#36;137/Euro (vs. &#36;145/US$ and &#36;155/Euro previously). Segment targets are unchanged too. Fujifilm budgets &#36;462.0bn in capital investments for FY3/26 (down &#36;70.1bn YoY), including &#36;339.0bn in healthcare (down &#36;110.2bn), a decline from the peak set in FY3/25.While it expects an FCF deficit again in FY3/26, Fujifilm intends to restore a surplus for the first time in five years in FY3/27.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "70302fa1f79bb1d4",
      "text": "FY (Mar)FY3/25AFY3/26EFY3/27EFY3/28ERev. (B)3,195.83,252.83,384.03,478.0Cons. Rev. (B)-3,275.63,434.23,572.4Operating Profit (B)330.1325.0368.0400.0EPS216.70210.60237.80258.00",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "93580a7aafb533bc",
      "text": "Please see analyst certifications, important disclosure information, and information regarding the status of non-US analysts on pages 27-32 of this report.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "b11f44cfa880e3d4",
      "text": "* Jefferies (Japan) Limited",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "fc563eb23da7720e",
      "text": "ESTIMATE CHANGERATINGBUYPRICE¥3,532*PRICE TARGET | % TO PT¥4,300|+22%52W HIGH-LOW¥3,994-¥2,516FLOAT (%) | ADV MM (USD)80.2%|84.52MARKET CAP¥4.8T|$32.3BTICKER4901 JP",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "d71d0dbd73775f67",
      "text": "*Prior trading day's closing price unless otherwise noted.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "d0f03a123d102dda",
      "text": "FY (Mar)CHANGE TO JEFeJEF vs CONS2025202620252026REVNANANANAEPS+2%NM-3%-2%2025 (¥)Q1Q2Q3Q4 FY3EPS----210.60PREV207.40",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "6ae87d2d9707f8f4",
      "text": "We believe the current stock price factors in CDMO potential to some extent. CDMOs are expected to see a limited contribution to profits until fiscal 2026, when increased capacity translates into higher sales, after which growth is expected to increase again and valuations are expected to pick up. Conversely, we see risk of a larger decline in business innovation and imaging profitability than expected by the market.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "f6c6d3e3fa19cf3d",
      "text": "Risk/Reward - 12 Month View",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "c4e31d8dde853a70",
      "text": "Fujifilm has revamped the business portfolio and strengthened balance sheet management over many years. It is also actively investing in growth and has clarified growth areas, mainly healthcare and materials. In healthcare, medical systems (medical equipment) and CDMO drive earnings over the medium term. Price target ¥4,300 (12x our estimated FY3/26 EV/EBITDA).",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "4c336bc0e2026243",
      "text": "Sales and profit increases, fueled by expansion of CDMO business and higher capital investments. Rise in medical systems profitability. In this scenario, our upside price target is ¥5,000 (14x our FY3/26 EV/EBITDA).",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "aa480b225daaa93f",
      "text": "CDMO's profitability improvement may fall short of company plans Decline in imaging business profitability. Market shrinkage and tougher competition in business innovation. In this scenario, our downside price target is ¥2,200 (ROE 5%, FY3/24 P/B of 0.83x).",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "aa6713ef3f8956e2",
      "text": "Top Material Issues: 1) Product Design & Lifecycle Management. 2) Supply Chain Management. 3) GHG Emissions.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "82cc685801da2a1f",
      "text": "Company Targets: GHG Emission Scope 1/2 2030: 50% vs 2019, Net zero by FY2040",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "dfe8536205456dfa",
      "text": "Qs to Mgmt: 1) In April 2024, Fujifilm disclosed its medium- term management plan VISION 2030 through FY2030. The company have clarified multifaceted approach to the realization of a sustainable society and disclosed KPIs. What's the progress? 2) Through its business, Fujifilm is working to improve the health and work styles of society. What's the progress on this?",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "c87e2a312e562d82",
      "text": "CDMO profitability, sales growth. Closing status for capacity increase Fluctuation in business innovation and imaging profitability",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "722668e92f5755c0",
      "text": "Exhibit 1-Fujifilm Earnings Summary",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "c3ad86277ba63fea",
      "text": "SalesOperatingPre-tax",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "55eb53853abfc872",
      "text": "- US\\\\$ Sales \\(\\) 5.0bn\\(, OP\\) \\ \\(1.0bn\\) - Euro: Sales \\(\\) 1.5bn\\(, OP\\) \\ \\(800mn\\) - FY3/22 actual: \\(\\) 113\\(/\\) \\ \\(131 / \\in\\) - FY3/23 actual: \\(\\) 136 / \\ \\(and\\) \\ \\(141 / \\in\\) - FY3/24 actual: \\(\\) 145 / \\ \\(and\\) \\ \\(157 / \\in\\) - FY3/25 actual: \\(\\) 152 / \\ \\(and\\) \\ \\(164 / \\in\\) - FY3/26 company assumption: \\(\\) 145 / \\ \\(and\\) \\ \\(157 / \\in\\) - 2Q-4Q FY3/26 company assumption: \\(\\) 145 / \\ \\(and\\) \\ \\(155 / \\in\\) (unchanged)",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "09e8a002e770ef89",
      "text": "Price Target of \\(\\) 4,300\\(calculated on FY3/26E EV/EBITDA of 12x. Fair - value multiple of 12x is the SOTP result using 15x for CDMO (FY25 forecast average of 22x, discounted for Fujifilm's margin), 14x for medical and healthcare, 13x for performance materials, and 5x for other (historical 5 - year average).",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "43468daab6d7f3c3",
      "text": "- Customer purchasing trends vs. CDMO supply capacity increase- Long-term deterioration in the CDMO demand-supply balance, potential margin decline- Higher COGS and fixed costs (e.g., depreciation), long-term decline in contract production prices, and possibility of margin improvement being below plan- Temporary sales/profit fluctuations due to change in the CDMO mix- Structural contraction of the office printing market- Cyclical decline in electronics earnings- Imaging business contracts again, shift in Instax consumption trend- Earnings impact from global macro-economic downturn due to Trump tariffs- Higher tariff costs due to Trump tariffs",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "f1bc7907b003bc78",
      "text": "1Q Sales were \\(749.5bn (+0.1\\% \\text{YoY}, +4.5\\% \\text{ex - forex})\\) and OP \\(75.3bn (+21.1\\% \\text{YoY}, +13.1bn, +21.8bn \\text{ex - forex})\\) . Sales/OP achieved new record highs for 1Q. Bio- CDMO, semiconductor materials, and imaging sales increased. Company- wide sales/profit increase as forex impact (yen appreciation) was offset. Consensus was for sales of \\(757.5bn\\) and OP \\(69.5bn\\) . Our estimate was for sales of \\(764.4bn\\) and OP \\(68.0bn\\) .",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "74ae576230b737bd",
      "text": "Compared with internal company expectations, mgmt. commented at OP beat (sales exceeded by \\(3.0bn - 4.0bn\\) and OP by \\(7.0bn - 8.0bn\\) ). By segment, imaging sales beat by roughly \\(8.0bn\\) and OP by \\(6.0bn - 7.0bn\\) . Digital cameras and Instax sales remained brisk. Electronics sales were in line and OP slightly above. Business innovation sales were slightly below, as MFP sales in Asia Pacific were less than expected. However, OP beat guidance due to a reduction in low- margin models and expense cuts. Healthcare sales and OP both missed by around \\(1.0bn - 1.5bn\\) . Medical sales missed, mainly in China.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "ed03a61f62e81d6c",
      "text": "1Q sales totaled \\(228.5bn (- 2.9\\% \\text{YoY}, +1.6\\% \\text{ex - forex})\\) . Sales ex- forex declined YoY for four straight quarters, from 4Q FY3/24 through 3Q FY3/25, but growth turned positive in 4Q FY3/25 and 1Q FY3/26 continued the trend. Higher sales supported by increased bio- CDMO capacity is starting to contribute.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "31bbe060d36a90b0",
      "text": "By sub- segment, medical systems 1Q sales were \\(144.0bn (- 8.7\\% \\text{YoY}, - 4.5\\% \\text{ex - forex})\\) . In 4Q FY3/25, sales rose YoY for the first time in three quarters, but 1Q FY3/26 declined. By region, Japan (approx. \\(30\\% +\\) composition) rose slightly YoY, the Americas (20) rose in the low- single digits (mid- single digits ex- forex), Europe (20%) declined in the high- single digits (mid- single digit decline ex- forex), and China (just under 10%) was down \\(30\\% - 40\\% \\text{YoY}\\) . In China, sales declined sharply partly due to inventory adjustments at sales agents. Endoscope sales (driver of Chinese sales) declined YoY, also partly due to inventory adjustments at agents.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "a57696c12d61928a",
      "text": "By product, sales of medical IT equipment ( \\(10\\% +\\) composition) and IVD (10%) were strong (around \\(+10\\%\\) YoY). However, endoscope (20%) sales corrected in China, and global sales were down slightly YoY. X- ray equipment (just under 20%) sales declined in the double digits and x- ray materials (just under 10%) fell \\(40\\% \\text{YoY}\\) . Amid a decline in demand globally, the degree of inventory adjustments at sales agents in China increased. CT/MRI (just under 10%) sales declined around \\(10\\% \\text{YoY}\\) (mainly the former medical equipment business of Hitachi). In FY3/25, sales were strong, partly because of cross- selling in the Fujifilm route, but in 1Q, in addition to yen appreciation, a pullback in demand in Europe caused sales to fall YoY.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "c6f3b3fa892eba62",
      "text": "Bio- CDMO 1Q sales were \\(53.2bn (+12.8\\% \\text{YoY}, +18.9\\% \\text{ex - forex})\\) . 1Q sales were \\(+6.0bn \\text{YoY}\\) . Sales related to the Phase 1 investment project in Denmark increased YoY. In 1Q FY3/25, utilization decline due to a project to upgrade the commercial manufacturing system in Texas, but sales in 1Q FY3/26 increased. Meanwhile, scheduled suspension of operations at existing facilities in Denmark caused sales to decline, but the net impact was positive \\(6.0bn\\) . CMO sales and profit were basically in line with internal company expectations. 1Q OP was an estimated negative \\(7.0bn - 8.0bn\\) . Looking at one- time expenses in 1Q, planned suspension of operations in Denmark had a \\(8.5bn\\) profit impact. Excluding this, OP was probably slightly positive. EBITDA excluding one- time expenses was in the low teens. Compared with the mid- teens in 1Q FY3/25, margin declined due to higher depreciation.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "c742d49861700d20",
      "text": "Full- FY3/26 outlook for sales of \\(260.0bn\\) and one- time expenses of \\(10.0bn\\) (planned suspension in Denmark) and OP negative \\(16.0bn\\) (unchanged vs. initial guidance). Expecting EBITDA market excluding one- time expenses to be in the mid- teens (low- teens in FY3/25). In 2Q, expecting EBITDA",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "edb4c2c47c4fc77d",
      "text": "margin to improve, but expecting OP to fall in 2H as depreciation related to the Phase 1 investment project in North Carolina starts.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "ef002385a0f8ae64",
      "text": "Mgmt. provided an update on negotiations concerning capital investment. Regarding changes vs. three months prior, negotiations have been finalized for one tank in Phase 2 investment in Denmark starting in 2026. Of the 8 tanks in the Phase 2 investment in North Carolina (operational in 2028), basic agreements/long- term contracts (around 5 years) have been concluded with several major pharmaceutical companies for four tanks. At this point, customers have been decided for 6 tanks in the Phase 1 project in Denmark (operational in 2025) and 6 tanks in the Phase 1 project in North Carolina. Customers for 3 of the 4 tanks in the Phase 2 project in Denmark (operational in 2026) have been decided. Of the 8 tanks in the Phase 2 project in North Carolina, customers have been decided for 4 tanks. Phase 1 investment to upgrade capacity in the US is scheduled to start operations in 2H FY3/26, so operations have not yet begun. In this situation, the fact that negotiations are progressing for projects through 2028 indicates that Fujifilm's execution and system are highly regarded. Other tailwinds are the possibility that the Trump administration will impose high tariffs on pharmaceuticals and promote policies aimed at reshaping pharmaceutical manufacturing to the US.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "943fc6dff265c3ee",
      "text": "LS solutions 1Q sales totaled \\(31.3bn (+3.2\\% \\text{YoY}, +6.2\\% \\text{ex - force})\\) . Regenerative medicine (70%+ composition) was \\(+3\\%\\) YoY. Cell media and reagent sales rebounded YoY. Pharmaceutical (10% +) sales were \\(+20\\%\\) YoY. Contact manufacturing of COVID- 19 vaccine ingredients contributed. Cosmetics (10%+) sales declined around 10%.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "9e9724d970e975d0",
      "text": "Segment OP in 1Q was \\(4.3bn (+800mn \\text{YoY})\\) , apparently around \\(1.0bn - 1.5bn\\) below internal company expectations.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "83e69cd8f8a1812a",
      "text": "1Q forex impact was \\(- 2.2bn\\) , raw materials prices \\(- 400mn\\) , and one- time expenses \\(- 7.3bn\\) . Adjusted OP was \\(- 500mn \\text{YoY}\\) . Medical systems 1Q profit margin declined slightly YoY due to inventory adjustments in China. Bio- CDMO and LS solutions posted narrower losses.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "86d50bad929d46e2",
      "text": "1Q sales were \\(102.1bn (- 0.9\\% \\text{YoY}, +3.7\\% \\text{ex - force})\\) . Sales were \\(- 4.5bn\\) vs. 4Q FY3/25. Sales were basically in line with internal company expectations.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "9f3cdce8ff2a34a3",
      "text": "Within electronics, semiconductor materials 1Q sales totaled \\(64.7bn (+3.8\\% \\text{YoY}, +10.6\\% \\text{ex - force})\\) . Sales vs. 4Q FY3/25 were \\(+1.5bn\\) . After the acquisition of the process business of US- based Entegris, quarterly sales have been around the \\(60.0bn\\) level. CMP slurry (nearly 30% composition) sales rose 20% YoY. Post- CMP cleaner (approx. 5%) sales rose approx. 10% YoY. CMP clear market share is 26%. Competitors include Entegris and Resonac. In Cu, market share is around 50%, making the company the market share leader. The company's product has superior corrosion protection performance for copper properties and a low defect rate. Sales continue to grow rapidly due to increased demand for high- end logic and expansion of packaging applications. Polyimide (mid- single digit share) sales were upbeat (2- digit growth YoY). Heat- resistant sealant materials for power semiconductor use weakened, but demand for interlayer insulating film materials has increased due to the expansion of multi- layered packages and advanced packages. Photoresist (10% composition) sales declined slightly YoY. In Oct 2025, sales started for EUV resist and developing fluid. Image sensor materials (mid- single digit composition) were - 5% YoY. Lithography materials (just under 50% composition: includes Entegris's process chemicals) declined slightly YoY. Sales to a North American logic maker (Entegris's main customer) apparently remain weak.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "180ef235315e5740",
      "text": "AF materials 1Q sales were \\(37.5bn (- 8.2\\% \\text{YoY}, - 6.8\\% \\text{ex - force})\\) , down \\(5.7bn \\text{QoQ}\\) . Within this, display materials (70% composition declined slightly YoY. TAC film was - 5% YoY for full- FY3/25, and sales again declined YoY in 1Q FY3/26. OLED rose YoY, but growth was somewhat weak. Industrial materials (20% composition) declined \\(20\\% + \\text{YoY}\\) . Fine chemicals (10% composition) growth was in the mid- teens YoY.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "ba34eaa63c928061",
      "text": "Segment OP totaled ¥22.5bn (+¥2.6bn YoY, +¥5.0bn ex- forex). Adjusted OP was +¥4.1vn YoY, rising YoY for the first time in two quarters. Results were basically in line with internal company expectations. In 4Q FY3/25, display materials corrected and mix worsened. As a result, profit declined YoY, but 1Q FY3/26 rebounded YoY.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "30092433923dcb43",
      "text": "1Q sales totaled ¥273.6bn (- 2.3% YoY, +0.9% ex- forex). Sales ex- forex rose YoY for the third straight quarter, and equated to 92% vs. 1Q 2019. The value vs. the same period in 2019 had trended around 80% in FY3/24- FY3/25, but has increased to the 90% level since 4Q FY3/25.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "516a3a110794e40a",
      "text": "Within this, office solutions 1Q sales amounted to ¥120.0bn (- 5.3% YoY, - 2.7% ex- forex). Within this, MFP sales were - 4%. Domestic sales were flat. In Asia Pacific, sales in China and Southeast Asia declined, partly because of a reduction in low- margin models. Exports to Europe and the US were +9% YoY. MFP sales by US Xerox (major OEM customer) continue to trend downward, but exports by Fujifilm have risen YoY since 2H FY3/25. Exports to US Xerox hinge on inventory accumulate by US Xerox. Consequently, there is no short- term link with US Xerox's sales. However, because US Xerox's sales continue to trend downward, it is possible that Fujifilm's exports to US Xerox will correct as well. Office printer sales were - 14% YoY. Sales in Japan declined slightly. Asia Pacific sales rose YoY in 1Q FY3/26 vs. a correction in Chinese sales in 1Q FY3/25. Exports to Europe and the US declined.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "b398c57a61863f87",
      "text": "Business solution 1Q sales were ¥75.8bn (+7.0% YoY, +9.9% ex- forex). Domestic DX solutions sales and service sales to municipal governments remained brisk. Overseas BPO business was also strong. Specifically, in 1Q, there was an election in Australia, and this pushed up BPO demand.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "8f443770c7287dbc",
      "text": "Graphic communications 1Q sales totaled ¥77.8bn (- 5.6% YoY, - 1.4% ex- forex), declining due to lower sales of analogue printing plate materials to Europe and the US declined, the end of low- margin plate making materials, and a drop in sales of inkjet heads. In Apr, Fujifilm announced the robot system Revoria Kamisa PH2, which is a robot system for printing companies that automates the paper sorting process for large, heavy printed books. The company is also strengthening its solutions offerings.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "34759eeb00211d76",
      "text": "1Q segment OP was ¥15.6bn (+¥1.1bn YoY, +¥2.3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectations by roughly ¥2.0bn- ¥3.0bn. Sales were about ¥3.0bn below company target but, in addition to strong results for business innovation, profit increased due to expense curbs.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "83f71fe5d2a7321e",
      "text": "1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥6.0bn- ¥7.0bn. This appears partly due to early demand ahead of Trump tariff rate hikes in Aug, and while the company says that there was probably some such movement, real earnings remained strong.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "e1d44889cbb178db",
      "text": "Within imaging, consumer 1Q sales were ¥77.3bn (+3.7% YoY, +9.9% ex- forex). By region, all regions were upbeat. Japan and China posted 2- digit growth, the US was flat on a yen basis (up on a local- currency basis), and Europe was up YoY on a yen basis. Instax remained strong. Sales of high- added- value products (e.g., Instax 400, Instax Wide Ev, launched in FY3/25) remained strong. New product Instax Mini 41 (entry- level model launched in Apr) also contributed. In May, the company launched the smartphone app UtsuRundesu+, which offers users a variety of ways to enjoy their photos, with the aim of expanding business.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "3fc6efff650ee864",
      "text": "Professional 1Q sales were ¥68.0bn (+21.1% YoY, +28.7% ex- forex). Digital camera sales rose in Europe, the US, and China. Sales of four models launched in FY3/25 (X100VI, GFXII, X- T50, and X- M5) remained strong. In China, online sales were also strong. In Jun, the company released the X Half, a compact digital camera that recreates and evolves the feel of film photography. This was followed in Aug by the launch of the new APS- C mirrorless X- E5 (back- illuminated, 40.2 megapixels,",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "e42571179e33e9ee",
      "text": "retail price in the ¥200,000 range). Fujifilm continues to launch distinctive new products, and business is going well.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "d9481f710744380e",
      "text": "Exhibit 2 - Earnings Growth by Segment Ex. Forex",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "ec01f2d05a4f932c",
      "text": "Source: Jefferies, company data",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "4577c810c81f704c",
      "text": "1Q OP totaled ¥75.3bn (+¥13.1bn YoY). Within this, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn, one- time expenses +¥5.3bn (¥8.9bn in 1Q FY3/26 vs. - ¥14.2bn in 1Q FY3/25). Breakdown of 1Q one- time expenses was healthcare - ¥8.5bn (planned CDMO operational pause in Denmark), and business innovation - ¥400mn (expenses related to structural upgrade of graphic communications and litigation expenses). In 1Q FY3/25, healthcare one- time expenses were ¥12.3bn (related to structural upgrade to cell and gene therapies in CDMO and upgrade to the commercial manufacturing system in Texas). In FY3/26, expecting one- time expenses to decline YoY. FY3/26 guidance for one- time expenses is ¥13.5bn, with healthcare accounting for ¥10.0bn (planned operational pause in Denmark) and business innovation ¥3.5bn (structural upgrade of graphic communications and litigation expenses). Of this, ¥8.9bn was incurred in 1Q.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "a44403a7f8ddd1e1",
      "text": "Company- wide operations (change adjusted for forex, raw materials prices, and one- time expenses was +¥16.4bn, remaining positive for the sixth straight quarter. By segment, healthcare was negative ¥500mn. While the negative amount was smaller, it remained negative for the sixth straight quarter. The amount was ¥1.0bn- ¥1.5bn less then internal company expectations, due to a smaller- than- expected amount for medical systems in China. CDMO was in line with plan. Electronics was + ¥4.1bn, turning positive for the first time in three quarters. The amount was approx. ¥500mn higher than internal company expectations.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "abaf6e58b846f87b",
      "text": "Business innovation was +¥1.2bn YoY, remaining positive YoY for the third straight quarter. The amount was ¥2.0bn- ¥3.0bn above internal company expectations. Sales missed plan, but the amount exceeded expectations due to the reduction of low- margin equipment and expense cuts.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "844309faf0bdc405",
      "text": "Imaging was +¥12.2bn, exceeding company expectations by ¥6.0bn- ¥7.0bn. Imaging adjusted profit has been positive since FY3/22. Mgmt. tends to issue relative conservative guidance, and 1Q greatly exceeded guidance and rose sharply YoY. Consumer imaging (mainly Instax) and high- end digital cameras remain strong.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "6193850b6056e907",
      "text": "Full- FY3/26 OP guidance for \\(\\yen 331.0bn\\) (unchanged vs. initial). Compared with initial guidance, slight adjustment for forex impact ( \\(\\yen 1.0bn\\) ) and raw materials prices ( \\(\\yen 500mn\\) ). Guidance now factors in \\(\\yen 6.0bn\\) for tariff impact, but also \\(\\yen 6.5bn\\) for operations. Plans are to cover tariff impact through actual business changes. By segment, guidance is for healthcare \\(\\yen 4.5bn\\) , electronics \\(\\yen 1.0bn\\) , and business innovation \\(\\yen 1.0bn\\) .",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "6b70ab6338c5fb0f",
      "text": "On a YoY basis, guidance for healthcare \\(\\yen 18.7bn\\) ( \\(\\yen 29.4bn\\) in FY3/25), electronics \\(\\yen 7.9bn\\) ( \\(\\yen 21.6bn\\) ), business innovation \\(\\yen 10.1bn\\) ( \\(\\yen 3.7bn\\) ), and imaging \\(\\yen 1.3bn\\) ( \\(\\yen 25.0bn\\) ). Based on trends through FY3/25 and 1Q results, the targets for healthcare and business innovation look aggressive, but we see substantial upside for imaging and electronics.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "6d12804f6b58cd26",
      "text": "Exhibit 3-OP Analysis",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "70065eb6878b9b35",
      "text": "ImagingHealthcareMaterialsBusiness InnovationElimination(Y bn) TotalFY21Previous year15.656.451.373.1-30.9165.5Currency6.77.96.64.10.025.3Raw material-2.1-2.0-15.20.00.0-19.3One time loss-3.3-0.7-2.91.5-1.2-6.6Actual20.138.928.620.8-7.064.8FY22Previous year37.0100.568.457.9-34.1229.7ActualCurrency13.919.417.657.9-34.1229.7Raw material-1.8-1.8-13.40.00.0-17.0One time loss3.61.611.64.21.222.2China Rockdown-1.5-1.1-0.6-0.80.0-4.0Actual21.7-18.1-15.917.8-3.91.6FY22 Actual72.9100.567.769.5-37.5273.1FY23Previous year72.9102.865.469.5-37.5273.1Currency10.27.36.41.3-0.125.1Raw material-0.2-1.52.20.30.00.8One time loss-2.5-10.1-12.59.40.0-15.7Actual21.5-1.1-18.6-9.71.3-6.6FY22 Actual101.997.442.970.8-36.3276.7ImagingHealthcareMaterialsBusiness InnovationElimination(Y bn) TotalFY24Previous year23.410.39.816.6-7.952.2Currency5.43.62.42.0-0.113.3Raw material-0.5-1.4-0.4-1.40.0-3.7One time loss0.4-6.4-0.7-0.50.0-7.2Actual3.8-2.79.0-2.3-0.27.6FY24Previous year32.53.420.114.4-8.262.2Currency1.71.20.60.2-0.13.7Raw material-0.6-1.0-0.4-0.80.0-2.7One time loss-0.1-4.80.2-0.40.0-5.1Actual6.5-8.19.0-3.50.24.2FY22 Actual33.718.819.510.8-9.473.4FY24Previous year39.518.413.616.6-8.879.4Currency0.20.61.00.40.02.2Raw material-0.5-1.4-0.3-0.50.0-2.7One time loss2.20.90.4-1.50.02.0Actual7.4-7.94.82.40.16.8FY22 Actual48.810.619.517.5-8.787.7FY24Previous year13.137.112.918.9-10.271.8Currency-0.90.60.20.7-0.10.5Raw material-0.5-0.80.20.00.0-1.1One time loss5.218.66.25.10.035.1Actual7.3-10.7-1.27.1-1.90.6FY22 Actual24.244.818.231.9-12.2106.9FY24Previous year102.097.446.367.4-36.4276.7Currency6.46.04.23.319.7Raw material-2.1-4.6-0.9-2.7-10.2One time loss7.78.36.12.724.8Actual25.0-29.421.63.7-1.819.2FY22 Actual139.277.677.374.6-38.6330.2ImagingHealthcareMaterialsBusiness InnovationElimination(Y bn) TotalFY25Previous year32.53.420.114.4-8.262.2Currency-2.9-2.2-2.4-1.20.0-8.7Raw material-0.1-0.40.20.40.00.1One time loss0.13.80.70.70.05.3Actual12.2-0.54.11.2-0.616.4FY22 Actual41.84.122.715.5-8.875.3FY25Previous year139.279.975.174.6-38.6330.2Currency-8.0-6.0-4.0-3.00.0-21.0Raw material0.0-1.00.0-0.50.0-1.5One time loss-5.5-1.10.0-1.20.0-7.8Actual1.314.26.99.1-0.431.1FY22 Actual127.086.078.079.0-39.0331.0FY25Previous year139.279.975.174.6-38.6330.2Currency-8.0-6.5-4.0-3.50.0-22.0Raw material0.0-1.00.00.00.0-1.0Tariffs0.0-4.0-1.0-1.00.0-6.0One time loss-5.5-1.10.0-1.20.0-7.8Actual1.318.77.910.1-0.437.6FY22 Actual127.086.078.079.0-39.0331.0FY25Previous year139.279.975.174.6-38.6330.2Currency-4.0-3.5-3.0-3.5-14.0Raw material0.0-1.00.00.0-1.0",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "fbf3c0ac7724569d",
      "text": "Source: Jefferies, company data",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "7b4c8b0334ccaaf3",
      "text": "Exhibit 4 - Fujifilm Actual OP Analysis (Wbn)",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "0e274f77b6789f47",
      "text": "Source: Jefferies, company data",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "d9b3a0c5de48533a",
      "text": "Exhibit 5-Earnings Estimates",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "a7e807261bc48ebf",
      "text": "Full year(¥ bn)3/22Actual3/23Actual3/24Actual3/25Actual3/26Co EJEF E3/27Co E(Vision2030)JEF E3/28JEF ETotal sales2,525.82,859.02,960.93,195.83,280.03,257.43,450.03,386.93,474.6YoY15.2%13.2%3.6%7.9%2.6%1.9%4.0%2.6%Healthcare801.7917.9975.11,022.61,100.01,074.01,200.01,182.01,254.0Medical System533.8611.1659.6693.2700.0705.0710.0754.0767.0CDMO150.3194.2203.4219.5260.0252.0355.0303.0353.0Life Science117.6112.6112.1109.9140.0117.0135.0125.0134.0Cosmetic23.025.021.024.025.028.0Regenerative61.063.072.577.084.090.0Others33.624.616.416.016.016.0Materials/Electronics627.2692.7690.0432.8420.0425.0470.0446.0477.0Electric Materials146.7180.6199.7250.4260.0259.0300.0280.0310.0Display94.770.178.390.090.088.085.0Other Materials96.4100.080.476.080.078.082.0AF Materials182.4160.0166.0170.0166.0167.0Graphic289.4342.0331.6Business Innovation763.5838.1826.11,198.51,220.01,212.01,275.01,214.01,209.0Office Solution507.5555.5524.3522.9510.0519.0525.0514.0499.0Business Solution256.0282.6301.8330.9370.0365.0380.0375.0380.0Graphic344.7340.0325.0370.0325.0330.0Imaging333.4410.3469.7542.0540.0546.4505.0544.9534.6Consumer219.0266.9297.6328.0320.0323.4310.0320.4308.8Professional114.4143.4172.1214.0220.0223.0195.0224.5225.8Total operating profits229.7273.1276.7330.2331.0325.0360.0368.0400.0Operating margin9.1%9.6%9.3%10.3%10.1%10.0%10.4%10.9%11.5%Healthcare100.5100.597.477.686.069.5102.0131.0OPM12.5%10.9%10.0%7.6%7.8%6.5%8.6%10.4%Medical System55.080.097.090.5105.098.0104.0114.0OPM10.3%13.1%14.7%13.1%15.0%13.9%13.8%14.9%CDMO31.019.212.0-19.0-16.0-19.01.015.0OPM20.6%9.9%5.9%-8.7%-6.2%-7.5%0.3%4.2%One time cost0.00.00.0-18.0-10.0-10.0-5.0-5.0Life Science14.51.3-2.5-7.0-5.0-9.5-3.02.0One time profit13.5Materials/Electronics68.467.742.977.378.078.085.090.0Business Innovation57.969.570.874.679.069.077.082.0Imaging37.072.9101.9139.2127.0148.0144.0140.0Elimination-34.1-37.5-36.3-38.6-39.0-39.5-40.0-43.0$/Y rate (JPY)113136145152145145140140€/Y rate (JPY)131141157164155165150160",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "be494ef6eb0f26c1",
      "text": "Source: Jefferies estimates, company data",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "14c2450ef49b81d2",
      "text": "Exhibit 6-Earnings Estimates by Quarter",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "16e3b4f3396c6d18",
      "text": "Quarterly(¥ bn)Q1 FY3/25 ActualQ2 FY3/25 New basisQ2 FY3/25 ActualQ3 FY3/25 ActualQ4 FY3/25 ActualQ1 FY3/26 JEF EQ1 FY3/26 ActualQ2 FY3/26 JEF EQ3 FY3/26 JEF EQ4 FY3/26 JEF ETotal sales749.0749.0765.7812.8868.3764.4749.5754.9854.5898.5YoY13.4%13.4%5.2%6.0%15.9%2.1%0.1%-1.4%5.1%3.5%Healthcare229.2235.2242.9240.5310.0244.4228.5235.9296.5313.1Medical System157.7157.7166.9162.6206.0163.0144.0174.0175.0212.0CDMO47.147.148.151.373.055.053.257.063.078.8Life Science24.430.427.926.730.926.431.328.529.228.0Cosmetic4.40.05.35.65.75.44.15.56.57.9Regenerative17.00.019.017.618.917.523.219.018.516.3Others3.40.03.63.55.93.50.34.04.27.5Materials/Electronics109.1103.1108.7108.4106.6104.0102.1106.0104.0112.9Electric Materials62.362.363.061.963.262.064.763.064.067.3Display23.00.026.5Other Materials23.80.018.8AF Materials46.840.845.746.543.242.037.543.040.045.5Graphic0.00.0Business Innovation280.0280.0287.7294.4336.4282.0273.6283.0294.0361.4Office Solution126.8126.8121.8130.5143.8125.0120.0120.0132.0147.0Business Solution70.870.881.177.9101.176.075.883.084.0122.2Graphic82.482.484.885.992.781.077.880.078.089.2Imaging130.7130.7126.5169.5115.3134.0145.3130.0160.0111.1Consumer74.674.677.6110.665.276.077.378.0105.063.1Professional56.156.148.958.950.158.068.052.055.048.0Total operating profits62.262.273.487.7106.968.075.378.088.083.7Operating margin8.3%8.3%9.6%10.8%12.3%8.9%10.0%10.3%10.3%9.3%Healthcare3.43.518.810.644.813.04.324.520.520.2OPM1.5%1.5%7.7%4.4%14.4%5.3%1.9%10.4%6.9%6.5%Medical System19.00.023.018.030.023.014.026.027.031.0OPM12.0%0.0%13.8%11.1%14.6%14.1%9.7%14.9%15.4%14.6%CDMO-11.00.0-2.0-5.0-1.0-7.0-7.5-0.5-5.5-5.5OPM-23.4%0.0%-4.2%-9.7%-1.4%-12.7%-14.1%-0.9%-8.7%-7.0%One time cost-11.00.0-5.0-2.01.4-4.0-8.5-1.5-2.02.0Life Science-4.60.0-2.0-1.81.4-3.0-1.0-1.0-1.0-6.5One time profit13.5Materials/Electronics20.119.919.519.518.220.022.520.516.019.0Business Innovation14.414.410.817.531.913.015.612.016.524.9Imaging32.532.533.748.824.233.041.833.045.028.2Elimination-8.2-8.2-9.4-8.7-12.3-11.0-8.8-12.0-10.0-8.7$/W rate (JPY)156156149153152145145145145145€/W rate (JPY)168168164163161163164165165165",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "5c32b3e9486372e4",
      "text": "Source: Jefferies estimates, company data",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "21af3bb9470f3b8b",
      "text": "FY3/25 operating CF amounted to \\(428.1bn (+\\) 20.2bn YoY). Cumulative operating CR for FY3/22- FY3/24 totaled \\(942.3bn\\) . The annual average was around \\(300.0bn\\) , but FY3/25 was higher. The breakdown was net profit \\(261.6bn (+\\) 18.3bn YoY) and change in working capital \\(+\\) 44.2bn \\((+\\) 31.6bn YoY). 1Q FY3/26 operating CF was \\(94.7bn (-\\) 6.2bn YoY). Net profit was \\(53.8bn (-\\) 7.0bn) and change in working capital \\(+\\) 10.8bn \\((+\\) 200mn).",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "ded0ea2873dd2531",
      "text": "Investing CF in FY3/25 was negative \\(541.9bn (-\\) 14.5bn YoY). Within this, capex was a negative \\(\\) 502.7bn(-\\) 84.8bn YoY), increasing mainly for CDMO. Business acquisition outlook was a \\(\\) 3.8bn\\(negative (+\\) 99.9bn YoY). In FY3/24, Fujifilm acquired Entegris, but there was no major acquisition in FY3/25. 1Q FY3/25 investing CF was negative \\(\\) 119.9bn(+\\) 25.3bn). Fixed tangible asset and software purchases declined \\(\\) 13.1bn\\(YoY. In 1Q, the sale of businesses produced a gain of\\) \\ \\(6.9bn\\) .",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "b6041eefa539b996",
      "text": "FCF in FY3/25 was negative \\(\\) 113.8bn(+\\) 5.7bn YoY). 1Q FY3/26 FCF was negative \\(\\) 25.2bn(+\\) 19.1bn). FCF has been negative since FY3/23. Mgmt. says that FCF will remain negative through FY3/27.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "3d52a7fab60dcb48",
      "text": "Adjusted FCF (actual cash- in and cash- out) in FY3/25 was negative \\(\\) 115.8bn(+\\) 75.8bn YoY). FCF adjusted for business acquisitions was negative \\(\\) 112.0bn(+\\) 94.2bn YoY). 1Q FY3/26 was negative \\(\\) 25.7bn(+\\) 19.7bn).",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "e0ede16c493c2dea",
      "text": "End- 1Q FY3/26 cash & deposits amounted to \\(159.9bn\\) (\\$35.3bn).",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "49100cdd34e6dc53",
      "text": "1Q fixed tangible asset investment totaled \\(116.6bn\\) (\\$2.0bn YoY). Within this, healthcare accounted for \\(105.3bn\\) (\\$4.0bn YoY). Of healthcare capex, CDMO accounted for approx. \\(80\\%\\) . Full- FY3/26 guidance for \\(462.0bn\\) (\\$60.1bn). Guidance unchanged vs. initial, including segment breakdown. Of this, projected healthcare investment is \\(339.0bn\\) (\\$110.2bn). FY3/26 expected to decline from a peak set in FY3/25. Electronics guidance for \\(63.0bn\\) (\\$24.1bn).",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "9b84c2b2cf91cf9f",
      "text": "1Q depreciation was \\(40.9bn\\) (\\$1.2bn YoY). Of this, healthcare accounted for \\(17.2bn\\) (\\$2.2bn YoY). Within this, we estimate that CDMO made up around \\(80\\%\\) (\\$2.0bn YoY).",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "cb8833bd6e09d360",
      "text": "FY3/26 guidance for \\(188.0bn\\) (\\$24.4bn), unchanged vs. initial guidance, including segment breakdown. Healthcare projected at \\(84.0bn\\) (\\$22.5bn). We estimate that CDMO investment will rise by around \\(15.0bn\\).",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "73e803d9df28e38f",
      "text": "1Q R&D expenses were \\(40.6bn\\) (\\$6.2bn YoY), for a ratio to sales of \\(5.4\\%\\) (flat YoY). Of this, healthcare accounted for \\(14.8bn\\) (\\$1.1bn). Healthcare R&D expense/sales ratio was \\(6.5\\%\\) , electronics \\(6.8\\%\\) , business innovation \\(5.1\\%\\) , and imaging \\(2.0\\%\\) . FY3/26 guidance for \\(173.0bn\\) and a ratio to sales of \\(5.3\\%\\) . Outlook unchanged vs. initial.",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "7c3e0d89e9baa3d9",
      "text": "Full- FY3/26 guidance for sales, OP, and NP left unchanged. Guidance is for sales of \\(3.28trn\\) (\\$2.6% YoY, \\(+5.3\\%\\) ex- forex) and OP \\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\) (\\$0.2ppt YoY), and NP \\(262.0bn\\) (\\$0.4%). Guidance for sales and OP to rise for the fifth straight year and to achieve new record highs. Assuming \\(145 / 5\\) (\\$4.6% yen appreciation) and \\(157 / 5\\) (\\$4.3% yen appreciation). Full- year assumption adjusted slightly vs. previous \\(145 / 5\\) and \\(155 / 6\\) based on 1Q actual rates. Assumption for 2Q onward left unchanged. One- time expenses projected at \\(13.5bn\\) (\\$7.5bn YoY), unchanged from previous. Tariff impact of \\(6.0bn\\) now factored into guidance, buy plans are to mitigation through business changes in each segment. Guidance for adjusted profit \\(+\\$ 37.6bn\\) (\\$6.5bn vs. previous). DPS projected at \\(70\\) (\\$500mn YoY) and a payout ratio of \\(32.2\\%\\) . Aiming for shareholder return of \\(30\\%\\) .",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "15633e8ddfa5b2f3",
      "text": "Med- term plan (VISION 2030) announced on 17 Apr 2024. The plan targets FY3/27 sales of \\(3.45trn\\) (\\$5.2% CAGR) and OP \\(360.0bn\\) (\\$9.1% CAGR), for an OPM of \\(10.4\\%\\) . Assuming \\(140 / 5\\) and \\(150 / 5\\) . Compared with FY3/26 guidance, achievement of the med- term plan goals for FY3/27 requires FY3/27 sales growth of \\(+5.1\\%\\) and OP \\(+8.7\\%\\) . FY3/26 guidance for growth (ex- forex) is basically the same. FY3/26 guidance is in line with the FY3/27 med- term plan targets.",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "fc4c8fb2b2eced83",
      "text": "Fujifilm had initially disclosed a calculation of \\(140mn\\) (\\$100mn), which was not initially factored into FY3/6 guidance.",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "a2ce24d5e631e8de",
      "text": "The \\(140mn\\) estimate was calculated after accounting for measures taken in response to the increase in direct tariff costs, such as supply chain revisions, additional expense reductions, and revisions to product and pricing strategies. It did not incorporate any indirect impacts related to the global recession due to the Trump tariffs.",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "aab0d5e8244ff663",
      "text": "Direct tariff cost was calculated using a \\(10\\%\\) uniform rate, and a \\(125\\%\\) rate on China.",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "4509786979feac88",
      "text": "Tariff impact calculation now revised using tariff rates as of 1 Aug (Japan \\(15\\%\\) , Vietnam \\(20\\%\\) , the Philippines and Thailand \\(19\\%\\) , and China \\(30\\%\\) for 90 days and \\(54\\%\\) thereafter (increases in direct tariff costs not disclosed). Taking into account mitigation benefits from price revisions and supply chain changes, mgmt. has now factored in a net negative for OP of \\(6.0bn\\) (\\$40mn). Plans are to cover this with operational initiatives (healthcare \\(4.0bn\\) and \\(1.0bn\\) each in electronic and business innovation).",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "ffc24d9ac43ee520",
      "text": "Fujifilm's FY3/25 sales in the Americas totaled \\(464.9bn (accounting for 20\\%\\) of company- wide sales). Of this, we estimate US sales at just under \\(600.0bn (15\\%)\\) with approx. \\(100.0bn+\\) of this consisting of OEM sales to US Xerox. Also, we estimate sales of CDMO products produced in the US in the several million dollar range. Fujifilm also produces semiconductor materials in the US.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "1320bf93937f9ec6",
      "text": "Of the approximately \\(400.0bn\\) remaining after excluding these sales, we estimate that roughly \\(300.0bn\\) is subject to tariffs. Applying a uniform tariff rate of \\(10\\%\\) across the board, rough calculation indicates an increase in direct tariff costs over 12 months of about \\(30.0bn\\) (however, the FY3/26 impact will only be for roughly 10 months due to inventories stockpiled prior to the change in tariff rates). Using tariff rates as of 1 Aug, the amount comes to around \\(45.0bn\\) (roughly \\(38.0bn\\) excluding pre- tariff rate change inventories).",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "5273f1c6fc8d9f63",
      "text": "In response, Fujifilm aims to offset the impact through price adjustments, cost reductions, and other mitigation measures. Within imaging, Instax is a unique Fujifilm product and demand is strong. The company also offers digital cameras that appeal to a certain consumer segment. Meanwhile, while price adjustments will be made for medical equipment and other B2B products, there is likely to be a certain time lag before price revisions are implemented. For OEM products exported to US Xerox, Xerox pays the tariffs, but sales volume is expected to decrease due to the introduction of reciprocal tariff rates and macroeconomic impacts.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "1dca76d07a174869",
      "text": "In its 2Q FY12/25 results (announced 31 Jul), Xerox estimated an increase in tariff costs for FY12/25 at \\(3.0mn - 3.5mn\\) . While sales for FY12/25 have been revised upward due to the inclusion of Lexmark in the consolidated financial statements, excluding this, actual figures are roughly on par with the previous year, down from the initial forecast (low single- digit growth). The reduction is around \\(150mn\\) . This reduction is expected to affect Fujifilm's exports to US Xerox (although the timing of the impact will not necessarily be synchronized).",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "0e4c119648e2f24f",
      "text": "Current guidance includes a \\(6.0bn\\) net tariff impact (PL impact considering price adjustments and lower volume). However, we believe the net impact could exceed the company's calculation when including the impact of reduced volume for US Xerox.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "fecbfac0d0d2ddf1",
      "text": "Fujifilm's facilities for producing products sold in the US (by segment) are as follows:",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "c1da0dbed32708dc",
      "text": "Imaging: Instax film is produced in Japan. Instax cameras are produced in the Philippines and other locations in Southeast Asia, digital cameras in Japan, the Philippines, and some in China.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "708d353a7b569e7c",
      "text": "Business Innovation: MFPs and printers are produced in Vietnam and some in China. Graphic Communication products are produced in Japan and some in China. Within Business Innovation, the OEM products for US Xerox are imported by US Xerox, and tariffs are directly borne by US Xerox (however, if higher tariffs become the norm, price negotiations with US Xerox are a possibility).",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "a04f141387ffc8c1",
      "text": "Healthcare: Medical systems are produced in Japan. Among ultrasound devices, SonoSite is produced in the US. For CDMO, some",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "02a004f4fb861d1b",
      "text": "Electronics: Semiconductor materials are generally produced in areas where they are consumed, but AF materials (recording media, FPD materials) are produced in Japan.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "e1789bdf22a08db1",
      "text": "Fujifilm has an estimated US sales ratio of around \\(15\\%\\) , which is relatively low vs. around \\(30\\%\\) for other precision instruments firms. Also, of these sales, CDMO products are produced in the US, and the company also has a semiconductor materials production base in the US. Tariffs on OEM exports to US Xerox are directly borne by the latter. In other words, Fujifilm's tariff impact is relatively low among precision instruments firm.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "cbcdda887460487c",
      "text": "No change to segment sales and OP guidance. 1Q progress rates toward initial full- FY3/26 guidance varied by segment (imaging ahead, healthcare slightly behind). It is possible that segment figures will be revised at 1H, but mgmt. says that at this point all segments remain on track for full- FY3/26 guidance achievement (imaging faces possible macro risks, but if conditions in 1Q continue, we see major upside potential). Also, the yen is much weaker vs. the euro compared with the company's forex assumption for 2Q onward (¥145/\\\\( and ¥155/\\)). Assuming a full- year rate of ¥165/€, we estimate a ¥4.0bn addition to company- wide OP.",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "5098d982bc90c703",
      "text": "Initial FY3/26 guidance is shown below.",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "0164cca2bf352b83",
      "text": "Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%).",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "393f90a87426bc44",
      "text": "Bio- CDMO EBITDA margin (ex- forex) expected to be in the mid- teens (low- teens in FY3/25). Onetime expenses projected at ¥10.0bn (¥18.0bn). OP guidance for negative ¥16.0bn (+¥3.0bn YoY). In FY3/26, outlook for adjusted CDMO profit to decline due to higher depreciation, while medical profit is expected to rise and LS Solutions to rebound slightly YoY.",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "9cebe3a1f4b109a0",
      "text": "Electronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semiconductor materials ¥260.0bn (+18% YoY) and AF materials ¥160.0bn (+1.8%).",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "938304de5fd8fcfb",
      "text": "Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%).",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "01b7bc3ec37613c4",
      "text": "Imaging guidance for sales of ¥540.0bn (- 0.4%, +3.1% ex- forex) and OP ¥127.0bn (- ¥12.2bn YoY, - ¥4.2bn ex- forex, adjusted OP +¥1.3bn). 1Q sales were ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn, and adjusted profit +¥12.2bn).",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "f033a848c25c5d51",
      "text": "Exhibit 7-Mid-Term Plan (Bbn)",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "52898f7505597d51",
      "text": "3/213/2420-233/253/263/2723-26ActualMid PlanActualCAGRCoEActualNew segmentCoEActualMid PlanCAGRCoEActualNew segmentSales2,192.52,700.02,960.910.5%3,150.03,195.83,195.83,195.83,280.03,450.05.2%Healthcare580.0860.0975.118.9%1,000.01,022.61,047.81,100.01,200.07.2%Materials569.5720.0690.06.6%Business Innovation757.8820.0826.12.9%Imaging285.2300.0469.718.1%530.0542.0542.0540.0505.02.4%Electronics360.0430.0432.8407.6420.0470.09.3%Business Innovation (New)1,157.01,190.01,198.51,198.51,220.01,275.03.3%OP165.5260.0276.718.7%315.0330.2330.2331.0360.09.2%One time cost24.030.020.020.020.05.7Ex one time cost189.5270.0307.0335.0350.2350.2336.7Adjusted OPM8.6%10.0%10.4%10.6%11.0%11.0%10.3%Healthcare55.8103.097.420.4%80.077.679.983.0140.012.9%Materials51.795.042.9-6.0%Business Innovation73.382.070.8-1.2%Imaging15.625.0101.986.9%130.0139.2139.2127.0105.01.0%Electronics46.577.077.375.178.070.014.6%Business Innovation (New)73.068.074.674.679.090.07.2%Elimination-30.9-45.0-36.3-40.0-38.6-38.6-39.0-45.07.4%OPM7.5%9.6%9.3%10.0%10.3%10.3%10.1%10.4%Healthcare9.6%12.0%10.0%8.0%7.6%7.6%7.5%11.7%Materials9.1%13.2%6.2%Business Innovation9.7%10.0%8.6%Imaging5.5%8.3%21.7%24.5%25.7%25.7%23.5%20.8%Electronics12.9%17.9%17.9%18.4%18.6%14.9%Business Innovation (New)6.3%5.7%6.2%6.2%6.5%7.1%ROE8.7%8.4%8.4%7.8%7.8%7.8%7.8%8.1%ROIC4.3%6.1%6.1%5.4%5.4%5.4%5.4%4.8%Healthcare3.5%5.3%3.6%3.7%2.5%2.5%2.5%4.1%Materials8.1%12.9%Business Innovation8.8%10.6%Imaging6.1%12.1%40.8%39.3%54.8%54.8%46.8%37.2%Electronics7.0%8.2%11.4%12.3%11.2%9.3%Business Innovation (New)4.8%5.0%5.4%5.4%5.6%6.7%CCC (Days)1231031221199595104112",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "494c22ebc95776af",
      "text": "Source: Jefferies, company data",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "b48f2a3592ee9cbb",
      "text": "assurance costs, and other costs continued to exceed expectations until FY3/25. However, since the start FY3/25, costs have been progressing roughly in line with plan, and negotiations for facility expansion from fiscal 2026 onwards are progressing smoothly.",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "449cdc6ed02d8a4d",
      "text": "Looking at Fujifilm's earnings, bio- CDMO will have a major impact on future profits. Sales levels are expected to steadily expand as negotiations for facility expansion progress. While margins are an issue, we expect improvement ahead as sales from major facilities expand and steps are taken to offset higher depreciation expense. We see the potential for slight downside to the company's FY3/27 EBITDA margin of \\(25\\% +\\) and FY3/21 target of \\(40\\%\\) , but the probability of strong growth in absolute OP supported by higher sales appears high. If electronics and imaging remain strong, we expect EPS to sustain growth and for this to create valuation upside.",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "194f4c5da4a507b3",
      "text": "Fujifilm has a business portfolio consisting of four sector (healthcare, electronics, business innovation, and imaging) that are loosely interconnected. However, some in the capital markets believe that Fujifilm should concentrate its business portfolio on the sectors with solid growth profiles (i.e., healthcare and electronics), and that this would elevate the company's market valuation. However, for sustainable long- term growth as a company, there is also a valid perspective that having a diversified business portfolio at different stages can support sales stability and capacity for growth investment. In the case of Fujifilm, the imaging segment been able to achieve new value creation in a market that is inherently mature, thereby sustaining earnings growth. While there are structural concerns that the business innovation market may mature and even shrink, it currently accounts for one- fourth of OP and maintains a position as a cash cow. By solidifying the earnings bases of these two segments while investing resources in the growth healthcare and electronics fields, Fujifilm's fundamental policy can be viewed as straightforward strategy for the ongoing enhancement of corporate value.",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "0c9c97405eb28925",
      "text": "Fujifilm's stock is often tagged with a conglomerate discount, but we believe Fujifilm deserves renewed recognition of the fact that the group as a whole has maintained a stable ROE while allocating resources to growth investment and has achieved record highs in sales and OP.",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "e61f4eec52aecfcd",
      "text": "Exhibit 8-Medical Imaging Comparison",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "7db03ef5f83c9f4a",
      "text": "2025203020242023FujifilmHitachiKonica MinoltaShimadzuOthersbn JPYbn JPYCAGRGE HealthcareKoeninkijk e PhilipsSiemens HealthineersCanon MedicalMedical equipment segment sales ($mn/Euro mn/Y100mn)19,67219,49324,2405,6886,932864726OP ($mn/Y100mn)2,9031,3353,57724710402043OPM14.8%6.8%14.8%4.3%15%2.3%5.9%Market Cap (6/13/2025) ($mn)33,90426,23861,04128,40629,0301,7167,295X ray5707205%13%24%25%8%3%3%2%7%15%X ray Fluoroscopy1501804%20%8%35%15%2%8%12%X ray Imaging (including DR)2002404%20%12%15%5%13%4%8%7%16%X ray Angiography2203006%35%15%32%5%4%9%X ray CT5205802%29%13%27%20%6%MRI5606503%25%14%28%12%13%PET2102604%36%10%30%15%6%Ultrasound84010705%27%23%7%12%4%10%1%16%Endoscope7509304%15%85%",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "e19dafb5f9a16f14",
      "text": "Source: Jefferies estimates, company data, FactSet",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "93180303c82c7613",
      "text": "Exhibit 9-CDMO Peer Comparison",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "b24361a64efbf6fd",
      "text": "CDMO Sales mn USD/100mn PYOP PYOPM 27-Aug $mnMarket Cap PYEV/EBITDA PSRPSRPERLonza2024/12 Actual6,5741,08616.5%48,64619.47.4Samsung Biologics2024/12 Actual4,5471,32029.0%52,00228.511.4Celltrion2024/12 Actual2,62844917.1%26,88125.710.2Wuxi Biologics2024/12 Actual2,59563724.6%16,59916.26.4Average4,08687321.4%22.58.939.4Fujifilm3/25 Actual2,195-10-0.5%29,0309.91.2",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "2817bcc7bfce6094",
      "text": "Source: Jefferies, FactSet",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "6b49d5abf14ea7f6",
      "text": "Exhibit 10-Healthcare Sales and OP (Y100mn)",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "f1fbe563be3fd58c",
      "text": "3/20 Actual3/21 Actual3/22 Actual3/23 Actual3/24 Actual3/25 Actual3/26 CoE6/24 Actual9/24 Actual12/24 Actual3/25 Actual6/25 ActualSalesHealthcareMedical SystemCDMOCORECOVID/ConeAtaraLife ScienceOPHealthcareOPMMedical SystemOPMHitachi M&amp;amp;A expenseFHC RestructuringEx onetimeOPMCDMOOPMCOREOPMCOVID/ConeSubsidy from US governmentCompensation from NOVAVAXWrite-down of gene therapy drug raw materialsAtaraM&amp;amp;A expense for AtaraCDMO RestructuringTexas Commercial shiftDenmark operation suspensionLife ScienceRadio Pharma business sellAsset write down of pharma businessAbiganWrite-downs in the culture mediumLaw suits in the culture mediumWrite-downs in the T817Business sale expenseEx onetimeOPMOPMAsset saleSource: Jefferies estimates, company data",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "aa42367de53a6cf5",
      "text": "Source: Jefferies estimates, company data",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "89a3e6f266a4a6db",
      "text": "Exhibit 11-Fujifilm CDMO Business Targets",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "ceed6d120281a9ab",
      "text": "FY2022 Actual estFY2023 Actual estFY2024 CoEActual estFY2025 CoEFY2026 Co TargetFY2027 Co TargetFY2030 Co TargetSales¥bn194.2203.4200.0219.5260.0252.0335.0303.0Bio CDMO¥bn166.0197.4200.0219.5260.0252.0Vaccine¥bn28.06.00.00.00.00.0EBITDA Margin (ex one time cost)%15%15%low teenlow teenmid teen12%17%One time profit/cost¥bn4.01.0-18.0-18.0-10.0-10.0-5.0EBITDA Margin%17%15%low single digit2%7%&amp;gt;25%17%40%Capex (Jefferies estimates)¥bn150250350250200Depreciation (Jefferies estimates) change from FY2022¥bn+2+7+20+24OP¥bn198loss-19-16-1920OPM%10%3%-1%-1%-8%7%",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "6d008dd65a481546",
      "text": "Source: Jefferies estimates, company data",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "e1142da53372590f",
      "text": "Exhibit 12 - CDMO Capacity (kL)",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "322480c021417329",
      "text": "Source:Jefferies estimates,company data",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "7d882d04759d6246",
      "text": "Exhibit 13 - Fujifilm CDMO Capacity Roadmap",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "ead6622535b255fe",
      "text": "202020212022202320242025202620272028Capacity at the end of FY(litter)180,000337,000467,000Antibody120,000240,000400,000480,000560,000Microbiota39,00067,00067,000TexasAntibody8,000",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "f682482767cb4567",
      "text": "Exhibit 14 - CDMO Peer EBIT Margin",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "98ae18a1ef4665dc",
      "text": "Source:Jefferies,company data Note:Fujifilm margin excluding one-time cost",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "e60a2d473e3ee36d",
      "text": "Exhibit 15 - Fujifilm Electronics Estimates",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "dfa0b1b0f1d2a7d3",
      "text": "Full-yearQuarterly(Y bn)FY3/19FY3/20FY3/21FY3/22FY3/23FY3/24FY3/25FY3/26FY3/27FY3/28Q1FY3/25Q2FY3/25Q3FY3/25Q4FY3/25Q1FY3/26ActualActualActualActualActualActualActualCoEJEFJEFJEFActualActualActualActualElectronics358.4432.8420.0425.0446.0477.0109.1108.7108.4106.8YoYMaterials667.0624.6566.2627.2692.7690.0432.8YoY-2.0%-6.4%-9.3%10.8%10.4%-0.4%-37.3%Electronic materials99.0106.7119.5146.7180.6199.7250.4260.0259.0280.0310.062.363.061.963.264.7YoY growth (%)4.0%7.8%12.0%22.8%23.1%10.6%25.4%3.8%3.4%8.1%10.7%53.8%46.5%12.5%3.3%3.9%AF Materials158.7182.4160.0166.0166.0167.046.845.746.543.637.5YoY growth (%)Flat panel display materials98.285.594.994.770.178.3104.00.090.088.085.021.2%15.1%19.2%5.6%-19.9%YoY growth (%)4.0%-12.9%11.0%-0.2%-26.0%11.7%32.8%0.0%-13.5%-2.2%-3.4%26.726.527.023.826.6Other materials109.8102.383.896.4100.080.378.40.076.078.082.032.8%31.8%42.9%24.0%-0.4%YoY growth (%)Recording media39.041.926.329.930.025.0-2.4%0.0%-3.1%2.6%5.1%7.6%-2.0%-3.0%-10.4%-45.2%Electronics OPOPM0.0%0.0%0.0%0.0%13.0%13.0%77.378.078.085.090.020.119.519.518.222.5Materials OP66.163.351.368.467.742.917.9%18.6%18.4%19.1%18.9%18.4%17.9%18.0%17.0%22.0%OPM9.9%10.1%9.1%10.9%9.8%6.2%",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "f15fe419c9bf0276",
      "text": "Source:Jefferies estimates, company data",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "8568db6bed2568e8",
      "text": "Exhibit 16 - Fujifilm Business Innovation Estimates",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "6b5589cf69aa862f",
      "text": "Full-yearQuarterly(¥ bn)FY3/22FY3/23FY3/24FY3/25FY3/26FY3/27FY3/28FY3/25FY3/26FY3/27Q1FY3/25Q2FY3/25Q3FY3/25Q4FY3/25Q1FY3/26ActualActualActualActualNew segmentActualCoEJEFJEFJEFActualActualActualActualActualBusiness Innovation763.5838.1826.11,157.71,198.51,220.01,212.01,214.01,209.0280.0287.7294.4336.4273.6YoY0.8%9.8%-1.4%0.0%3.5%1.8%5.1%0.2%-0.4%44.2%38.8%47.3%49.7%-2.3%Office Solution507.5555.5524.3524.3522.9510.0519.0514.0499.0126.8121.8130.5143.8126.8Business Solution256.0282.6301.8301.8330.9370.0365.0375.0380.070.881.177.9101.175.8Graphic---331.6344.7340.0328.0325.0330.082.484.885.991.677.8Total sales853.2943.0926.1-------YoY growth (%)-0.2%10.5%-1.8%-------Office products370.5438.8430.0438.6437.0433.0418.0105.2101.1112.3120.0101.0YoY growth (%)-2.3%18.5%-2.0%2.0%3.6%-0.9%-3.5%2.0%-7.5%5.0%8.5%-4.0%Domestic218.6272.1230.0232.5225.0218.0205.056.855.658.461.657.1Overseas103.7127.3120.0109.7110.0115.0118.029.528.328.123.824.2Exportation48.283.480.096.590.085.080.017.917.225.835.619.7Office printers96.4109.094.379.282.081.081.021.620.718.218.718.5YoY growth (%)1.2%13.0%-13.5%-16.0%-1.2%-1.2%0.0%-4.8%-5.9%-14.7%-33.8%-14.0%Production services89.7104.9100.00.0104.0105.0105.0-----YoY growth (%)-7.4%17.0%2.0%0.0%2.0%1.0%0.0%70.881.177.9101.175.8Office services/Global service256.0282.6330.9370.0328.0340.0340.03.5%6.7%8.8%17.8%7.1%YoY growth (%)2.6%10.4%17.1%11.8%4.1%3.7%0.0%3.5%6.7%8.8%17.8%7.1%Others40.67.7-----14.410.817.531.915.6Business Innovation OP57.969.570.867.274.679.069.077.082.05.1%3.8%5.9%9.5%5.7%OPM7.6%8.3%8.6%5.8%6.2%6.5%5.7%6.3%6.8%5.1%3.8%5.9%9.5%5.7%",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "ce2ee4fad998e090",
      "text": "Source:Jefferies estimates, company data",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "597ad9179215325a",
      "text": "Exhibit 17 - MFP Comparison",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "2a4950b0823681ec",
      "text": "2019/Full2020/Full2021/Full2022/Full2023/Full2024/Full2025/Full2026/Full2027/Full2028/Full2029/Full2030/Full2031/Full2032/Full2033/Full2034/Full2035/Full2036/Full2037/Full2038/Full2039/Full2040/Full2041/Full2042/Full2043/Full2044/Full2045/Full2046/Full2047/Full2048/Full2049/Full2050/Full2051/Full2052/Full2053/Full2054/Full2055/Full2056/Full2057/Full2058/Full2059/Full2060/Full2061/Full2062/Full2063/Full2064/Full2065/Full2066/Full2067/Full2068/Full2069/Full2070/Full2071/Full2072/Full2073/Full2074/Full2075/Full2076/Full2077/Full2078/Full2079/Full2080/Full2081/Full2082/Full2083/Full2084/Full2085/Full2086/Full2087/Full2088/Full2089/Full2090/Full2091/Full2092/Full2093/Full2094/Full2095/Full2096/Full2097/Full2098/Full2099/Full2100/Full2101/Full2102/Full2103/Full2104/Full2105/Full2106/Full2107/Full2108/Full2109/Full2110/Full2111/Full2112/Full2113/Full2114/Full2115/Full2116/Full2117/Full2118/Full2119/Full2120/Full2121/Full2122/Full2123/Full2124/Full2125/Full2126/Full2127/Full2128/Full2129/Full2130/Full2131/Full2132/Full2133/Full2134/Full2135/Full2136/Full2137/Full2138/Full2139/Full2140/Full2141/Full2142/Full2143/Full2144/Full2145/Full2146/Full2147/Full2148/Full2149/Full2150/Full2151/Full2152/Full2153/Full2154/Full2155/Full2156/Full2157/Full2158/Full2159/Full2160/Full2161/Full2162/Full2163/Full2164/Full2165/Full2166/Full2167/Full2168/Full2169/Full2170/Full2171/Full2172/Full2173/Full2174/Full2175/Full2176/Full2177/Full2178/Full2179/Full2180/Full2181/Full2182/Full2183/Full2184/Full2185/Full2186/Full2187/Full2188/Full2189/Full2190/Full2191/Full2192/Full2193/Full2194/Full2195/Full2196/Full2197/Full2198/Full2199/Full2200/Full2201/Full2202/Full2203/Full2204/Full2205/Full2206/Full2207/Full2208/Full2209/Full2210/Full2211/Full2212/Full2213/Full2214/Full2215/Full2216/Full2217/Full2218/Full2219/Full2220/Full2221/Full2222/Full2223/Full2224/Full2225/Full2226/Full2227/Full2228/Full2229/Full2230/Full2231/Full2232/Full2233/Full2234/Full2235/Full2236/Full2237/Full2238/Full2239/Full2240/Full2241/Full2242/Full2243/Full2244/Full2245/Full2246/Full2247/Full2248/Full2249/Full2250/Full2251/Full2252/Full2253/Full2254/Full2255/Full2256/Full2257/Full2258/Full2259/Full2260/Full2261/Full2262/Full2263/Full2264/Full2265/Full2266/Full2267/Full2268/Full2269/Full2270/Full2271/Full2272/Full2273/Full2274/Full2275/Full2276/Full2277/Full2278/Full2279/Full2280/Full2281/Full2282/Full2283/Full2284/Full2285/Full2286/Full2287/Full2288/Full2289/Full2290/Full2291/Full2292/Full2293/Full2294/Full2295/Full2296/Full2297/Full2298/Full2299/Full2300/Full2301/Full2302/Full2303/Full2304/Full2305/Full2306/Full2307/Full2308/Full2309/Full2310/Full2311/Full2312/Full2313/Full2314/Full2315/Full2316/Full2317/Full2318/Full2319/Full2320/Full2321/Full2322/Full2323/Full2324/Full2325/Full2326/Full2327/Full2328/Full2329/Full2330/Full2331/Full2332/Full2333/Full2334/Full2335/Full2336/Full2337/Full2338/Full2339/Full2340/Full2341/Full2342/Full2343/Full2344/Full2345/Full2346/Full2347/Full2348/Full2349/Full2350/Full2351/Full2352/Full2353/Full2354/Full2355/Full2356/Full2357/Full2358/Full2359/Full2360/Full2361/Full2362/Full2363/Full2364/Full2365/Full2366/Full2367/Full2368/Full2369/Full2370/Full2371/Full2372/Full2373/Full2374/Full2375/Full2376/Full2377/Full2378/Full2379/Full2380/Full2381/Full2382/Full2383/Full2384/Full2385/Full2386/Full2387/Full2388/Full2389/Full2390/Full2391/Full2392/Full2393/Full2394/Full2395/Full2396/Full2397/Full2398/Full2399/Full2400/Full2401/Full2402/Full2403/Full2404/Full2405/Full2406/Full2407/Full2408/Full2409/Full2410/Full2411/Full2412/Full2413/Full2414/Full2415/Full2416/Full2417/Full2418/Full2419/Full2420/Full2421/Full2422/Full2423/Full2424/Full2425/Full2426/Full2427/Full2428/Full2429/Full2430/Full2431/Full2432/Full2433/Full2434/Full2435/Full2436/Full2437/Full2438/Full2439/Full2440/Full2441/Full2442/Full2443/Full2444/Full2445/Full2446/Full2447/Full2448/Full2449/Full2450/Full2451/Full2452/Full2453/Full2454/Full2455/Full2456/Full2457/Full2458/Full2459/Full2460/Full2461/Full2462/Full2463/Full2464/Full2465/Full2466/Full2467/Full2468/Full2469/Full2470/Full2471/Full2472/Full2473/Full2474/Full2475/Full2476/Full2477/Full2478/Full2479/Full2480/Full2481/Full2482/Full2483/Full2484/Full2485/Full2486/Full2487/Full2488/Full2489/Full2490/Full2491/Full2492/Full2493/Full2494/Full2495/Full2496/Full2497/Full2498/Full2499/Full2500/Full2501/Full2502/Full2503/Full2504/Full2505/Full2506/Full2507/Full2508/Full2509/Full2510/Full2511/Full2512/Full2513/Full2514/Full2515/Full2516/Full2517/Full2518/Full2519/Full2520/Full2521/Full2522/Full2523/Full2524/Full2525/Full2526/Full2527/Full2528/Full2529/Full2530/Full2531/Full2532/Full2533/Full2534/Full2535/Full2536/Full2537/Full2538/Full2539/Full2540/Full2541/Full2542/Full2543/Full2544/Full2545/Full2546/Full2547/Full2548/Full2549/Full2550/Full2551/Full2552/Full2553/Full2554/Full2555/Full2556/Full2557/Full2558/Full2559/Full2560/Full2561/Full2562/Full2563/Full2564/Full2565/Full2566/Full2567/Full2568/Full2569/Full2570/Full2571/Full2572/Full2573/Full2574/Full2575/Full2576/Full2577/Full2578/Full2579/Full2580/Full2581/Full2582/Full2583/Full2584/Full2585/Full2586/Full2587/Full2588/Full2589/Full2590/Full2591/Full2592/Full2593/Full2594/Full2595/Full2596/Full2597/Full2598/Full2599/Full2600/Full2601/Full2602/Full2603/Full2604/Full2605/Full2606/Full2607/Full2608/Full2609/Full2610/Full2611/Full2612/Full2613/Full2614/Full2615/Full2616/Full2617/Full2618/Full2619/Full2620/Full2621/Full2622/Full2623/Full2624/Full2625/Full2626/Full2627/Full2628/Full2629/Full2630/Full2631/Full2632/Full2633/Full2634/Full2635/Full2636/Full2637/Full2638/Full2639/Full2640/Full2641/Full2642/Full2643/Full2644/Full2645/Full2646/Full2647/Full2648/Full2649/Full2650/Full2651/Full2652/Full2653/Full2654/Full2655/Full2656/Full2657/Full2658/Full2659/Full2660/Full2661/Full2662/Full2663/Full2664/Full2665/Full2666/Full2667/Full2668/Full2669/Full2670/Full2671/Full2672/Full2673/Full2674/Full2675/Full2676/Full2677/Full2678/Full2679/Full2680/Full2681/Full2682/Full2683/Full2684/Full2685/Full2686/Full2687/Full2688/Full2689/Full2690/Full2691/Full2692/Full2693/Full2694/Full2695/Full2696/Full2697/Full2698/Full2699/Full2700/Full2701/Full2702/Full2703/Full2704/Full2705/Full2706/Full2707/Full2708/Full2709/Full2710/Full2711/Full2712/Full2713/Full2714/Full2715/Full2716/Full2717/Full2718/Full2719/Full2720/Full2721/Full2722/Full2723/Full2724/Full2725/Full2726/Full2727/Full2728/Full2729/Full2730/Full2731/Full2732/Full2733/Full2734/Full2735/Full2736/Full2737/Full2738/Full2739/Full2740/Full2741/Full2742/Full2743/Full2744/Full2745/Full2746/Full2747/Full2748/Full2749/Full2750/Full2751/Full2752/Full2753/Full2754/Full2755/Full2756/Full2757/Full2758/Full2759/Full2760/Full2761/Full2762/Full2763/Full2764/Full2765/Full2766/Full2767/Full2768/Full2769/Full2770/Full2771/Full2772/Full2773/Full2774/Full2775/Full2776/Full2777/Full2778/Full2779/Full2780/Full2781/Full2782/Full2783/Full2784/Full2785/Full2786/Full2787/Full2788/Full2789/Full2790/Full2791/Full2792/Full2793/Full2794/Full2795/Full2796/Full2797/Full2798/Full2799/Full2800/Full2801/Full2802/Full2803/Full2804/Full2805/Full2806/Full2807/Full2808/Full2809/Full2810/Full2811/Full2812/Full2813/Full2814/Full2815/Full2816/Full2817/Full2818/Full2819/Full2820/Full2821/Full2822/Full2823/Full2824/Full2825/Full2826/Full2827/Full2828/Full2829/Full2830/Full2831/Full2832/Full2833/Full2834/Full2835/Full2836/Full2837/Full2838/Full2839/Full2840/Full2841/Full2842/Full2843/Full2844/Full2845/Full2846/Full2847/Full2848/Full2849/Full2850/Full2851/Full2852/Full2853/Full2854/Full2855/Full2856/Full2857/Full2858/Full2859/Full2860/Full2861/Full2862/Full2863/Full2864/Full2865/Full2866/Full2867/Full2868/Full2869/Full2870/Full2871/Full2872/Full2873/Full2874/Full2875/Full2876/Full2877/Full2878/Full2879/Full2880/Full2881/Full2882/Full2883/Full2884/Full2885/Full2886/Full2887/Full2888/Full2889/Full2890/Full2891/Full2892/Full2893/Full2894/Full2895/Full2896/Full2897/Full2898/Full2899/Full2900/Full2901/Full2902/Full2903/Full",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "7b2ea1f4acea785d",
      "text": "Exhibit 19 - OA Paper Shipments (2019 average=100)",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "d96697014f9a892f",
      "text": "Source:Jefferies,AP&MA,EAGPP,METI",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "bdf9f03375464bc5",
      "text": "Exhibit 20 - Xerox Sales and Adjusted OP (S'mn)",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "426dbcf307a3d4db",
      "text": "Source:Jefferies,company data",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "08bca5f9fca59977",
      "text": "Exhibit 21 - Xerox Equipment and Post Sales",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "daf1b1ccfa9a79bb",
      "text": "Source:Jefferies,company data",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "7810cd2a829e8672",
      "text": "Exhibit 22 - Production Sales (Ybn)",
      "page": 23,
      "section": null
    },
    {
      "passage_id": "89f7b5e693c2323a",
      "text": "Source:Jefferies,company data",
      "page": 23,
      "section": null
    },
    {
      "passage_id": "f2e3919e2c642161",
      "text": "Exhibit 23 - Fujifilm Imaging Estimates",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "ace40ea9d9f27e41",
      "text": "Full-yearQuarterly(¥ bn)FY3/17FY3/18FY3/19FY3/20FY3/21FY3/22FY3/23FY3/24FY3/25FY3/26FY3/27FY3/28Q1FY3/25Q2FY3/25Q3FY3/25Q4FY3/25Q1FY3/26Total sales341.8383.0386.9332.6285.2333.4410.3469.7542.0540.0546.4544.9534.6130.7126.7169.5115.1145.3YoY growth (%)-3.1%12.1%1.0%-14.0%-14.3%16.9%23.1%14.5%15.4%-0.4%0.8%-0.3%-1.9%24.2%11.2%13.5%13.8%11.2%Photo imaging/Consumer Imaging236.8255.4257.5228.9195.8219.0266.9297.6328.0320.0323.4320.4308.874.677.6110.665.277.3YoY growth (%)-5.1%7.9%0.8%-11.1%-14.5%11.8%21.9%11.5%10.2%2.3%-0.9%-3.6%18.0%7.3%7.9%9.4%3.6%Color paper66.363.961.850.432.239.448.047.645.944.042.040.0Labo.47.446.048.945.841.736.040.040.040.038.036.035.0Others52.153.548.950.440.440.750.852.352.550.652.048.0Professional Imaging89.4114.4143.4172.1214.0220.0223.0224.5225.851.649.158.954.468.0Electronic imaging69.888.890.672.068.178.9105.0132.5173.3184.0184.5184.847.139.649.537.159.2YoY growth (%)9.1%27.2%2.0%-20.5%-5.4%15.9%33.1%26.2%30.8%6.2%0.3%0.2%45.6%23.4%32.0%21.4%25.7%Digital camera sales (mn units)0.990.981.030.810.570.480.440.440.450.460.450.44YoY growth (%)-21.4%-1.0%5.1%-21.4%-29.6%-15.8%-8.3%0.0%2.3%7.0%-2.2%-2.2%ASP (JPY&#x27;000)70.590.688.088.9119.5164.4238.6301.1385.1400.0410.0420.0Optical device35.238.838.831.721.335.539.439.640.739.040.041.04.59.59.417.38.8Operating Profit36.856.051.135.035.035.072.9101.9139.2127.0148.0144.0140.032.533.748.824.241.8Operating margin10.8%14.6%13.2%7.5%5.5%11.1%17.8%21.7%25.7%23.5%27.1%26.4%26.2%24.9%26.6%28.8%21.0%28.7%",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "801df7b934595605",
      "text": "Source: Jefferies estimates, company data",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "bbd2dcd2cec53595",
      "text": "Source: Jefferies estimates, company data",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "9bdcb53f9a8f2b3a",
      "text": "Exhibit 25-Fujifilm Profit and Loss Statement",
      "page": 25,
      "section": null
    },
    {
      "passage_id": "73158894e688c3c3",
      "text": "Full yearFY19ActualFY20ActualFY21ActualFY22ActualFY23ActualFY24ActualFY25ActualFY26ActualFY27ActualFY28ActualFY29ActualFY30ActualFY31ActualFY32ActualFY33ActualFY34ActualFY35ActualFY36ActualFY37ActualFY38ActualFY39ActualFY40ActualFY41ActualFY42ActualFY43ActualFY44ActualFY45ActualFY46ActualFY47ActualFY48ActualFY49ActualFY50ActualFY51ActualFY52ActualFY53ActualFY54ActualFY55ActualFY56ActualFY57ActualFY58ActualFY59ActualFY60ActualFY61ActualFY62ActualFY63ActualFY64ActualFY65ActualFY66ActualFY67ActualFY68ActualFY69ActualFY70ActualFY71ActualFY72ActualFY73ActualFY74ActualFY75ActualFY76ActualFY77ActualFY78ActualFY79ActualFY80ActualFY81ActualFY82ActualFY83ActualFY84ActualFY85ActualFY86ActualFY87ActualFY88ActualFY89ActualFY90ActualFY91ActualFY92ActualFY93ActualFY94ActualFY95ActualFY96ActualFY97ActualFY98ActualFY99ActualFY100ActualFY101ActualFY102ActualFY103ActualFY104ActualFY105ActualFY106ActualFY107ActualFY108ActualFY109ActualFY110ActualFY111ActualFY112ActualFY113ActualFY114ActualFY115ActualFY116ActualFY117ActualFY118ActualFY119ActualFY120ActualFY121ActualFY122ActualFY123ActualFY124ActualFY125ActualFY126ActualFY127ActualFY128ActualFY129ActualFY130ActualFY131ActualFY132ActualFY133ActualFY134ActualFY135ActualFY136ActualFY137ActualFY138ActualFY139ActualFY140ActualFY141ActualFY142ActualFY143ActualFY144ActualFY145ActualFY146ActualFY147ActualFY148ActualFY149ActualFY150ActualFY151ActualFY152ActualFY153ActualFY154ActualFY155ActualFY156ActualFY157ActualFY158ActualFY159ActualFY160ActualFY161ActualFY162ActualFY163ActualFY164ActualFY165ActualFY166ActualFY167ActualFY168ActualFY169ActualFY170ActualFY171ActualFY172ActualFY173ActualFY174ActualFY175ActualFY176ActualFY177ActualFY178ActualFY179ActualFY180ActualFY181ActualFY182ActualFY183ActualFY184ActualFY185ActualFY186ActualFY187ActualFY188ActualFY189ActualFY190ActualFY191ActualFY192ActualFY193ActualFY194ActualFY195ActualFY196ActualFY197ActualFY198ActualFY199ActualFY200ActualFY201ActualFY202ActualFY203ActualFY204ActualFY205ActualFY206ActualFY207ActualFY208ActualFY209ActualFY210ActualFY211ActualFY212ActualFY213ActualFY214ActualFY215ActualFY216ActualFY217ActualFY218ActualFY219ActualFY220ActualFY221ActualFY222ActualFY223ActualFY224ActualFY225ActualFY226ActualFY227ActualFY228ActualFY229ActualFY230ActualFY231ActualFY232ActualFY233ActualFY234ActualFY235ActualFY236ActualFY237ActualFY238ActualFY239ActualFY240ActualFY241ActualFY242ActualFY243ActualFY244ActualFY245ActualFY246ActualFY247ActualFY248ActualFY249ActualFY250ActualFY251ActualFY252ActualFY253ActualFY254ActualFY255ActualFY256ActualFY257ActualFY258ActualFY259ActualFY260ActualFY261ActualFY262ActualFY263ActualFY264ActualFY265ActualFY266ActualFY267ActualFY268ActualFY269ActualFY270ActualFY271ActualFY272ActualFY273ActualFY274ActualFY275ActualFY276ActualFY277ActualFY278ActualFY279ActualFY280ActualFY281ActualFY282ActualFY283ActualFY284ActualFY285ActualFY286ActualFY287ActualFY288ActualFY289ActualFY290ActualFY291ActualFY292ActualFY293ActualFY294ActualFY295ActualFY296ActualFY297ActualFY298ActualFY299ActualFY300ActualFY301ActualFY302ActualFY303ActualFY304ActualFY305ActualFY306ActualFY307ActualFY308ActualFY309ActualFY310ActualFY311ActualFY312ActualFY313ActualFY314ActualFY315ActualFY316ActualFY317ActualFY318ActualFY319ActualFY320ActualFY321ActualFY322ActualFY323ActualFY324ActualFY325ActualFY326ActualFY327ActualFY328ActualFY329ActualFY330ActualFY331ActualFY332ActualFY333ActualFY334ActualFY335ActualFY336ActualFY337ActualFY338ActualFY339ActualFY340ActualFY341ActualFY342ActualFY343ActualFY344ActualFY345ActualFY346ActualFY347ActualFY348ActualFY349ActualFY350ActualFY351ActualFY352ActualFY353ActualFY354ActualFY355ActualFY356ActualFY357ActualFY358ActualFY359ActualFY360ActualFY361ActualFY362ActualFY363ActualFY364ActualFY365ActualFY366ActualFY367ActualFY368ActualFY369ActualFY370ActualFY371ActualFY372ActualFY373ActualFY374ActualFY375ActualFY376ActualFY377ActualFY378ActualFY379ActualFY380ActualFY381ActualFY382ActualFY383ActualFY384ActualFY385ActualFY386ActualFY387ActualFY388ActualFY389ActualFY390ActualFY391ActualFY392ActualFY393ActualFY394ActualFY395ActualFY396ActualFY397ActualFY398ActualFY399ActualFY400ActualFY401ActualFY402ActualFY403ActualFY404ActualFY405ActualFY406ActualFY407ActualFY408ActualFY409ActualFY410ActualFY411ActualFY412ActualFY413ActualFY414ActualFY415ActualFY416ActualFY417ActualFY418ActualFY419ActualFY420ActualFY421ActualFY422ActualFY423ActualFY424ActualFY425ActualFY426ActualFY427ActualFY428ActualFY429ActualFY430ActualFY431ActualFY432ActualFY433ActualFY434ActualFY435ActualFY436ActualFY437ActualFY438ActualFY439ActualFY440ActualFY441ActualFY442ActualFY443ActualFY444ActualFY445ActualFY446ActualFY447ActualFY448ActualFY449ActualFY450ActualFY451ActualFY452ActualFY453ActualFY454ActualFY455ActualFY456ActualFY457ActualFY458ActualFY459ActualFY460ActualFY461ActualFY462ActualFY463ActualFY464ActualFY465ActualFY466ActualFY467ActualFY468ActualFY469ActualFY470ActualFY471ActualFY472ActualFY473ActualFY474ActualFY475ActualFY476ActualFY477ActualFY478ActualFY479ActualFY480ActualFY481ActualFY482ActualFY483ActualFY484ActualFY485ActualFY486ActualFY487ActualFY488ActualFY489ActualFY490ActualFY491ActualFY492ActualFY493ActualFY494ActualFY495ActualFY496ActualFY497ActualFY498ActualFY499ActualFY500ActualFY501ActualFY502ActualFY503ActualFY504ActualFY505ActualFY506ActualFY507ActualFY508ActualFY509ActualFY510ActualFY511ActualFY512ActualFY513ActualFY514ActualFY515ActualFY516ActualFY517ActualFY518ActualFY519ActualFY520ActualFY521ActualFY522ActualFY523ActualFY524ActualFY525ActualFY526ActualFY527ActualFY528ActualFY529ActualFY530ActualFY531ActualFY532ActualFY533ActualFY534ActualFY535ActualFY536ActualFY537ActualFY538ActualFY539ActualFY540ActualFY541ActualFY542ActualFY543ActualFY544ActualFY545ActualFY546ActualFY547ActualFY548ActualFY549ActualFY550ActualFY551ActualFY552ActualFY553ActualFY554ActualFY555ActualFY556ActualFY557ActualFY558ActualFY559ActualFY560ActualFY561ActualFY562ActualFY563ActualFY564ActualFY565ActualFY566ActualFY567ActualFY568ActualFY569ActualFY570ActualFY571ActualFY572ActualFY573ActualFY574ActualFY575ActualFY576ActualFY577ActualFY578ActualFY579ActualFY580ActualFY581ActualFY582ActualFY583ActualFY584ActualFY585ActualFY586ActualFY587ActualFY588ActualFY589ActualFY590ActualFY591ActualFY592ActualFY593ActualFY594ActualFY595ActualFY596ActualFY597ActualFY598ActualFY599ActualFY600ActualFY601ActualFY602ActualFY603ActualFY604ActualFY605ActualFY606ActualFY607ActualFY608ActualFY609ActualFY610ActualFY611ActualFY612ActualFY613ActualFY614ActualFY615ActualFY616ActualFY617ActualFY618ActualFY619ActualFY620ActualFY621ActualFY622ActualFY623ActualFY624ActualFY625ActualFY626ActualFY627ActualFY628ActualFY629ActualFY630ActualFY631ActualFY632ActualFY633ActualFY634ActualFY635ActualFY636ActualFY637ActualFY638ActualFY639ActualFY640ActualFY641ActualFY642ActualFY643ActualFY644ActualFY645ActualFY646ActualFY647ActualFY648ActualFY649ActualFY650ActualFY651ActualFY652ActualFY653ActualFY654ActualFY655ActualFY656ActualFY657ActualFY658ActualFY659ActualFY660ActualFY661ActualFY662ActualFY663ActualFY664ActualFY665ActualFY666ActualFY667ActualFY668ActualFY669ActualFY670ActualFY671ActualFY672ActualFY673ActualFY674ActualFY675ActualFY676ActualFY677ActualFY678ActualFY679ActualFY680ActualFY681ActualFY682ActualFY683ActualFY684ActualFY685ActualFY686ActualFY687ActualFY688ActualFY689ActualFY690ActualFY691ActualFY692ActualFY693ActualFY694ActualFY695ActualFY696ActualFY697ActualFY698ActualFY699ActualFY700ActualFY701ActualFY702ActualFY703ActualFY704ActualFY705ActualFY706ActualFY707ActualFY708ActualFY709ActualFY710ActualFY711ActualFY712ActualFY713ActualFY714ActualFY715ActualFY716ActualFY717ActualFY718ActualFY719ActualFY720ActualFY721ActualFY722ActualFY723ActualFY724ActualFY725ActualFY726ActualFY727ActualFY728ActualFY729ActualFY730ActualFY731ActualFY732ActualFY733ActualFY734ActualFY735ActualFY736ActualFY737ActualFY738ActualFY739ActualFY740ActualFY741ActualFY742ActualFY743ActualFY744ActualFY745ActualFY746ActualFY747ActualFY748ActualFY749ActualFY750ActualFY751ActualFY752ActualFY753ActualFY754ActualFY755ActualFY756ActualFY757ActualFY758ActualFY759ActualFY760ActualFY761ActualFY762ActualFY763ActualFY764ActualFY765ActualFY766ActualFY767ActualFY768ActualFY769ActualFY770ActualFY771ActualFY772ActualFY773ActualFY774ActualFY775ActualFY776ActualFY777ActualFY778ActualFY779ActualFY780ActualFY781ActualFY782ActualFY783ActualFY784ActualFY785ActualFY786ActualFY787ActualFY788ActualFY789ActualFY790ActualFY791ActualFY792ActualFY793ActualFY794ActualFY795ActualFY796ActualFY797ActualFY798ActualFY799ActualFY800ActualFY801ActualFY802ActualFY803ActualFY804ActualFY805ActualFY806ActualFY807ActualFY808ActualFY809ActualFY810ActualFY811ActualFY812ActualFY813ActualFY814ActualFY815ActualFY816ActualFY817ActualFY818ActualFY819ActualFY820ActualFY821ActualFY822ActualFY823ActualFY824ActualFY825ActualFY826ActualFY827ActualFY828ActualFY829ActualFY830ActualFY831ActualFY832ActualFY833ActualFY834ActualFY835ActualFY836ActualFY837ActualFY838ActualFY839ActualFY840ActualFY841ActualFY842ActualFY843ActualFY844ActualFY845ActualFY846ActualFY847ActualFY848ActualFY849ActualFY850ActualFY851ActualFY852ActualFY853ActualFY854ActualFY855ActualFY856ActualFY857ActualFY858ActualFY859ActualFY860ActualFY861ActualFY862ActualFY863ActualFY864ActualFY865ActualFY866ActualFY867ActualFY868ActualFY869ActualFY870ActualFY871ActualFY872ActualFY873ActualFY874ActualFY875ActualFY876ActualFY877ActualFY878ActualFY879ActualFY880ActualFY881ActualFY882ActualFY883ActualFY884ActualFY885ActualFY886ActualFY887ActualFY888ActualFY889ActualFY890ActualFY891ActualFY892ActualFY893ActualFY894ActualFY895ActualFY896ActualFY897ActualFY898ActualFY899ActualFY900ActualFY901ActualFY902ActualFY903ActualFY904ActualFY905ActualFY906ActualFY907ActualFY908ActualFY909ActualFY910ActualFY911ActualFY912ActualFY913ActualFY914ActualFY915ActualFY916ActualFY917ActualFY918ActualFY919ActualFY920ActualFY921ActualFY922ActualFY923ActualFY924ActualFY925ActualFY926ActualFY927ActualFY928ActualFY929ActualFY930ActualFY931ActualFY932ActualFY933ActualFY934ActualFY935ActualFY936ActualFY937ActualFY938ActualFY939ActualFY940ActualFY941ActualFY942ActualFY943ActualFY944ActualFY945ActualFY946ActualFY947ActualFY948ActualFY949ActualFY950ActualFY951ActualFY952ActualFY953ActualFY954ActualFY955ActualFY956ActualFY957ActualFY958ActualFY959ActualFY960ActualFY961ActualFY962ActualFY963ActualFY964ActualFY965ActualFY966ActualFY967ActualFY968ActualFY969ActualFY970ActualFY971ActualFY972ActualFY973ActualFY974ActualFY975ActualFY976ActualFY977ActualFY978ActualFY979ActualFY980ActualFY981ActualFY982ActualFY983ActualFY984ActualFY985ActualFY986ActualFY987ActualFY988ActualFY989ActualFY990ActualFY991ActualFY992ActualFY993ActualFY994ActualFY995ActualFY996ActualFY997ActualFY998ActualFY999ActualFY1000ActualFY1001ActualFY1002ActualFY1003ActualFY1004ActualFY1005ActualFY1006ActualFY1007ActualFY1008ActualFY1009ActualFY1010ActualFY1011ActualFY1012ActualFY1013ActualFY1014ActualFY1015ActualFY1016ActualFY1017ActualFY1018ActualFY1019ActualFY1020ActualFY1021ActualFY1022ActualFY1023ActualFY1024ActualFY1025ActualFY1026ActualFY1027ActualFY1028ActualFY1029ActualFY1030ActualFY1031ActualFY1032ActualFY1033ActualFY1034ActualFY1035ActualFY1036ActualFY1037ActualFY1038ActualFY1039ActualFY1040ActualFY1041ActualFY1042ActualFY1043Actual",
      "page": 25,
      "section": null
    },
    {
      "passage_id": "0fc6c8f46110f65c",
      "text": "FUJIFILM HoldingsFUJIFILM Holdings Corporation develops, sells, and services Imaging, Information, and Document Solutions. Its products include color films, digital cameras, and photofinishing products and equipment. The Group also manufactures medical and graphic arts use equipment and materials, FPD materials, and optical devices, and it provides services on office copy machines, printers, and related equipment.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "1e26c651e196d651",
      "text": "Price target of 4,300 based on FY3/26 EV/EBITDA multiple of 12x. The 12x multiple is based on SOTP for CDMO (15x, FactSet average 22x and add discount considering profitability), medical systems and healthcare (14x), semiconductor material (13x) and other business (5x, the historical average of the past five years). Risks include market decline due to COVID impact on the document business and earnings deterioration, contraction of OEM business due to change in relationship with Fuji Xerox, and faster market contraction for the imaging business.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "842227366eb7d7ef",
      "text": "(Article 3(1)e and Article 7 of MAR) Recommendation Published Recommendation Distributed",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "5fff636da5e75234",
      "text": "August 28, 2025 23:31 P.M. August 29, 2025 2:30 A.M.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "f3c35068c6d72b75",
      "text": "Buy - Describes securities that we expect to provide a total return (price appreciation plus yield) of \\(15\\%\\) or more within a 12- month period. Hold - Describes securities that we expect to provide a total return (price appreciation plus yield) of plus \\(15\\%\\) or minus \\(10\\%\\) within a 12- month period. Underperform - Describes securities that we expect to provide a total return (price appreciation plus yield) of minus \\(10\\%\\) or less within a 12- month period. The expected total return (price appreciation plus yield) for Buy rated securities with an average security price consistently below \\(10\\) or more within a 12- month period as these companies are typically more volatile than the overall stock market. For Hold rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is plus or minus \\(20\\%\\) within a 12- month period. For Underperform rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is minus \\(20\\%\\) or less within a 12- month period.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "c052d73794fc539e",
      "text": "NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies policies.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "9c897b10547f293f",
      "text": "CS - Coverage Suspended. Jefferies has suspended coverage of this company.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "b86074c0f20744c5",
      "text": "NC - Not covered. Jefferies does not cover this company.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "241fa0e818794e28",
      "text": "Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "dfbac524b913ad9a",
      "text": "Monitor - Describes securities whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided.",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "237cf6f128ce7320",
      "text": "Jefferies' methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months.",
      "page": 27,
      "section": null
    },
    {
      "passage_id": "2de741c5b12fb1c9",
      "text": "Jefferies Franchise PicksJefferies Franchise Picks include stock selections from among the best stock ideas from our equity analysts over a 12 month period. Stock selection is based on fundamental analysis and may take into account other factors such as analyst conviction, differentiated analysis, a favorable risk/reward ratio and investment themes that Jefferies analysts are recommending. Jefferies Franchise Picks will include only Buy rated stocks and the number can vary depending on analyst recommendations for inclusion. Stocks will be added as new opportunities arise and removed when the reason for inclusion changes, the stock has met its desired return, if it is no longer rated Buy and/or if it triggers a stop loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not sector based, but we may note where we believe a Pick falls within an investment style such as growth or value.",
      "page": 27,
      "section": null
    },
    {
      "passage_id": "79ddae0d05af4d5b",
      "text": "Distribution of Ratings",
      "page": 28,
      "section": null
    },
    {
      "passage_id": "a4384eb0711bf659",
      "text": "CountPercentCountPercentCountPercentBUY211160.63%37017.53%1185.59%HOLD121334.84%1058.66%221.81%UNDERPERFORM1584.54%31.90%31.90%",
      "page": 28,
      "section": null
    },
    {
      "passage_id": "3bbf2ed2d9431ec2",
      "text": "Jefries does busines and seeks to do busines with companies covered in its research reports, and expects to receive or intends to seek compensation for investment banking services among other activities from such companies. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Financial Group Inc. (Jefferies) companies:",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "dce9306725b61076",
      "text": "United States: Jefferies LLC which is an SEC registered broker- dealer and a member of FINRA (and distributed by Jefferies Research Services, LLC, an SEC registered Investment Adviser, to clients paying separately for such research).",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "49dd75c2ffff8a54",
      "text": "Canada: Jefferies Securities Inc., which is an investment dealer registered in each of the thirteen Canadian jurisdictions and a dealer member of the Canadian Investment Regulatory Organization, including research reports produced jointly by Jefferies Securities Inc. and another Jefferies entity (and distributed by Jefferies Securities Inc.).",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "88b5896b14c5a16c",
      "text": "Where Jefferies Securities Inc. distributes research reports produced by Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch or Jefferies India Private Limited, you are advised that each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited operates as a dealer in your jurisdiction under an exemption from the dealer registration requirements contained in National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations and, as such, each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited is not required to be and is not a registered dealer or adviser in your jurisdiction. You are advised that where Jefferies LLC or Jefferies International Limited prepared this research report, it was not prepared in accordance with Canadian disclosure requirements relating to research reports in Canada.",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "df8d92ea4f434cf3",
      "text": "United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Conduct Authority, registered in England and Wales No. 1978621; registered office: 100 Bishopsgate, London EC2N 4JL; telephone +44 (0)20 7029 8000; facsimile +44 (0)20 7029 8010.",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "b7f79ec52d3ca23a",
      "text": "Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a member of the Japan Securities Dealers Association; located at Tokyo Midtown Hibiya 30F Hibiya Mitsui Tower, 1- 1- 2 Yurakucho, Chiyoda- ku, Tokyo 100- 0006; telephone +813 5251 6100; facsimile +813 5251 6101.",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "45de119bae632a4c",
      "text": "Australia: Jefferies (Australia) Pty Limited (ACN 623 059 898), which holds an Australian financial services license (AFSL 504712) and is located at Level 20, 60 Martin Place, Sydney NSW 2000; telephone +61 2 9364 2800.",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "dd4837f81e6102fd",
      "text": "Dubai: Jefferies International Limited, Dubai branch, which is licensed by the Dubai Financial Services Authority (DFSA Reference Number F007325); registered office Unit L31- 06, L31- 07, Level 31, ICD Brookfield Pace, DIFC, PO Box 121208, Dubai, UAE.",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "cdb18cbcc567b44d",
      "text": "This report was prepared by personnel who are associated with Jefferies (Jefferies Securities Inc., Jefferies International Limited, Jefferies GmbH, Jefferies Hong Kong Limited, Jefferies Singapore Limited, Jefferies (Japan) Limited, Tokyo Branch, Jefferies India Private Limited), and Jefferies (Australia) Pty Ltd; or by personnel who are associated with both Jefferies LLC and Jefferies Research Services LLC (\"JRS\"). Jefferies LLC is a US registered broker- dealer and is affiliated with JRS, which is a US registered investment adviser. JRS does not create tailored or personalized research and all research provided by JRS is impersonal. If you are paying separately for this research, it is being provided to you by JRS. Otherwise, it is being provided by Jefferies LLC. Jefferies LLC, JRS, and their affiliates are collectively referred to below as \"Jefferies\". Jefferies may seek to do business with companies covered in this research report. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only one of many factors in making their investment decisions. Specific conflict of interest and other disclosures that are required by FINRA, the Canadian Investment Regulatory Organization and other rules are set forth in this disclosure section.",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "b115db010cdffd91",
      "text": "If you are receiving this report from a non- US Jefferies entity, please note the following: Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, as amended, this material is distributed in the United States by Jefferies LLC, which accepts responsibility for its contents in accordance with the provisions of Rule 15a- 6 under the US Securities Exchange Act of 1934, as amended. Transactions by or on behalf of any US person may only be effected through Jefferies LLC. In the United Kingdom and European Economic Area this report is issued and/or approved for distribution by Jefferies International Limited (\"JIL\") and/or Jefferies GmbH and is intended for use only by persons who have, or have been assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. Jefferies LLC, JIL, Jefferies GmbH and their affiliates, may make a market or provide liquidity in the financial instruments referred to in this report; and where they do make a market, such activity is disclosed specifically in this report under \"company specific disclosures\".",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "6555c4f0da29144c",
      "text": "For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available to other persons or to anyone in Canada who is not a \"permitted client\" as defined by National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations, as applicable. This research report is a general discussion of the merits and",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "3971a54388d5535c",
      "text": "first considering whether any advice or recommendation in this report is suitable for the recipient based on the recipient's particular circumstances and, if appropriate or otherwise needed, seeking professional advice, including tax advice. Jefferies does not perform any suitability or other analysis to check whether an investment decision made by the recipient based on this report is consistent with a recipient's investment objectives, portfolio holdings, strategy, financial situation, or needs.",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "eb46b16916a2d658",
      "text": "By providing this report, neither JRS nor any other Jefferies entity accepts any authority, discretion, or control over the management of the recipient's assets. Any action taken by the recipient of this report, based on the information in the report, is at the recipient's sole judgment and risk. The recipient must perform his or her own independent review of any prospective investment. If the recipient uses the services of Jefferies LLC (or other affiliated broker- dealers), in connection with a purchase or sale of a security that is a subject of these materials, such broker- dealer may act as principal for its own accounts or as agent for another person. Only JRS is registered with the SEC as an investment adviser; and therefore neither Jefferies LLC nor any other Jefferies affiliate has any fiduciary duty in connection with distribution of these reports.",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "9976d15658629fb4",
      "text": "The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "55e0d2413378d9fa",
      "text": "This report may contain forward looking statements that may be affected by inaccurate assumptions or by known or unknown risks, uncertainties, and other important factors. As a result, the actual results, events, performance or achievements of the financial product may be materially different from those expressed or implied in such statements.",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "35b5e3ac5812fbd1",
      "text": "This report has been prepared independently of any issuer of securities mentioned herein and not as agent of any issuer of securities. No Equity Research personnel have authority whatsoever to make any representations or warranty on behalf of the issuer(s). Any comments or statements made herein are those of the Jefferies entity producing this report and may differ from the views of other Jefferies entities.",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "d25040c5f130e1d8",
      "text": "This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor's, and information derived from third- party or proprietary generative artificial intelligence (Gen AI) models. Jefferies does not guarantee the accuracy, completeness, timeliness or availability of this information, and is not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Neither Jefferies nor any third- party content providers, including providers of Gen AI models, give any express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Neither Jefferies nor any third- party content provider shall be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs,",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "0b81c3a088f1b245",
      "text": "expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Reproduction and distribution of third party content in any form is prohibited except with the prior written permission of the related third party.",
      "page": 31,
      "section": null
    },
    {
      "passage_id": "052a330c05d33e35",
      "text": "Jefferies research reports are disseminated and available electronically, and, in some cases, also in printed form. Electronic research is simultaneously made available to all clients. This report or any portion hereof may not be copied, reprinted, sold, or redistributed or disclosed by the recipient or any third party, by content scraping or extraction, automated processing, or any other form or means, without the prior written consent of Jefferies. Any unauthorized use is prohibited. Neither Jefferies nor any of its respective directors, officers or employees, is responsible for guaranteeing the financial success of any investment, or accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents. Nothing herein shall be construed to waive any liability Jefferies has under applicable U.S. federal or state securities laws.",
      "page": 31,
      "section": null
    },
    {
      "passage_id": "8c93b6ce8a9acf11",
      "text": "For Important Disclosure information relating to JRS, please see https://adviserinfo.sec.gov/lAPD/Content/Common/crd_iapd_Brochure.aspx? BRCHR_VRSN_ID=483878 and https://adviserinfo.sec.gov/Firm/292142 or visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action, or www.jefferies.com, or call 1.888.JEFFERIES.",
      "page": 31,
      "section": null
    },
    {
      "passage_id": "db1d08c7ae4ac3e4",
      "text": "\\(①\\) 2025 Jefferies",
      "page": 31,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "3ddf751923e795bd",
      "name": "AF Materials",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "60ddb7aba5cb7c02",
      "name": "Adjusted FCF",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ff6986f815e8cdcf",
      "name": "Adjusted OP",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "758fdd516f5ec6b6",
      "name": "Adjusted OPM",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "2ebc1f6a39f03ec8",
      "name": "Asia Pacific",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "091ea27f0512d847",
      "name": "Base Case",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f8f1ef42a6cbd5be",
      "name": "Bio CDMO",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "d800d368acfe579a",
      "name": "Business Innovation",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6f59100cda671683",
      "name": "Business Solution",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "2e81dfdb832560d4",
      "name": "Business Targets",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "71bad1a7ccd51163",
      "name": "CDMO Capacity",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "dc7eef73bf94b420",
      "name": "CDMO Peer",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "01ddf451589a3150",
      "name": "CDMO Restructuring",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "c0be67bcb78740ce",
      "name": "CDMO Sales",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7860a2554c61a53f",
      "name": "Canadian Investment",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f4d0053f396135ae",
      "name": "Canon Medical",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ca3f82960008e428",
      "name": "Capacity Roadmap",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7233302b3f892447",
      "name": "Catalysts\n\nCDMO",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "bd172949c6d35eaf",
      "name": "China Rockdown",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "922ba83209a76720",
      "name": "Co Target",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "combo",
        "title": null,
        "page": 11,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1Q/15",
              "3Q/15",
              "1Q/16",
              "3Q/16",
              "1Q/17",
              "3Q/17",
              "1Q/18",
              "3Q/18",
              "1Q/19",
              "3Q/19",
              "1Q/20",
              "3Q/20",
              "1Q/21",
              "3Q/21",
              "1Q/22",
              "3Q/22",
              "1Q/23",
              "3Q/23",
              "1Q/24",
              "3Q/24",
              "1Q/25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": -40,
              "max": 40
            }
          }
        },
        "series": [
          {
            "name": "Imaging",
            "unit": null,
            "values": [
              3,
              -1,
              2,
              -1,
              4,
              -1,
              2,
              -1,
              -2,
              -4,
              -5,
              -1,
              5,
              -2,
              -1,
              -2,
              4,
              -1,
              5,
              -1,
              8
            ]
          },
          {
            "name": "Healthcare",
            "unit": null,
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              10,
              5,
              -2,
              -5,
              -1,
              -3,
              -2,
              -5,
              -1
            ]
          },
          {
            "name": "Document/Business Innovation",
            "unit": null,
            "values": [
              2,
              1,
              3,
              2,
              5,
              1,
              2,
              -1,
              -3,
              -8,
              -10,
              -5,
              5,
              -5,
              -10,
              -2,
              2,
              -1,
              3,
              -1,
              5
            ]
          },
          {
            "name": "Healthcare & Materials",
            "unit": null,
            "values": [
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              -1,
              -2,
              -1,
              0,
              2,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1
            ]
          },
          {
            "name": "Materials/Electronics",
            "unit": null,
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              5,
              10,
              5,
              5,
              5,
              5,
              5,
              5,
              5
            ]
          },
          {
            "name": "Total",
            "unit": null,
            "values": [
              5,
              -5,
              -1,
              -8,
              -1,
              -2,
              -1,
              -1,
              -8,
              -10,
              -30,
              -25,
              32,
              15,
              -5,
              -10,
              -5,
              -15,
              -10,
              -10,
              15
            ]
          }
        ],
        "figure_id": "e7328d4e16ceef7c",
        "provenance": {
          "page": 11
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 8,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1Q/18",
              "3Q/18",
              "1Q/19",
              "3Q/19",
              "1Q/20",
              "3Q/20",
              "1Q/21",
              "3Q/21",
              "1Q/22",
              "3Q/22",
              "1Q/23",
              "3Q/23",
              "1Q/24",
              "3Q/24",
              "1Q/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -40.0,
              "max": 60.0
            }
          }
        },
        "series": [
          {
            "name": "Imaging",
            "unit": "%",
            "values": [
              2.0,
              6.0,
              -2.0,
              -12.0,
              -30.0,
              -18.0,
              38.0,
              -2.0,
              6.0,
              17.0,
              23.0,
              -2.0,
              17.0,
              12.0,
              18.0
            ]
          },
          {
            "name": "Healthcare",
            "unit": "%",
            "values": [
              12.0,
              12.0,
              7.0,
              4.0,
              10.0,
              7.0,
              53.0,
              38.0,
              -3.0,
              5.0,
              17.0,
              -5.0,
              3.0,
              -1.0,
              6.0
            ]
          },
          {
            "name": "Materials/Electronics",
            "unit": "%",
            "values": [
              -2.0,
              -1.0,
              5.0,
              -5.0,
              -1.0,
              0.0,
              15.0,
              5.0,
              8.0,
              -5.0,
              -12.0,
              -5.0,
              29.0,
              20.0,
              3.0
            ]
          },
          {
            "name": "Document/Business Innovation",
            "unit": "%",
            "values": [
              -5.0,
              0.0,
              -8.0,
              -1.0,
              -10.0,
              -15.0,
              7.0,
              -5.0,
              -10.0,
              10.0,
              10.0,
              -10.0,
              -5.0,
              5.0,
              2.0
            ]
          }
        ],
        "figure_id": "d3aa2f94cd0cfac4",
        "provenance": {
          "page": 8
        }
      },
      {
        "type": "bar",
        "title": null,
        "page": 23,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jan-19",
              "Mar-19",
              "May-19",
              "Jul-19",
              "Sep-19",
              "Nov-19",
              "Jan-20",
              "Mar-20",
              "May-20",
              "Jul-20",
              "Sep-20",
              "Nov-20",
              "Jan-21",
              "Mar-21",
              "May-21",
              "Jul-21",
              "Sep-21",
              "Nov-21",
              "Jan-22",
              "Mar-22",
              "May-22",
              "Jul-22",
              "Sep-22",
              "Nov-22",
              "Jan-23",
              "Mar-23",
              "May-23",
              "Jul-23",
              "Sep-23",
              "Nov-23",
              "Jan-24",
              "Mar-24",
              "May-24",
              "Jul-24",
              "Sep-24",
              "Nov-24",
              "Jan-25",
              "Mar-25",
              "May-25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 140
            }
          }
        },
        "series": [
          {
            "name": "Japan",
            "unit": null,
            "values": [
              100,
              98,
              102,
              99,
              97,
              95,
              92,
              90,
              78,
              75,
              80,
              82,
              85,
              88,
              90,
              85,
              82,
              80,
              85,
              82,
              80,
              83,
              80,
              78,
              80,
              75,
              78,
              75,
              72,
              70,
              75,
              72,
              70,
              78,
              75,
              72,
              78,
              75,
              72
            ]
          },
          {
            "name": "EU",
            "unit": null,
            "values": [
              110,
              105,
              100,
              102,
              100,
              98,
              108,
              105,
              85,
              82,
              88,
              90,
              112,
              108,
              100,
              95,
              90,
              88,
              105,
              100,
              95,
              98,
              95,
              92,
              100,
              95,
              90,
              85,
              82,
              80,
              88,
              85,
              82,
              80,
              78,
              75,
              85,
              82,
              78
            ]
          },
          {
            "name": "USA",
            "unit": null,
            "values": [
              115,
              108,
              103,
              105,
              102,
              100,
              110,
              107,
              88,
              85,
              90,
              92,
              115,
              110,
              102,
              98,
              92,
              90,
              108,
              102,
              98,
              100,
              98,
              95,
              102,
              98,
              92,
              88,
              85,
              82,
              90,
              88,
              85,
              82,
              80,
              78,
              88,
              85,
              80
            ]
          }
        ],
        "figure_id": "7801280506c39c99",
        "provenance": {
          "page": 23
        }
      },
      {
        "type": "combo",
        "title": null,
        "page": 25,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1998",
              "1999",
              "2000",
              "2001",
              "2002",
              "2003",
              "2004",
              "2005",
              "2006",
              "2007",
              "2008",
              "2009",
              "2010",
              "2011",
              "2012",
              "2013",
              "2014",
              "2015",
              "2016",
              "2017",
              "2018",
              "2019",
              "2020",
              "2021",
              "2022",
              "2023",
              "2024"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 16000
            }
          }
        },
        "series": [
          {
            "name": "Instax (1000 units)",
            "unit": "1000 units",
            "values": [
              100,
              600,
              900,
              1000,
              1200,
              200,
              100,
              100,
              200,
              300,
              500,
              800,
              1200,
              1800,
              2400,
              4000,
              5200,
              7600,
              9800,
              10000,
              8400,
              9600,
              9000,
              9200,
              9400,
              9600
            ]
          },
          {
            "name": "Instax revenue estimates (RHS mn JPY)",
            "unit": "mn JPY",
            "values": [
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              1000,
              800,
              1000,
              1100,
              1400,
              1600,
              1800,
              1950
            ]
          }
        ],
        "figure_id": "feae824805bbd0c3",
        "provenance": {
          "page": 25
        }
      },
      {
        "type": "line",
        "title": "Rating and Price Target History for: FUJIFILM Holdings Corporation (4901 JP) as of 08-28-2025",
        "page": 28,
        "axes": {
          "x": {
            "type": "time",
            "labels": [
              "Oct 22",
              "Jan 23",
              "Apr 23",
              "Jul 23",
              "Oct 23",
              "Jan 24",
              "Apr 24",
              "Jul 24",
              "Oct 24",
              "Jan 25",
              "Apr 25",
              "Jul 25"
            ]
          },
          "y": {
            "unit": "¥",
            "range": {
              "min": 2000,
              "max": 4500
            }
          }
        },
        "series": [
          {
            "name": "Stock Price",
            "unit": "¥",
            "values": [
              {
                "date": "Oct 22",
                "value": 2300
              },
              {
                "date": "Nov 22",
                "value": 2200
              },
              {
                "date": "Dec 22",
                "value": 2100
              },
              {
                "date": "Jan 23",
                "value": 2200
              },
              {
                "date": "Feb 23",
                "value": 2400
              },
              {
                "date": "Mar 23",
                "value": 2600
              },
              {
                "date": "Apr 23",
                "value": 2700
              },
              {
                "date": "May 23",
                "value": 2800
              },
              {
                "date": "Jun 23",
                "value": 2900
              },
              {
                "date": "Jul 23",
                "value": 2700
              },
              {
                "date": "Aug 23",
                "value": 2800
              },
              {
                "date": "Sep 23",
                "value": 3000
              },
              {
                "date": "Oct 23",
                "value": 3100
              },
              {
                "date": "Nov 23",
                "value": 3200
              },
              {
                "date": "Dec 23",
                "value": 3400
              },
              {
                "date": "Jan 24",
                "value": 3500
              },
              {
                "date": "Feb 24",
                "value": 3700
              },
              {
                "date": "Mar 24",
                "value": 3800
              },
              {
                "date": "Apr 24",
                "value": 3900
              },
              {
                "date": "May 24",
                "value": 4000
              },
              {
                "date": "Jun 24",
                "value": 3800
              },
              {
                "date": "Jul 24",
                "value": 2700
              },
              {
                "date": "Aug 24",
                "value": 3200
              },
              {
                "date": "Sep 24",
                "value": 3400
              },
              {
                "date": "Oct 24",
                "value": 3200
              },
              {
                "date": "Nov 24",
                "value": 3000
              },
              {
                "date": "Dec 24",
                "value": 2800
              },
              {
                "date": "Jan 25",
                "value": 2700
              },
              {
                "date": "Feb 25",
                "value": 2800
              },
              {
                "date": "Mar 25",
                "value": 3000
              },
              {
                "date": "Apr 25",
                "value": 3100
              },
              {
                "date": "May 25",
                "value": 3200
              },
              {
                "date": "Jun 25",
                "value": 3400
              },
              {
                "date": "Jul 25",
                "value": 3600
              }
            ]
          },
          {
            "name": "Rating and Price Target",
            "unit": "¥",
            "values": [
              {
                "date": "02/28/2024",
                "rating": "BUY",
                "target": 3766.67
              },
              {
                "date": "04/05/2024",
                "rating": "BUY",
                "target": 3766.0
              },
              {
                "date": "04/05/2024",
                "rating": "BUY",
                "target": 4000.0
              },
              {
                "date": "04/16/2024",
                "rating": "BUY",
                "target": 4100.0
              },
              {
                "date": "06/06/2024",
                "rating": "BUY",
                "target": 4300.0
              },
              {
                "date": "07/09/2024",
                "rating": "HOLD",
                "target": 4300.0
              },
              {
                "date": "08/20/2024",
                "rating": "BUY",
                "target": 4300.0
              },
              {
                "date": "09/24/2024",
                "rating": "BUY",
                "target": 4500.0
              },
              {
                "date": "04/14/2025",
                "rating": "BUY",
                "target": 4300.0
              }
            ]
          }
        ],
        "figure_id": "e207f881d1c0ab35",
        "provenance": {
          "page": 28
        }
      },
      {
        "type": "other",
        "title": null,
        "page": 1,
        "axes": {
          "x": {
            "type": "other",
            "labels": []
          },
          "y": {
            "unit": null,
            "range": {
              "min": null,
              "max": null
            }
          }
        },
        "series": [],
        "figure_id": "94b42b5f6402d451",
        "provenance": {
          "page": 1
        }
      },
      {
        "type": "combo",
        "title": null,
        "page": 20,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2021",
              "2022",
              "2023",
              "2024",
              "2025E",
              "2026E",
              "2027E",
              "2028E"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 3500
            }
          }
        },
        "series": [
          {
            "name": "Lonza",
            "unit": null,
            "values": [
              390,
              400,
              470,
              650,
              680,
              700,
              700,
              800
            ]
          },
          {
            "name": "Samsung Biologics",
            "unit": null,
            "values": [
              400,
              350,
              380,
              600,
              700,
              800,
              900,
              950
            ]
          },
          {
            "name": "WuXi Biologics",
            "unit": null,
            "values": [
              200,
              250,
              300,
              450,
              500,
              550,
              600,
              600
            ]
          },
          {
            "name": "Fujifilm",
            "unit": null,
            "values": [
              50,
              100,
              100,
              200,
              400,
              500,
              600,
              700
            ]
          },
          {
            "name": "JSR",
            "unit": null,
            "values": [
              10,
              10,
              10,
              20,
              20,
              20,
              20,
              20
            ]
          },
          {
            "name": "AGC",
            "unit": null,
            "values": [
              20,
              30,
              30,
              50,
              50,
              50,
              50,
              50
            ]
          },
          {
            "name": "YoY",
            "unit": "%",
            "values": [
              null,
              15,
              12,
              48,
              20,
              12,
              10,
              8
            ]
          }
        ],
        "figure_id": "3e2673ebd26fdb07",
        "provenance": {
          "page": 20
        }
      },
      {
        "type": "line",
        "title": "Upside: Downside 1.1:1",
        "page": 2,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2024",
              "2025",
              "+12 mo."
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 2000,
              "max": 5500
            }
          }
        },
        "series": [
          {
            "name": "Historical Data",
            "unit": null,
            "values": [
              {
                "x": "2023-10",
                "y": 2900
              },
              {
                "x": "2023-11",
                "y": 2700
              },
              {
                "x": "2023-12",
                "y": 2800
              },
              {
                "x": "2024-01",
                "y": 3000
              },
              {
                "x": "2024-02",
                "y": 3200
              },
              {
                "x": "2024-03",
                "y": 3500
              },
              {
                "x": "2024-04",
                "y": 3800
              },
              {
                "x": "2024-05",
                "y": 3900
              },
              {
                "x": "2024-06",
                "y": 3600
              },
              {
                "x": "2024-07",
                "y": 3900
              },
              {
                "x": "2024-08",
                "y": 3700
              },
              {
                "x": "2024-09",
                "y": 3400
              },
              {
                "x": "2024-10",
                "y": 3200
              },
              {
                "x": "2024-11",
                "y": 3500
              },
              {
                "x": "2024-12",
                "y": 3300
              },
              {
                "x": "2025-01",
                "y": 3000
              },
              {
                "x": "2025-02",
                "y": 2700
              },
              {
                "x": "2025-03",
                "y": 3000
              },
              {
                "x": "2025-04",
                "y": 3200
              },
              {
                "x": "2025-05",
                "y": 3400
              },
              {
                "x": "2025-06",
                "y": 3600
              },
              {
                "x": "2025-07",
                "y": 3200
              },
              {
                "x": "2025-08",
                "y": 2900
              },
              {
                "x": "2025-09",
                "y": 3100
              },
              {
                "x": "2025-10",
                "y": 3300
              },
              {
                "x": "2025-11",
                "y": 3600
              }
            ]
          },
          {
            "name": "Forecast - Upside",
            "unit": null,
            "values": [
              {
                "x": "2025-11",
                "y": 3600
              },
              {
                "x": "+12 mo.",
                "y": 5000
              }
            ]
          },
          {
            "name": "Forecast - Base",
            "unit": null,
            "values": [
              {
                "x": "2025-11",
                "y": 3600
              },
              {
                "x": "+12 mo.",
                "y": 4300
              }
            ]
          },
          {
            "name": "Forecast - Downside",
            "unit": null,
            "values": [
              {
                "x": "2025-11",
                "y": 3600
              },
              {
                "x": "+12 mo.",
                "y": 2200
              }
            ]
          }
        ],
        "figure_id": "9067f947d27ebf15",
        "provenance": {
          "page": 2
        }
      },
      {
        "type": "combo",
        "title": null,
        "page": 23,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2016/1Q",
              "2016/2Q",
              "2016/3Q",
              "2016/4Q",
              "2017/1Q",
              "2017/2Q",
              "2017/3Q",
              "2017/4Q",
              "2018/1Q",
              "2018/2Q",
              "2018/3Q",
              "2018/4Q",
              "2019/1Q",
              "2019/2Q",
              "2019/3Q",
              "2019/4Q",
              "2020/1Q",
              "2020/2Q",
              "2020/3Q",
              "2020/4Q",
              "2021/1Q",
              "2021/2Q",
              "2021/3Q",
              "2021/4Q",
              "2022/1Q",
              "2022/2Q",
              "2022/3Q",
              "2022/4Q",
              "2023/1Q",
              "2023/2Q",
              "2023/3Q",
              "2023/4Q",
              "2024/1Q",
              "2024/2Q",
              "2024/3Q",
              "2024/4Q",
              "2025/1Q",
              "2025/2Q"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": -50,
              "max": 3000
            }
          }
        },
        "series": [
          {
            "name": "revenue",
            "unit": null,
            "values": [
              2600,
              2800,
              2750,
              2600,
              2500,
              2400,
              2600,
              2450,
              2550,
              2400,
              2500,
              2300,
              2500,
              2400,
              2000,
              2800,
              1800,
              1700,
              1900,
              1950,
              1750,
              1750,
              1800,
              1750,
              1750,
              1700,
              1750,
              1900,
              1750,
              1700,
              1750,
              1700,
              1600,
              1550,
              1600,
              1550,
              1500,
              1500
            ]
          },
          {
            "name": "Adjusted OP(RHS)",
            "unit": null,
            "values": [
              100,
              170,
              140,
              190,
              110,
              170,
              140,
              190,
              170,
              195,
              180,
              240,
              170,
              200,
              180,
              400,
              70,
              50,
              100,
              180,
              120,
              80,
              120,
              70,
              30,
              60,
              100,
              180,
              120,
              90,
              70,
              100,
              70,
              40,
              80,
              110,
              20,
              60
            ]
          }
        ],
        "figure_id": "7d2adf3885700ffc",
        "provenance": {
          "page": 23
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 21,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "6/21",
              "9/21",
              "12/21",
              "3/22",
              "6/22",
              "9/22",
              "12/22",
              "3/23",
              "6/23",
              "9/23",
              "12/23",
              "3/24",
              "6/24",
              "9/24",
              "12/24",
              "3/25",
              "6/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0.0,
              "max": 40.0
            }
          }
        },
        "series": [
          {
            "name": "Fujifilm",
            "unit": "%",
            "values": [
              17.5,
              15.0,
              14.5,
              20.0,
              15.0,
              11.5,
              0.0,
              9.5,
              10.0,
              12.0,
              8.0,
              3.0,
              3.0,
              0.0,
              0.0,
              2.0,
              2.0
            ]
          },
          {
            "name": "Lonza",
            "unit": "%",
            "values": [
              16.0,
              15.0,
              15.5,
              20.5,
              20.5,
              22.5,
              22.5,
              20.0,
              20.0,
              8.5,
              8.5,
              24.0,
              24.0,
              8.0,
              8.0,
              17.5,
              17.5
            ]
          },
          {
            "name": "Samsung Biologics",
            "unit": "%",
            "values": [
              29.5,
              32.5,
              34.0,
              35.0,
              32.0,
              31.0,
              32.5,
              29.5,
              30.5,
              32.0,
              29.0,
              31.0,
              26.0,
              27.0,
              25.5,
              37.5,
              36.0
            ]
          },
          {
            "name": "Wuxi Biologics",
            "unit": "%",
            "values": [
              34.5,
              30.5,
              30.5,
              30.5,
              30.5,
              22.5,
              22.5,
              27.0,
              27.0,
              27.0,
              23.0,
              23.0,
              23.0,
              27.5,
              27.5,
              27.5,
              27.5
            ]
          }
        ],
        "figure_id": "4b5596926f928a18",
        "provenance": {
          "page": 21
        }
      },
      {
        "type": "combo",
        "title": null,
        "page": 24,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2015",
              "2016",
              "2017",
              "2018",
              "2019",
              "2020",
              "2021",
              "2022",
              "2023",
              "2024"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 1600
            }
          }
        },
        "series": [
          {
            "name": "Fujifilm",
            "unit": null,
            "values": [
              150,
              150,
              130,
              120,
              100,
              80,
              90,
              280,
              300,
              400
            ]
          },
          {
            "name": "Ricoh",
            "unit": null,
            "values": [
              230,
              180,
              190,
              190,
              200,
              150,
              160,
              200,
              200,
              200
            ]
          },
          {
            "name": "Canon",
            "unit": null,
            "values": [
              260,
              270,
              270,
              250,
              250,
              250,
              320,
              350,
              400,
              450
            ]
          },
          {
            "name": "Konica Minolta",
            "unit": null,
            "values": [
              200,
              200,
              200,
              200,
              200,
              150,
              180,
              250,
              280,
              300
            ]
          },
          {
            "name": "Seiko Epson",
            "unit": null,
            "values": [
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              250,
              250,
              250
            ]
          },
          {
            "name": "Fujifilm share",
            "unit": "%",
            "values": [
              15.0,
              14.5,
              13.5,
              12.5,
              12.0,
              10.0,
              8.0,
              7.5,
              7.0,
              7.0
            ]
          }
        ],
        "figure_id": "313b887f5a808d64",
        "provenance": {
          "page": 24
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "03fc3ad9f103cafa",
        "value": 0.21100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ernal Environment Fujifilm announced 1Q FY3/26 results on Aug 6. It reported &#36;75.3bn in OP (up 21.1% YoY), exceeding the market view and delivering healthy progress toward the internal outlook. It",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "d3a8d9f39381966a",
        "value": 0.001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "our PT &#36;4,300 and Buy rating. **1Q** **results:** Fujifilm reported &#36;749.5bn in sales (up 0.1% YoY, up 4.5% ex. forex) and &#36;75.3bn in OP (up 21.1% (up &#36;13.1bn) YoY, up &#36;21.8bn ex. ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "065f1985af3f2cf9",
        "value": 0.045,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "4,300 and Buy rating. **1Q** **results:** Fujifilm reported &#36;749.5bn in sales (up 0.1% YoY, up 4.5% ex. forex) and &#36;75.3bn in OP (up 21.1% (up &#36;13.1bn) YoY, up &#36;21.8bn ex. forex), sett",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "265868ac2e1cdc15",
        "value": 0.21100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Fujifilm reported &#36;749.5bn in sales (up 0.1% YoY, up 4.5% ex. forex) and &#36;75.3bn in OP (up 21.1% (up &#36;13.1bn) YoY, up &#36;21.8bn ex. forex), setting all-time sales and OP highs for 1Q. Co",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "4c54037c2538b9df",
        "value": 0.028999999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "the Imaging business beat sales and OP guidance. **Healthcare:** 1Q sales were &#36;228.5bn (down 2.9% YoY, up 1.6% ex. forex) with medical systems at &#36;144.0bn (down 2.9%, up 1.6% ex. forex). Medi",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "bb9b6cdaa4572769",
        "value": 0.016,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "business beat sales and OP guidance. **Healthcare:** 1Q sales were &#36;228.5bn (down 2.9% YoY, up 1.6% ex. forex) with medical systems at &#36;144.0bn (down 2.9%, up 1.6% ex. forex). Medical material",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "76f2d9a472942bae",
        "value": 0.028999999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "les were &#36;228.5bn (down 2.9% YoY, up 1.6% ex. forex) with medical systems at &#36;144.0bn (down 2.9%, up 1.6% ex. forex). Medical materials for China declined on inventory adjustments. Bio CDMO bo",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "25ae6c643a99ae2d",
        "value": 0.016,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "&#36;228.5bn (down 2.9% YoY, up 1.6% ex. forex) with medical systems at &#36;144.0bn (down 2.9%, up 1.6% ex. forex). Medical materials for China declined on inventory adjustments. Bio CDMO booked &#36",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "073ea15d57f7f332",
        "value": 0.128,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "materials for China declined on inventory adjustments. Bio CDMO booked &#36;53.2bn in 1Q sales (up 12.8%, up 18.9% ex. forex) with contributions from the first-phase investments in Denmark and recover",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "8c02d45d29f7b26f",
        "value": 0.18899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "for China declined on inventory adjustments. Bio CDMO booked &#36;53.2bn in 1Q sales (up 12.8%, up 18.9% ex. forex) with contributions from the first-phase investments in Denmark and recovery in opera",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "baa7da871f58bc0d",
        "value": 0.18,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "his business started the fiscal year on track with full-year guidance for &#36;260.0bn in sales (up 18% YoY). Segment OP was &#36;4.3bn in 1Q (up &#36;700mn YoY). Decline in one-time items added &#36;",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "570ec566bdc8e2e7",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ies. **FY3/26 guidance:** Fujifilm retained existing FY3/26 targets of &#36;3,280.0bn in sales (up 2.6% YoY) and &#36;331.0bn in OP (up 0.3%). It also targets a &#36;70 dividend (up by &#36;5), raisin",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "5e09c8aee000ef07",
        "value": 0.003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "etained existing FY3/26 targets of &#36;3,280.0bn in sales (up 2.6% YoY) and &#36;331.0bn in OP (up 0.3%). It also targets a &#36;70 dividend (up by &#36;5), raising the dividend in a 16th straight ye",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "831256207e8e1c5a",
        "value": 0.322,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "&#36;70 dividend (up by &#36;5), raising the dividend in a 16th straight year. This works out to a 32.2% dividend payout ratio. Forex assumptions are &#36;145/US$ and &#36;137/Euro (vs. &#36;145/US$ a",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "24744c8344e93ef7",
        "value": 0.22,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>BUY</td></tr><tr><td>PRICE</td><td>¥3,532*</td></tr><tr><td>PRICE TARGET | % TO PT</td><td>¥4,300|+22%</td></tr><tr><td>52W HIGH-LOW</td><td>¥3,994-¥2,516</td></tr><tr><td>FLOAT (%) | ADV MM (USD)</",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "cabd1edcc05ba71a",
        "value": 0.802,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></tr><tr><td>52W HIGH-LOW</td><td>¥3,994-¥2,516</td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td>80.2%|84.52</td></tr><tr><td>MARKET CAP</td><td>¥4.8T|$32.3B</td></tr><tr><td>TICKER</td><td>4901 JP",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "01f101aa396ce178",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">2026</td></tr><tr><td>REV</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>EPS</td><td>+2%</td><td>NM</td><td>-3%</td><td>-2%</td></tr><tr><td></td><td></td><td></td><td></td><td></td></t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "f056a73e8a998c3a",
        "value": -0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "REV</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>EPS</td><td>+2%</td><td>NM</td><td>-3%</td><td>-2%</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2025 (¥)</td>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "81a5e90d1d0d18aa",
        "value": -0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>EPS</td><td>+2%</td><td>NM</td><td>-3%</td><td>-2%</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2025 (¥)</td><td>Q1</td><",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "3d191ba24aa4370e",
        "value": 3532.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "><td colspan=\"2\">ESTIMATE CHANGE</td></tr><tr><td>RATING</td><td>BUY</td></tr><tr><td>PRICE</td><td>¥3,532*</td></tr><tr><td>PRICE TARGET | % TO PT</td><td>¥4,300|+22%</td></tr><tr><td>52W HIGH-LOW</t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "ca1c60eaafe6df9a",
        "value": 4300.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "</td><td>BUY</td></tr><tr><td>PRICE</td><td>¥3,532*</td></tr><tr><td>PRICE TARGET | % TO PT</td><td>¥4,300|+22%</td></tr><tr><td>52W HIGH-LOW</td><td>¥3,994-¥2,516</td></tr><tr><td>FLOAT (%) | ADV MM ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "53429b88d7aa7aeb",
        "value": 3994.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "*</td></tr><tr><td>PRICE TARGET | % TO PT</td><td>¥4,300|+22%</td></tr><tr><td>52W HIGH-LOW</td><td>¥3,994-¥2,516</td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td>80.2%|84.52</td></tr><tr><td>MARKET ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "3d7dfbd965eba184",
        "value": 2516.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "/tr><tr><td>PRICE TARGET | % TO PT</td><td>¥4,300|+22%</td></tr><tr><td>52W HIGH-LOW</td><td>¥3,994-¥2,516</td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td>80.2%|84.52</td></tr><tr><td>MARKET CAP</td",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "af9fc6af8c0203ec",
        "value": 4.8,
        "unit": "¥",
        "metric_type": "currency",
        "context": "6</td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td>80.2%|84.52</td></tr><tr><td>MARKET CAP</td><td>¥4.8T|$32.3B</td></tr><tr><td>TICKER</td><td>4901 JP</td></tr></table> *Prior trading day's closing ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "31fe87915ad1556d",
        "value": 32299999999.999996,
        "unit": "$",
        "metric_type": "currency",
        "context": "</tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td>80.2%|84.52</td></tr><tr><td>MARKET CAP</td><td>¥4.8T|$32.3B</td></tr><tr><td>TICKER</td><td>4901 JP</td></tr></table> *Prior trading day's closing price ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "626976a5787a6fb3",
        "value": 0.22,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "![Figure 1-0](images/1_0.jpg) <center>Risk/Reward - 12 Month View </center> ## Base Case, ¥4300, +22% Fujifilm has revamped the business portfolio and strengthened balance sheet management over many y",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "454930d19cd40057",
        "value": 0.42,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "medium term. Price target ¥4,300 (12x our estimated FY3/26 EV/EBITDA). ## Upside Scenario, ¥5000, +42% Sales and profit increases, fueled by expansion of CDMO business and higher capital investments. ",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "4d81a4b4f518df85",
        "value": -0.38,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "enario, our upside price target is ¥5,000 (14x our FY3/26 EV/EBITDA). ## Downside Scenario, ¥2200, -38% CDMO's profitability improvement may fall short of company plans Decline in imaging business pro",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "35b8b006328f97c5",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "gher competition in business innovation. In this scenario, our downside price target is ¥2,200 (ROE 5%, FY3/24 P/B of 0.83x). ## Sustainability Matters Top Material Issues: 1) Product Design & Lifecyc",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "fd639e572c1afe6f",
        "value": 0.5,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ement. 2) Supply Chain Management. 3) GHG Emissions. Company Targets: GHG Emission Scope 1/2 2030: 50% vs 2019, Net zero by FY2040 Qs to Mgmt: 1) In April 2024, Fujifilm disclosed its medium- term man",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "674369879ca00706",
        "value": 4300.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "arket. ![Figure 1-0](images/1_0.jpg) <center>Risk/Reward - 12 Month View </center> ## Base Case, ¥4300, +22% Fujifilm has revamped the business portfolio and strengthened balance sheet management over",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "ea8527b867ab0a1f",
        "value": 4300.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "are, medical systems (medical equipment) and CDMO drive earnings over the medium term. Price target ¥4,300 (12x our estimated FY3/26 EV/EBITDA). ## Upside Scenario, ¥5000, +42% Sales and profit increa",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "ce08371390a78330",
        "value": 5000.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ver the medium term. Price target ¥4,300 (12x our estimated FY3/26 EV/EBITDA). ## Upside Scenario, ¥5000, +42% Sales and profit increases, fueled by expansion of CDMO business and higher capital inves",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "fa2aafc5e7af99e9",
        "value": 5000.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "al investments. Rise in medical systems profitability. In this scenario, our upside price target is ¥5,000 (14x our FY3/26 EV/EBITDA). ## Downside Scenario, ¥2200, -38% CDMO's profitability improvemen",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "3bb8b30610d63b76",
        "value": 2200.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "this scenario, our upside price target is ¥5,000 (14x our FY3/26 EV/EBITDA). ## Downside Scenario, ¥2200, -38% CDMO's profitability improvement may fall short of company plans Decline in imaging busin",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "87a119e4b85cfa33",
        "value": 2200.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "kage and tougher competition in business innovation. In this scenario, our downside price target is ¥2,200 (ROE 5%, FY3/24 P/B of 0.83x). ## Sustainability Matters Top Material Issues: 1) Product Desi",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "d68a6397d81be7d3",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ghtly YoY, the Americas (20) rose in the low- single digits (mid- single digits ex- forex), Europe (20%) declined in the high- single digits (mid- single digit decline ex- forex), and China (just unde",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "c07f22958768686f",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%) declined in the high- single digits (mid- single digit decline ex- forex), and China (just under 10%) was down \\(30\\% - 40\\% \\text{YoY}\\) . In China, sales declined sharply partly due to inventory ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "0fc0dd22f86ea649",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "djustments at agents. By product, sales of medical IT equipment ( \\(10\\% +\\) composition) and IVD (10%) were strong (around \\(+10\\%\\) YoY). However, endoscope (20%) sales corrected in China, and globa",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "4a42734988df05fa",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ent ( \\(10\\% +\\) composition) and IVD (10%) were strong (around \\(+10\\%\\) YoY). However, endoscope (20%) sales corrected in China, and global sales were down slightly YoY. X- ray equipment (just under",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "a0235c4e6130e3e6",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0%) sales corrected in China, and global sales were down slightly YoY. X- ray equipment (just under 20%) sales declined in the double digits and x- ray materials (just under 10%) fell \\(40\\% \\text{YoY",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "2ad14130db9a45a6",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ray equipment (just under 20%) sales declined in the double digits and x- ray materials (just under 10%) fell \\(40\\% \\text{YoY}\\) . Amid a decline in demand globally, the degree of inventory adjustmen",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "23abb741f3564863",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lobally, the degree of inventory adjustments at sales agents in China increased. CT/MRI (just under 10%) sales declined around \\(10\\% \\text{YoY}\\) (mainly the former medical equipment business of Hita",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "771e5c6555adb21a",
        "value": 0.7,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "1Q sales totaled \\(31.3bn (+3.2\\% \\text{YoY}, +6.2\\% \\text{ex - force})\\) . Regenerative medicine (70%+ composition) was \\(+3\\%\\) YoY. Cell media and reagent sales rebounded YoY. Pharmaceutical (10% +",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "47f3b51d10a92587",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ne (70%+ composition) was \\(+3\\%\\) YoY. Cell media and reagent sales rebounded YoY. Pharmaceutical (10% +) sales were \\(+20\\%\\) YoY. Contact manufacturing of COVID- 19 vaccine ingredients contributed.",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "54757f3e0aca8839",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "were \\(+20\\%\\) YoY. Contact manufacturing of COVID- 19 vaccine ingredients contributed. Cosmetics (10%+) sales declined around 10%. Segment OP in 1Q was \\(4.3bn (+800mn \\text{YoY})\\) , apparently arou",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "64d45804a4de8fd0",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "manufacturing of COVID- 19 vaccine ingredients contributed. Cosmetics (10%+) sales declined around 10%. Segment OP in 1Q was \\(4.3bn (+800mn \\text{YoY})\\) , apparently around \\(1.0bn - 1.5bn\\) below i",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "d360e88a1ac2b447",
        "value": 0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ss of US- based Entegris, quarterly sales have been around the \\(60.0bn\\) level. CMP slurry (nearly 30% composition) sales rose 20% YoY. Post- CMP cleaner (approx. 5%) sales rose approx. 10% YoY. CMP ",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "a86544b79e9cd0df",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "arterly sales have been around the \\(60.0bn\\) level. CMP slurry (nearly 30% composition) sales rose 20% YoY. Post- CMP cleaner (approx. 5%) sales rose approx. 10% YoY. CMP clear market share is 26%. C",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "973572561a27aa28",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "(60.0bn\\) level. CMP slurry (nearly 30% composition) sales rose 20% YoY. Post- CMP cleaner (approx. 5%) sales rose approx. 10% YoY. CMP clear market share is 26%. Competitors include Entegris and Reso",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "373484eef1e6d33f",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "urry (nearly 30% composition) sales rose 20% YoY. Post- CMP cleaner (approx. 5%) sales rose approx. 10% YoY. CMP clear market share is 26%. Competitors include Entegris and Resonac. In Cu, market shar",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "2d76a10fe87c3d93",
        "value": 0.26,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rose 20% YoY. Post- CMP cleaner (approx. 5%) sales rose approx. 10% YoY. CMP clear market share is 26%. Competitors include Entegris and Resonac. In Cu, market share is around 50%, making the company ",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "a1ae7cf4e725080e",
        "value": 0.5,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "clear market share is 26%. Competitors include Entegris and Resonac. In Cu, market share is around 50%, making the company the market share leader. The company's product has superior corrosion protect",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "1f3d86a6cf0066d5",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "s has increased due to the expansion of multi- layered packages and advanced packages. Photoresist (10% composition) sales declined slightly YoY. In Oct 2025, sales started for EUV resist and developi",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "42c0cfbe6ea5d740",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "for EUV resist and developing fluid. Image sensor materials (mid- single digit composition) were - 5% YoY. Lithography materials (just under 50% composition: includes Entegris's process chemicals) dec",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "774c65ed4436ea38",
        "value": 0.5,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "e sensor materials (mid- single digit composition) were - 5% YoY. Lithography materials (just under 50% composition: includes Entegris's process chemicals) declined slightly YoY. Sales to a North Amer",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "c4024cae456cd191",
        "value": 0.7,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "xt{YoY}, - 6.8\\% \\text{ex - force})\\) , down \\(5.7bn \\text{QoQ}\\) . Within this, display materials (70% composition declined slightly YoY. TAC film was - 5% YoY for full- FY3/25, and sales again decli",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "b066a09e9de57c93",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "text{QoQ}\\) . Within this, display materials (70% composition declined slightly YoY. TAC film was - 5% YoY for full- FY3/25, and sales again declined YoY in 1Q FY3/26. OLED rose YoY, but growth was so",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "c9031dbc9a9e6297",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "again declined YoY in 1Q FY3/26. OLED rose YoY, but growth was somewhat weak. Industrial materials (20% composition) declined \\(20\\% + \\text{YoY}\\) . Fine chemicals (10% composition) growth was in the",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "9d063e4be45f050d",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ewhat weak. Industrial materials (20% composition) declined \\(20\\% + \\text{YoY}\\) . Fine chemicals (10% composition) growth was in the mid- teens YoY.<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "737cc9141dc850fd",
        "value": 0.023,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "eclined YoY, but 1Q FY3/26 rebounded YoY. ## (3) Business Innovation 1Q sales totaled ¥273.6bn (- 2.3% YoY, +0.9% ex- forex). Sales ex- forex rose YoY for the third straight quarter, and equated to 92",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "2bcde4abc5b92e65",
        "value": 0.009000000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Y, but 1Q FY3/26 rebounded YoY. ## (3) Business Innovation 1Q sales totaled ¥273.6bn (- 2.3% YoY, +0.9% ex- forex). Sales ex- forex rose YoY for the third straight quarter, and equated to 92% vs. 1Q 2",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "fa42b0aa3e7fc7d8",
        "value": 0.92,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "2.3% YoY, +0.9% ex- forex). Sales ex- forex rose YoY for the third straight quarter, and equated to 92% vs. 1Q 2019. The value vs. the same period in 2019 had trended around 80% in FY3/24- FY3/25, but",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "a071033c0a88bb5a",
        "value": 0.8,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "t quarter, and equated to 92% vs. 1Q 2019. The value vs. the same period in 2019 had trended around 80% in FY3/24- FY3/25, but has increased to the 90% level since 4Q FY3/25. Within this, office solut",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "042c8f53a0b7cdc9",
        "value": 0.9,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "alue vs. the same period in 2019 had trended around 80% in FY3/24- FY3/25, but has increased to the 90% level since 4Q FY3/25. Within this, office solutions 1Q sales amounted to ¥120.0bn (- 5.3% YoY, ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "3f4bdd4679d996f7",
        "value": 0.053,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d to the 90% level since 4Q FY3/25. Within this, office solutions 1Q sales amounted to ¥120.0bn (- 5.3% YoY, - 2.7% ex- forex). Within this, MFP sales were - 4%. Domestic sales were flat. In Asia Paci",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "90473fe9c650bbbc",
        "value": 0.027000000000000003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "level since 4Q FY3/25. Within this, office solutions 1Q sales amounted to ¥120.0bn (- 5.3% YoY, - 2.7% ex- forex). Within this, MFP sales were - 4%. Domestic sales were flat. In Asia Pacific, sales in",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "ffc37459b05d72f5",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lutions 1Q sales amounted to ¥120.0bn (- 5.3% YoY, - 2.7% ex- forex). Within this, MFP sales were - 4%. Domestic sales were flat. In Asia Pacific, sales in China and Southeast Asia declined, partly be",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "0f2b77eb7dba09b5",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ia declined, partly because of a reduction in low- margin models. Exports to Europe and the US were +9% YoY. MFP sales by US Xerox (major OEM customer) continue to trend downward, but exports by Fujif",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "04ca92c42f49c49b",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "t is possible that Fujifilm's exports to US Xerox will correct as well. Office printer sales were - 14% YoY. Sales in Japan declined slightly. Asia Pacific sales rose YoY in 1Q FY3/26 vs. a correction",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "d4ac89a6e9ed89e3",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ales in 1Q FY3/25. Exports to Europe and the US declined. Business solution 1Q sales were ¥75.8bn (+7.0% YoY, +9.9% ex- forex). Domestic DX solutions sales and service sales to municipal governments r",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "bee0fc11a4173096",
        "value": 0.099,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "FY3/25. Exports to Europe and the US declined. Business solution 1Q sales were ¥75.8bn (+7.0% YoY, +9.9% ex- forex). Domestic DX solutions sales and service sales to municipal governments remained bri",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "338974e8eace842e",
        "value": 0.055999999999999994,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "on in Australia, and this pushed up BPO demand. Graphic communications 1Q sales totaled ¥77.8bn (- 5.6% YoY, - 1.4% ex- forex), declining due to lower sales of analogue printing plate materials to Eur",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "80dd4fdfd0e586d6",
        "value": 0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lia, and this pushed up BPO demand. Graphic communications 1Q sales totaled ¥77.8bn (- 5.6% YoY, - 1.4% ex- forex), declining due to lower sales of analogue printing plate materials to Europe and the ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "aeb4e0583e4ef526",
        "value": 0.11199999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ness innovation, profit increased due to expense curbs. ## (4) Imaging 1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "45a1331a1ae13f0e",
        "value": 0.179,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ion, profit increased due to expense curbs. ## (4) Imaging 1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "26160e4a05e6b231",
        "value": 0.037000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "some such movement, real earnings remained strong. Within imaging, consumer 1Q sales were ¥77.3bn (+3.7% YoY, +9.9% ex- forex). By region, all regions were upbeat. Japan and China posted 2- digit grow",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "520fafe01fb6b6f1",
        "value": 0.099,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ovement, real earnings remained strong. Within imaging, consumer 1Q sales were ¥77.3bn (+3.7% YoY, +9.9% ex- forex). By region, all regions were upbeat. Japan and China posted 2- digit growth, the US ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "9b75f25d574ea604",
        "value": 0.21100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ays to enjoy their photos, with the aim of expanding business. Professional 1Q sales were ¥68.0bn (+21.1% YoY, +28.7% ex- forex). Digital camera sales rose in Europe, the US, and China. Sales of four ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "fdaf525a8b1e30fc",
        "value": 0.287,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "their photos, with the aim of expanding business. Professional 1Q sales were ¥68.0bn (+21.1% YoY, +28.7% ex- forex). Digital camera sales rose in Europe, the US, and China. Sales of four models launch",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "39c2a4c2c8a5e4fd",
        "value": 22.5,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Segment OP totaled ¥22.5bn (+¥2.6bn YoY, +¥5.0bn ex- forex). Adjusted OP was +¥4.1vn YoY, rising YoY for the first time in t",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "c708852b2210f5cb",
        "value": 2.6,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Segment OP totaled ¥22.5bn (+¥2.6bn YoY, +¥5.0bn ex- forex). Adjusted OP was +¥4.1vn YoY, rising YoY for the first time in two quarte",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "4cbbce3c7f3fce3a",
        "value": 5.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Segment OP totaled ¥22.5bn (+¥2.6bn YoY, +¥5.0bn ex- forex). Adjusted OP was +¥4.1vn YoY, rising YoY for the first time in two quarters. Results w",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "0959c52979e9a73a",
        "value": 4.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Segment OP totaled ¥22.5bn (+¥2.6bn YoY, +¥5.0bn ex- forex). Adjusted OP was +¥4.1vn YoY, rising YoY for the first time in two quarters. Results were basically in line with internal",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "de35c44d9ad700a8",
        "value": 273.6,
        "unit": "¥",
        "metric_type": "currency",
        "context": "lt, profit declined YoY, but 1Q FY3/26 rebounded YoY. ## (3) Business Innovation 1Q sales totaled ¥273.6bn (- 2.3% YoY, +0.9% ex- forex). Sales ex- forex rose YoY for the third straight quarter, and e",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "9cbe49e820ad13ac",
        "value": 120.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "has increased to the 90% level since 4Q FY3/25. Within this, office solutions 1Q sales amounted to ¥120.0bn (- 5.3% YoY, - 2.7% ex- forex). Within this, MFP sales were - 4%. Domestic sales were flat. ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "8adb6d3c1ce9ab2d",
        "value": 75.8,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Chinese sales in 1Q FY3/25. Exports to Europe and the US declined. Business solution 1Q sales were ¥75.8bn (+7.0% YoY, +9.9% ex- forex). Domestic DX solutions sales and service sales to municipal gove",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "3c2065b2dad5dbfb",
        "value": 77.8,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s an election in Australia, and this pushed up BPO demand. Graphic communications 1Q sales totaled ¥77.8bn (- 5.6% YoY, - 1.4% ex- forex), declining due to lower sales of analogue printing plate mater",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "ed3d3a0db7bc66d8",
        "value": 15.6,
        "unit": "¥",
        "metric_type": "currency",
        "context": "heavy printed books. The company is also strengthening its solutions offerings. 1Q segment OP was ¥15.6bn (+¥1.1bn YoY, +¥2.3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectat",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "aa921fb90e99babe",
        "value": 1.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "nted books. The company is also strengthening its solutions offerings. 1Q segment OP was ¥15.6bn (+¥1.1bn YoY, +¥2.3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectations by r",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "d0420551daa20438",
        "value": 2.3,
        "unit": "¥",
        "metric_type": "currency",
        "context": "he company is also strengthening its solutions offerings. 1Q segment OP was ¥15.6bn (+¥1.1bn YoY, +¥2.3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectations by roughly ¥2.0bn",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "1155075471f8cc22",
        "value": 1.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "solutions offerings. 1Q segment OP was ¥15.6bn (+¥1.1bn YoY, +¥2.3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectations by roughly ¥2.0bn- ¥3.0bn. Sales were about ¥3.0bn bel",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "c32162303e3319c9",
        "value": 2.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "oY, +¥2.3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectations by roughly ¥2.0bn- ¥3.0bn. Sales were about ¥3.0bn below company target but, in addition to strong results for ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "864848938fc2c22e",
        "value": 3.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "3bn ex- forex). Adjusted OP was +¥1.1bn, exceeding internal company expectations by roughly ¥2.0bn- ¥3.0bn. Sales were about ¥3.0bn below company target but, in addition to strong results for business",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "30235c5f8aca0537",
        "value": 3.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "OP was +¥1.1bn, exceeding internal company expectations by roughly ¥2.0bn- ¥3.0bn. Sales were about ¥3.0bn below company target but, in addition to strong results for business innovation, profit incre",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "79ebcb3a072cdc5f",
        "value": 145.3,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s for business innovation, profit increased due to expense curbs. ## (4) Imaging 1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP ",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "8fabde52309e350d",
        "value": 41.8,
        "unit": "¥",
        "metric_type": "currency",
        "context": "to expense curbs. ## (4) Imaging 1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "e198753bf7d08a60",
        "value": 9.2,
        "unit": "¥",
        "metric_type": "currency",
        "context": "e curbs. ## (4) Imaging 1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥6.0bn- ¥7",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "60ff409fac6e2b58",
        "value": 12.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "(4) Imaging 1Q sales totaled ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥6.0bn- ¥7.0bn. This a",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "591e7e6778a67cb7",
        "value": 12.2,
        "unit": "¥",
        "metric_type": "currency",
        "context": "n (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥6.0bn- ¥7.0bn. This appears partly due to early demand ah",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "49e4a979db542693",
        "value": 6.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "1.8bn (+¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥6.0bn- ¥7.0bn. This appears partly due to early demand ahead of Trump tariff rate hikes in Aug, and",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "a93fb42e6e2c8df9",
        "value": 7.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "¥9.2bn YoY, +¥12.1bn ex- forex). Adjusted OP was +¥12.2bn, beating internal expectations by ¥6.0bn- ¥7.0bn. This appears partly due to early demand ahead of Trump tariff rate hikes in Aug, and while t",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "01829db3b00c7099",
        "value": 77.3,
        "unit": "¥",
        "metric_type": "currency",
        "context": "probably some such movement, real earnings remained strong. Within imaging, consumer 1Q sales were ¥77.3bn (+3.7% YoY, +9.9% ex- forex). By region, all regions were upbeat. Japan and China posted 2- d",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "7d7977ce6f389de4",
        "value": 68.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "iety of ways to enjoy their photos, with the aim of expanding business. Professional 1Q sales were ¥68.0bn (+21.1% YoY, +28.7% ex- forex). Digital camera sales rose in Europe, the US, and China. Sales",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "87020693bf510b3f",
        "value": 200000.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "retail price in the ¥200,000 range). Fujifilm continues to launch distinctive new products, and business is going well. ![Figure",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "f3bc395430fababa",
        "value": 75.3,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ex </center> <center>Source: Jefferies, company data </center> ## Change in Profit 1Q OP totaled ¥75.3bn (+¥13.1bn YoY). Within this, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn,",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "b9d1126371735acd",
        "value": 13.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "r> <center>Source: Jefferies, company data </center> ## Change in Profit 1Q OP totaled ¥75.3bn (+¥13.1bn YoY). Within this, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn, one- time",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "c6d33373b28bcbbe",
        "value": 8.7,
        "unit": "¥",
        "metric_type": "currency",
        "context": "center> ## Change in Profit 1Q OP totaled ¥75.3bn (+¥13.1bn YoY). Within this, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn, one- time expenses +¥5.3bn (¥8.9bn in 1Q FY3/26 vs. - ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "2df71a5e87e9f04b",
        "value": 100.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "led ¥75.3bn (+¥13.1bn YoY). Within this, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn, one- time expenses +¥5.3bn (¥8.9bn in 1Q FY3/26 vs. - ¥14.2bn in 1Q FY3/25). Breakdown of 1Q",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "9f80e172ab6b61ee",
        "value": 5.3,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Within this, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn, one- time expenses +¥5.3bn (¥8.9bn in 1Q FY3/26 vs. - ¥14.2bn in 1Q FY3/25). Breakdown of 1Q one- time expenses was heal",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "ff54bf1ceb565932",
        "value": 8.9,
        "unit": "¥",
        "metric_type": "currency",
        "context": "his, forex impact was - ¥8.7bn, change in raw materials prices +¥100mn, one- time expenses +¥5.3bn (¥8.9bn in 1Q FY3/26 vs. - ¥14.2bn in 1Q FY3/25). Breakdown of 1Q one- time expenses was healthcare -",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "93c165ae231d04b8",
        "value": 14.2,
        "unit": "¥",
        "metric_type": "currency",
        "context": ".7bn, change in raw materials prices +¥100mn, one- time expenses +¥5.3bn (¥8.9bn in 1Q FY3/26 vs. - ¥14.2bn in 1Q FY3/25). Breakdown of 1Q one- time expenses was healthcare - ¥8.5bn (planned CDMO oper",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "cfc6a3e958c1bc61",
        "value": 8.5,
        "unit": "¥",
        "metric_type": "currency",
        "context": "8.9bn in 1Q FY3/26 vs. - ¥14.2bn in 1Q FY3/25). Breakdown of 1Q one- time expenses was healthcare - ¥8.5bn (planned CDMO operational pause in Denmark), and business innovation - ¥400mn (expenses relat",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "3f8ea18a5e0ed5ce",
        "value": 400.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "nses was healthcare - ¥8.5bn (planned CDMO operational pause in Denmark), and business innovation - ¥400mn (expenses related to structural upgrade of graphic communications and litigation expenses). I",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "beb54256695b45f9",
        "value": 12.3,
        "unit": "¥",
        "metric_type": "currency",
        "context": "f graphic communications and litigation expenses). In 1Q FY3/25, healthcare one- time expenses were ¥12.3bn (related to structural upgrade to cell and gene therapies in CDMO and upgrade to the commerc",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "eb0ef1251ea58d80",
        "value": 13.5,
        "unit": "¥",
        "metric_type": "currency",
        "context": ". In FY3/26, expecting one- time expenses to decline YoY. FY3/26 guidance for one- time expenses is ¥13.5bn, with healthcare accounting for ¥10.0bn (planned operational pause in Denmark) and business ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "8f41a606e3c38ed7",
        "value": 10.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s to decline YoY. FY3/26 guidance for one- time expenses is ¥13.5bn, with healthcare accounting for ¥10.0bn (planned operational pause in Denmark) and business innovation ¥3.5bn (structural upgrade of",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "f166125858f09627",
        "value": 3.5,
        "unit": "¥",
        "metric_type": "currency",
        "context": "th healthcare accounting for ¥10.0bn (planned operational pause in Denmark) and business innovation ¥3.5bn (structural upgrade of graphic communications and litigation expenses). Of this, ¥8.9bn was i",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "17c14a54f12f39ec",
        "value": 8.9,
        "unit": "¥",
        "metric_type": "currency",
        "context": "innovation ¥3.5bn (structural upgrade of graphic communications and litigation expenses). Of this, ¥8.9bn was incurred in 1Q. Company- wide operations (change adjusted for forex, raw materials prices,",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "f7717be9180c9c3f",
        "value": 16.4,
        "unit": "¥",
        "metric_type": "currency",
        "context": "pany- wide operations (change adjusted for forex, raw materials prices, and one- time expenses was +¥16.4bn, remaining positive for the sixth straight quarter. By segment, healthcare was negative ¥500",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "41c756796ed4ed13",
        "value": 500.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "as +¥16.4bn, remaining positive for the sixth straight quarter. By segment, healthcare was negative ¥500mn. While the negative amount was smaller, it remained negative for the sixth straight quarter. ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "19f7be54a0d64530",
        "value": 1.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "he negative amount was smaller, it remained negative for the sixth straight quarter. The amount was ¥1.0bn- ¥1.5bn less then internal company expectations, due to a smaller- than- expected amount for ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "5e77a307f8b5143b",
        "value": 1.5,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ive amount was smaller, it remained negative for the sixth straight quarter. The amount was ¥1.0bn- ¥1.5bn less then internal company expectations, due to a smaller- than- expected amount for medical ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "9cacf5ebd2d4bba3",
        "value": 4.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "- than- expected amount for medical systems in China. CDMO was in line with plan. Electronics was + ¥4.1bn, turning positive for the first time in three quarters. The amount was approx. ¥500mn higher ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "62483bfb25aa10ba",
        "value": 500.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "tronics was + ¥4.1bn, turning positive for the first time in three quarters. The amount was approx. ¥500mn higher than internal company expectations. Business innovation was +¥1.2bn YoY, remaining pos",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "a6fe22c7159c5a62",
        "value": 1.2,
        "unit": "¥",
        "metric_type": "currency",
        "context": "The amount was approx. ¥500mn higher than internal company expectations. Business innovation was +¥1.2bn YoY, remaining positive YoY for the third straight quarter. The amount was ¥2.0bn- ¥3.0bn above",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "f34734e2b9746d6e",
        "value": 2.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s innovation was +¥1.2bn YoY, remaining positive YoY for the third straight quarter. The amount was ¥2.0bn- ¥3.0bn above internal company expectations. Sales missed plan, but the amount exceeded expec",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "3785579257ecedf5",
        "value": 3.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "tion was +¥1.2bn YoY, remaining positive YoY for the third straight quarter. The amount was ¥2.0bn- ¥3.0bn above internal company expectations. Sales missed plan, but the amount exceeded expectations ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "d654f0cbda4df65e",
        "value": 12.2,
        "unit": "¥",
        "metric_type": "currency",
        "context": "exceeded expectations due to the reduction of low- margin equipment and expense cuts. Imaging was +¥12.2bn, exceeding company expectations by ¥6.0bn- ¥7.0bn. Imaging adjusted profit has been positive ",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "3dcdb085c64f18f9",
        "value": 6.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "of low- margin equipment and expense cuts. Imaging was +¥12.2bn, exceeding company expectations by ¥6.0bn- ¥7.0bn. Imaging adjusted profit has been positive since FY3/22. Mgmt. tends to issue relative",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "574e2acd081a86ec",
        "value": 7.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "margin equipment and expense cuts. Imaging was +¥12.2bn, exceeding company expectations by ¥6.0bn- ¥7.0bn. Imaging adjusted profit has been positive since FY3/22. Mgmt. tends to issue relative conserv",
        "provenance": {
          "page": 7
        }
      },
      {
        "num_id": "755caa165572c4d2",
        "value": 0.152,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>3,257.4</td><td>3,450.0</td><td>3,386.9</td><td>3,474.6</td><td></td></tr><tr><td>YoY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "57483ba97805e9c4",
        "value": 0.132,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>3,450.0</td><td>3,386.9</td><td>3,474.6</td><td></td></tr><tr><td>YoY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "f3d6b3970f4f7b42",
        "value": 0.036000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0</td><td>3,386.9</td><td>3,474.6</td><td></td></tr><tr><td>YoY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td></td></tr><tr",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "0539afb94983e20c",
        "value": 0.079,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "86.9</td><td>3,474.6</td><td></td></tr><tr><td>YoY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td></td></tr><tr><td>Healthca",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "4f6abbfb6526c607",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "3,474.6</td><td></td></tr><tr><td>YoY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td></td></tr><tr><td>Healthcare</td><td>80",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "f4f35c4445841573",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td></tr><tr><td>YoY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td></td></tr><tr><td>Healthcare</td><td>801.7</td><td>9",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "7dd2433582a81c37",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "oY</td><td>15.2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td></td></tr><tr><td>Healthcare</td><td>801.7</td><td>917.9</td><td>975.1</td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "a8ba9d2a8a99565b",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".2%</td><td>13.2%</td><td>3.6%</td><td>7.9%</td><td>2.6%</td><td>1.9%</td><td></td><td>4.0%</td><td>2.6%</td><td></td></tr><tr><td>Healthcare</td><td>801.7</td><td>917.9</td><td>975.1</td><td>1,022.6<",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "f650e3309e36c2b8",
        "value": 0.091,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">325.0</td><td>360.0</td><td>368.0</td><td>400.0</td><td></td></tr><tr><td>Operating margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "4b5d2abe3dc13049",
        "value": 0.096,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>360.0</td><td>368.0</td><td>400.0</td><td></td></tr><tr><td>Operating margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "28b4727f80071b29",
        "value": 0.09300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>368.0</td><td>400.0</td><td></td></tr><tr><td>Operating margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "3ebfdbd156cb4544",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>400.0</td><td></td></tr><tr><td>Operating margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></td></tr><tr><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "5afb166e687e7980",
        "value": 0.10099999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>Operating margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></td></tr><tr><td>Healthcare</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "bde60df1a0aea7a2",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<tr><td>Operating margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></td></tr><tr><td>Healthcare</td><td>100.5</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "8c7d67f5124e5a4a",
        "value": 0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ing margin</td><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></td></tr><tr><td>Healthcare</td><td>100.5</td><td>100.5</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "8630749c32981d06",
        "value": 0.109,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>9.1%</td><td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></td></tr><tr><td>Healthcare</td><td>100.5</td><td>100.5</td><td>97.4</t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "ad8f62561dd245b7",
        "value": 0.115,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>9.6%</td><td>9.3%</td><td>10.3%</td><td>10.1%</td><td>10.0%</td><td>10.4%</td><td>10.9%</td><td>11.5%</td><td></td></tr><tr><td>Healthcare</td><td>100.5</td><td>100.5</td><td>97.4</td><td>77.6</td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "ab0ca0ce6a483c7a",
        "value": 0.125,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>86.0</td><td>69.5</td><td></td><td>102.0</td><td>131.0</td><td></td></tr><tr><td>OPM</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "e6614896dd9b2a81",
        "value": 0.109,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>69.5</td><td></td><td>102.0</td><td>131.0</td><td></td></tr><tr><td>OPM</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "8e7d95465a5b6278",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td>102.0</td><td>131.0</td><td></td></tr><tr><td>OPM</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><td></td></tr><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "0c1d11d6a4694bd6",
        "value": 0.076,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "102.0</td><td>131.0</td><td></td></tr><tr><td>OPM</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><td></td></tr><tr><td>Medical",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "fadb17e281bdd7a5",
        "value": 0.078,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">131.0</td><td></td></tr><tr><td>OPM</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><td></td></tr><tr><td>Medical System</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "4d7727c2b8ac4343",
        "value": 0.065,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td></tr><tr><td>OPM</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><td></td></tr><tr><td>Medical System</td><td>55.0</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "eb5762ff12b4149b",
        "value": 0.086,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "M</td><td>12.5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><td></td></tr><tr><td>Medical System</td><td>55.0</td><td>80.0</td><td>97.0</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "66a36b58fa0bbd9a",
        "value": 0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "5%</td><td>10.9%</td><td>10.0%</td><td>7.6%</td><td>7.8%</td><td>6.5%</td><td></td><td>8.6%</td><td>10.4%</td><td></td></tr><tr><td>Medical System</td><td>55.0</td><td>80.0</td><td>97.0</td><td>90.5</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "c3523063c114028f",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>105.0</td><td>98.0</td><td></td><td>104.0</td><td>114.0</td><td></td></tr><tr><td>OPM</td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "4262047f72671278",
        "value": 0.131,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>98.0</td><td></td><td>104.0</td><td>114.0</td><td></td></tr><tr><td>OPM</td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "07e7fa6514599d13",
        "value": 0.147,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td>104.0</td><td>114.0</td><td></td></tr><tr><td>OPM</td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</td><td></td></",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "e9181859fbe8ff64",
        "value": 0.131,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "104.0</td><td>114.0</td><td></td></tr><tr><td>OPM</td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</td><td></td></tr><tr><td>CDM",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "53db6c98d4f323ef",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "114.0</td><td></td></tr><tr><td>OPM</td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</td><td></td></tr><tr><td>CDMO</td><td>31.0",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "278cb3c9e838e3a4",
        "value": 0.139,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>OPM</td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</td><td></td></tr><tr><td>CDMO</td><td>31.0</td><td>19.2<",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "384ea2589d65f392",
        "value": 0.138,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>10.3%</td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</td><td></td></tr><tr><td>CDMO</td><td>31.0</td><td>19.2</td><td>12.0</td><td>-1",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "97992a447d14e634",
        "value": 0.149,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>13.1%</td><td>14.7%</td><td>13.1%</td><td>15.0%</td><td>13.9%</td><td></td><td>13.8%</td><td>14.9%</td><td></td></tr><tr><td>CDMO</td><td>31.0</td><td>19.2</td><td>12.0</td><td>-19.0</td><td>-1",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "7238d797ee449efb",
        "value": 0.20600000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>-16.0</td><td>-19.0</td><td></td><td>1.0</td><td>15.0</td><td></td></tr><tr><td>OPM</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "67dbae54a18940de",
        "value": 0.099,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>-19.0</td><td></td><td>1.0</td><td>15.0</td><td></td></tr><tr><td>OPM</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "3e20c4a2c7927bd8",
        "value": 0.059000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td>1.0</td><td>15.0</td><td></td></tr><tr><td>OPM</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><td></td></tr>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "f6e46733522e9b88",
        "value": -0.087,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>1.0</td><td>15.0</td><td></td></tr><tr><td>OPM</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><td></td></tr><tr><td>One t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "a196545469e22e44",
        "value": -0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>15.0</td><td></td></tr><tr><td>OPM</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><td></td></tr><tr><td>One time cost</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "13a137fa9706b554",
        "value": -0.075,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td></tr><tr><td>OPM</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><td></td></tr><tr><td>One time cost</td><td>0.0</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "fe24e899a0722153",
        "value": 0.003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>20.6%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><td></td></tr><tr><td>One time cost</td><td>0.0</td><td>0.0</td><td>0.0</td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "1c35d93a34cc23ef",
        "value": 0.042,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>9.9%</td><td>5.9%</td><td>-8.7%</td><td>-6.2%</td><td>-7.5%</td><td></td><td>0.3%</td><td>4.2%</td><td></td></tr><tr><td>One time cost</td><td>0.0</td><td>0.0</td><td>0.0</td><td>-18.0</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "ec6d4d65105d54d2",
        "value": 0.134,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "764.4</td><td>749.5</td><td>754.9</td><td>854.5</td><td>898.5</td><td></td></tr><tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d1f3a31e3ae15050",
        "value": 0.134,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "749.5</td><td>754.9</td><td>854.5</td><td>898.5</td><td></td></tr><tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "018de93bae6df4cd",
        "value": 0.052000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "754.9</td><td>854.5</td><td>898.5</td><td></td></tr><tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "ef182374d9be85a0",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">854.5</td><td>898.5</td><td></td></tr><tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "b958913a0f114d1a",
        "value": 0.159,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>898.5</td><td></td></tr><tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></tr><tr><td>He",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "015e8a6538b36d45",
        "value": 0.021,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td></tr><tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></tr><tr><td>Healthcare</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "a14a9c0b473ff549",
        "value": 0.001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><td>YoY</td><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></tr><tr><td>Healthcare</td><td>229.2</td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "a7bac968224bd5f1",
        "value": -0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>13.4%</td><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></tr><tr><td>Healthcare</td><td>229.2</td><td>235.2</td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "c81a669fd40af8f5",
        "value": 0.051,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>13.4%</td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></tr><tr><td>Healthcare</td><td>229.2</td><td>235.2</td><td>242.9</td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "b3a295a61282577e",
        "value": 0.035,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>5.2%</td><td>6.0%</td><td>15.9%</td><td>2.1%</td><td>0.1%</td><td>-1.4%</td><td>5.1%</td><td>3.5%</td><td></td></tr><tr><td>Healthcare</td><td>229.2</td><td>235.2</td><td>242.9</td><td>240.5</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "09748fbb49b754cb",
        "value": 0.083,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>75.3</td><td>78.0</td><td>88.0</td><td>83.7</td><td></td></tr><tr><td>Operating margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "64b0a9b8cb2dfb1a",
        "value": 0.083,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>78.0</td><td>88.0</td><td>83.7</td><td></td></tr><tr><td>Operating margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "8463c07d36f2eeae",
        "value": 0.096,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>88.0</td><td>83.7</td><td></td></tr><tr><td>Operating margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "1de16b406c47c60b",
        "value": 0.10800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>83.7</td><td></td></tr><tr><td>Operating margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "cbb8b50ecb3c7e64",
        "value": 0.12300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>Operating margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td></tr><tr><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "91b423536b2f264b",
        "value": 0.08900000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<tr><td>Operating margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td></tr><tr><td>Healthcare</td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "89bc02a7f9dd274b",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ting margin</td><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td></tr><tr><td>Healthcare</td><td>3.4</td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "6b61611cbdff41bb",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>8.3%</td><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td></tr><tr><td>Healthcare</td><td>3.4</td><td>3.5</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "368e65438fc08f60",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>8.3%</td><td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td></tr><tr><td>Healthcare</td><td>3.4</td><td>3.5</td><td>18.8</td><td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "af44365855b93b38",
        "value": 0.09300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>9.6%</td><td>10.8%</td><td>12.3%</td><td>8.9%</td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>9.3%</td><td></td></tr><tr><td>Healthcare</td><td>3.4</td><td>3.5</td><td>18.8</td><td>10.6</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "4fbdcfee91cea9f0",
        "value": 0.015,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>13.0</td><td>4.3</td><td>24.5</td><td>20.5</td><td>20.2</td><td></td></tr><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d94851e13d023307",
        "value": 0.015,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>4.3</td><td>24.5</td><td>20.5</td><td>20.2</td><td></td></tr><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "dc572e6d5fc3598d",
        "value": 0.077,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>24.5</td><td>20.5</td><td>20.2</td><td></td></tr><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "da5c892bd3ddcd00",
        "value": 0.044000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>20.5</td><td>20.2</td><td></td></tr><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "85531db88c089eef",
        "value": 0.14400000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>20.2</td><td></td></tr><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></tr><tr><td>Me",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "5d73f5a13932ad47",
        "value": 0.053,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></tr><tr><td>Medical System</",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "a6aae1ce82d1959a",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>OPM</td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></tr><tr><td>Medical System</td><td>19.0</",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "4b89aacde30c2407",
        "value": 0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>1.5%</td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></tr><tr><td>Medical System</td><td>19.0</td><td>0.0</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "a8a6c83ff56e730f",
        "value": 0.069,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>1.5%</td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></tr><tr><td>Medical System</td><td>19.0</td><td>0.0</td><td>23.0</td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "955b9063cd755a01",
        "value": 0.065,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>7.7%</td><td>4.4%</td><td>14.4%</td><td>5.3%</td><td>1.9%</td><td>10.4%</td><td>6.9%</td><td>6.5%</td><td></td></tr><tr><td>Medical System</td><td>19.0</td><td>0.0</td><td>23.0</td><td>18.0</td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "75dd5632b60e7af5",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>23.0</td><td>14.0</td><td>26.0</td><td>27.0</td><td>31.0</td><td></td></tr><tr><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "2e45f0ca68bc1960",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>14.0</td><td>26.0</td><td>27.0</td><td>31.0</td><td></td></tr><tr><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "8b1795e5c7f94806",
        "value": 0.138,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>26.0</td><td>27.0</td><td>31.0</td><td></td></tr><tr><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "c6dbe02b34f3a485",
        "value": 0.111,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>27.0</td><td>31.0</td><td></td></tr><tr><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "eae13537b9a9cdf8",
        "value": 0.146,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>31.0</td><td></td></tr><tr><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></td></tr><tr><td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "686d88eb45299721",
        "value": 0.141,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td></tr><tr><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></td></tr><tr><td>CDMO</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "664abaa869c6e5fc",
        "value": 0.09699999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>OPM</td><td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></td></tr><tr><td>CDMO</td><td>-11.0</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "8c7712af0b7d2929",
        "value": 0.149,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>12.0%</td><td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></td></tr><tr><td>CDMO</td><td>-11.0</td><td>0.0</td><td>-",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "eaaa040cbb5276e6",
        "value": 0.154,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>0.0%</td><td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></td></tr><tr><td>CDMO</td><td>-11.0</td><td>0.0</td><td>-2.0</td><td>-5",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "2e79896b8748e9c5",
        "value": 0.146,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>13.8%</td><td>11.1%</td><td>14.6%</td><td>14.1%</td><td>9.7%</td><td>14.9%</td><td>15.4%</td><td>14.6%</td><td></td></tr><tr><td>CDMO</td><td>-11.0</td><td>0.0</td><td>-2.0</td><td>-5.0</td><td>-1.",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "55d1abe87fcb34b8",
        "value": -0.23399999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-7.0</td><td>-7.5</td><td>-0.5</td><td>-5.5</td><td>-5.5</td><td></td></tr><tr><td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "83aa86addbcf29b4",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-7.5</td><td>-0.5</td><td>-5.5</td><td>-5.5</td><td></td></tr><tr><td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "b03bef2592646fe5",
        "value": -0.042,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-0.5</td><td>-5.5</td><td>-5.5</td><td></td></tr><tr><td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "70be69802f180ba2",
        "value": -0.09699999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-5.5</td><td>-5.5</td><td></td></tr><tr><td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "0b2a15002d71a3d9",
        "value": -0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-5.5</td><td></td></tr><tr><td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td></td></tr><tr>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "3d1d604bd9a60349",
        "value": -0.127,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td></td></tr><tr><td>One time c",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "6450468d8dd5ec22",
        "value": -0.141,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>OPM</td><td>-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td></td></tr><tr><td>One time cost</td><td>-11",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "69772778a4f422d5",
        "value": -0.009000000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "-23.4%</td><td>0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td></td></tr><tr><td>One time cost</td><td>-11.0</td><td>0.0<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "bfd2957b36ebcfdd",
        "value": -0.087,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">0.0%</td><td>-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td></td></tr><tr><td>One time cost</td><td>-11.0</td><td>0.0</td><td>-5.0</",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d3bdc508b542c56c",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "-4.2%</td><td>-9.7%</td><td>-1.4%</td><td>-12.7%</td><td>-14.1%</td><td>-0.9%</td><td>-8.7%</td><td>-7.0%</td><td></td></tr><tr><td>One time cost</td><td>-11.0</td><td>0.0</td><td>-5.0</td><td>-2.0</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "71b2f1ea7c29be16",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Full- FY3/26 guidance for sales, OP, and NP left unchanged. Guidance is for sales of \\(3.28trn\\) (\\$2.6% YoY, \\(+5.3\\%\\) ex- forex) and OP \\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "35cdf5267508e4d6",
        "value": 0.003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "nged. Guidance is for sales of \\(3.28trn\\) (\\$2.6% YoY, \\(+5.3\\%\\) ex- forex) and OP \\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\) (\\$0.2ppt YoY), and NP \\(262.0bn\\) (\\$0.4%). Guidanc",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "e137b7cbf80e3c2a",
        "value": 0.004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\) (\\$0.2ppt YoY), and NP \\(262.0bn\\) (\\$0.4%). Guidance for sales and OP to rise for the fifth straight year and to achieve new record highs",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "6c748c1f74286cf1",
        "value": 0.046,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "and OP to rise for the fifth straight year and to achieve new record highs. Assuming \\(145 / 5\\) (\\$4.6% yen appreciation) and \\(157 / 5\\) (\\$4.3% yen appreciation). Full- year assumption adjusted sli",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "3e31de55a891f1de",
        "value": 0.043,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "and to achieve new record highs. Assuming \\(145 / 5\\) (\\$4.6% yen appreciation) and \\(157 / 5\\) (\\$4.3% yen appreciation). Full- year assumption adjusted slightly vs. previous \\(145 / 5\\) and \\(155 / ",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "5f66b9b07d6a189c",
        "value": 0.052000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "- term plan (VISION 2030) announced on 17 Apr 2024. The plan targets FY3/27 sales of \\(3.45trn\\) (\\$5.2% CAGR) and OP \\(360.0bn\\) (\\$9.1% CAGR), for an OPM of \\(10.4\\%\\) . Assuming \\(140 / 5\\) and \\(1",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "a568d64025bd613a",
        "value": 0.091,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ed on 17 Apr 2024. The plan targets FY3/27 sales of \\(3.45trn\\) (\\$5.2% CAGR) and OP \\(360.0bn\\) (\\$9.1% CAGR), for an OPM of \\(10.4\\%\\) . Assuming \\(140 / 5\\) and \\(150 / 5\\) . Compared with FY3/26 g",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "0dba873c3fbe7379",
        "value": 35.3,
        "unit": "$",
        "metric_type": "currency",
        "context": "End- 1Q FY3/26 cash & deposits amounted to \\(159.9bn\\) (\\$35.3bn). 1Q fixed tangible asset investment totaled \\(116.6bn\\) (\\$2.0bn YoY). Within this, healthcare",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "500299e572366f25",
        "value": 2.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "osits amounted to \\(159.9bn\\) (\\$35.3bn). 1Q fixed tangible asset investment totaled \\(116.6bn\\) (\\$2.0bn YoY). Within this, healthcare accounted for \\(105.3bn\\) (\\$4.0bn YoY). Of healthcare capex, CD",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "aab0ea2647552a14",
        "value": 4.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "t investment totaled \\(116.6bn\\) (\\$2.0bn YoY). Within this, healthcare accounted for \\(105.3bn\\) (\\$4.0bn YoY). Of healthcare capex, CDMO accounted for approx. \\(80\\%\\) . Full- FY3/26 guidance for \\(",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "95869f68b7771430",
        "value": 60.1,
        "unit": "$",
        "metric_type": "currency",
        "context": "Of healthcare capex, CDMO accounted for approx. \\(80\\%\\) . Full- FY3/26 guidance for \\(462.0bn\\) (\\$60.1bn). Guidance unchanged vs. initial, including segment breakdown. Of this, projected healthcare ",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "23f79ea1a6e92057",
        "value": 110.2,
        "unit": "$",
        "metric_type": "currency",
        "context": "vs. initial, including segment breakdown. Of this, projected healthcare investment is \\(339.0bn\\) (\\$110.2bn). FY3/26 expected to decline from a peak set in FY3/25. Electronics guidance for \\(63.0bn\\)",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "afa1ea335420db88",
        "value": 24.1,
        "unit": "$",
        "metric_type": "currency",
        "context": "0.2bn). FY3/26 expected to decline from a peak set in FY3/25. Electronics guidance for \\(63.0bn\\) (\\$24.1bn). 1Q depreciation was \\(40.9bn\\) (\\$1.2bn YoY). Of this, healthcare accounted for \\(17.2bn\\)",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "6637070776d6026e",
        "value": 1.2,
        "unit": "$",
        "metric_type": "currency",
        "context": "ak set in FY3/25. Electronics guidance for \\(63.0bn\\) (\\$24.1bn). 1Q depreciation was \\(40.9bn\\) (\\$1.2bn YoY). Of this, healthcare accounted for \\(17.2bn\\) (\\$2.2bn YoY). Within this, we estimate tha",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "ccae7ceae42c720f",
        "value": 2.2,
        "unit": "$",
        "metric_type": "currency",
        "context": "1bn). 1Q depreciation was \\(40.9bn\\) (\\$1.2bn YoY). Of this, healthcare accounted for \\(17.2bn\\) (\\$2.2bn YoY). Within this, we estimate that CDMO made up around \\(80\\%\\) (\\$2.0bn YoY). FY3/26 guidanc",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "46995b267d3745ba",
        "value": 2.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "ccounted for \\(17.2bn\\) (\\$2.2bn YoY). Within this, we estimate that CDMO made up around \\(80\\%\\) (\\$2.0bn YoY). FY3/26 guidance for \\(188.0bn\\) (\\$24.4bn), unchanged vs. initial guidance, including s",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "d8f1bf22fd8fec60",
        "value": 24.4,
        "unit": "$",
        "metric_type": "currency",
        "context": "is, we estimate that CDMO made up around \\(80\\%\\) (\\$2.0bn YoY). FY3/26 guidance for \\(188.0bn\\) (\\$24.4bn), unchanged vs. initial guidance, including segment breakdown. Healthcare projected at \\(84.0",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "6742afb6b0aabd52",
        "value": 22.5,
        "unit": "$",
        "metric_type": "currency",
        "context": ", unchanged vs. initial guidance, including segment breakdown. Healthcare projected at \\(84.0bn\\) (\\$22.5bn). We estimate that CDMO investment will rise by around \\(15.0bn\\). 1Q R&D expenses were \\(40",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "2b6606feb17cda50",
        "value": 6.2,
        "unit": "$",
        "metric_type": "currency",
        "context": "We estimate that CDMO investment will rise by around \\(15.0bn\\). 1Q R&D expenses were \\(40.6bn\\) (\\$6.2bn YoY), for a ratio to sales of \\(5.4\\%\\) (flat YoY). Of this, healthcare accounted for \\(14.8bn",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "45a222b599ad8242",
        "value": 1.1,
        "unit": "$",
        "metric_type": "currency",
        "context": "YoY), for a ratio to sales of \\(5.4\\%\\) (flat YoY). Of this, healthcare accounted for \\(14.8bn\\) (\\$1.1bn). Healthcare R&D expense/sales ratio was \\(6.5\\%\\) , electronics \\(6.8\\%\\) , business innovati",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "71b2f1ea7c29be16",
        "value": 2.6,
        "unit": "$",
        "metric_type": "currency",
        "context": "Full- FY3/26 guidance for sales, OP, and NP left unchanged. Guidance is for sales of \\(3.28trn\\) (\\$2.6% YoY, \\(+5.3\\%\\) ex- forex) and OP \\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "a74b27719357bb35",
        "value": 0.3,
        "unit": "$",
        "metric_type": "currency",
        "context": "anged. Guidance is for sales of \\(3.28trn\\) (\\$2.6% YoY, \\(+5.3\\%\\) ex- forex) and OP \\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\) (\\$0.2ppt YoY), and NP \\(262.0bn\\) (\\$0.4%). Guidan",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "7ddf859b7a218f8b",
        "value": 0.2,
        "unit": "$",
        "metric_type": "currency",
        "context": "YoY, \\(+5.3\\%\\) ex- forex) and OP \\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\) (\\$0.2ppt YoY), and NP \\(262.0bn\\) (\\$0.4%). Guidance for sales and OP to rise for the fifth straight y",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "49ed8cdbdd467862",
        "value": 0.4,
        "unit": "$",
        "metric_type": "currency",
        "context": "\\(331.0bn\\) (\\$0.3% YoY, \\(+9.4\\%\\) ex- forex), OPM \\(10.1\\%\\) (\\$0.2ppt YoY), and NP \\(262.0bn\\) (\\$0.4%). Guidance for sales and OP to rise for the fifth straight year and to achieve new record high",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "6c748c1f74286cf1",
        "value": 4.6,
        "unit": "$",
        "metric_type": "currency",
        "context": "and OP to rise for the fifth straight year and to achieve new record highs. Assuming \\(145 / 5\\) (\\$4.6% yen appreciation) and \\(157 / 5\\) (\\$4.3% yen appreciation). Full- year assumption adjusted sli",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "610d3473463bcc6a",
        "value": 4.3,
        "unit": "$",
        "metric_type": "currency",
        "context": "r and to achieve new record highs. Assuming \\(145 / 5\\) (\\$4.6% yen appreciation) and \\(157 / 5\\) (\\$4.3% yen appreciation). Full- year assumption adjusted slightly vs. previous \\(145 / 5\\) and \\(155 ",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "3c313c28c96d4fe0",
        "value": 7.5,
        "unit": "$",
        "metric_type": "currency",
        "context": "actual rates. Assumption for 2Q onward left unchanged. One- time expenses projected at \\(13.5bn\\) (\\$7.5bn YoY), unchanged from previous. Tariff impact of \\(6.0bn\\) now factored into guidance, buy pla",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "606f78d1f7e65618",
        "value": 37.6,
        "unit": "$",
        "metric_type": "currency",
        "context": "plans are to mitigation through business changes in each segment. Guidance for adjusted profit \\(+\\$ 37.6bn\\) (\\$6.5bn vs. previous). DPS projected at \\(70\\) (\\$500mn YoY) and a payout ratio of \\(32.2",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "f45f3d72a499a4b5",
        "value": 6.5,
        "unit": "$",
        "metric_type": "currency",
        "context": "mitigation through business changes in each segment. Guidance for adjusted profit \\(+\\$ 37.6bn\\) (\\$6.5bn vs. previous). DPS projected at \\(70\\) (\\$500mn YoY) and a payout ratio of \\(32.2\\%\\) . Aiming",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "925ee64e22f19021",
        "value": 500.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "ment. Guidance for adjusted profit \\(+\\$ 37.6bn\\) (\\$6.5bn vs. previous). DPS projected at \\(70\\) (\\$500mn YoY) and a payout ratio of \\(32.2\\%\\) . Aiming for shareholder return of \\(30\\%\\) . Med- term",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "2d8d0db54523ccd4",
        "value": 5.2,
        "unit": "$",
        "metric_type": "currency",
        "context": "d- term plan (VISION 2030) announced on 17 Apr 2024. The plan targets FY3/27 sales of \\(3.45trn\\) (\\$5.2% CAGR) and OP \\(360.0bn\\) (\\$9.1% CAGR), for an OPM of \\(10.4\\%\\) . Assuming \\(140 / 5\\) and \\(",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "160aecd7662420e1",
        "value": 9.1,
        "unit": "$",
        "metric_type": "currency",
        "context": "ced on 17 Apr 2024. The plan targets FY3/27 sales of \\(3.45trn\\) (\\$5.2% CAGR) and OP \\(360.0bn\\) (\\$9.1% CAGR), for an OPM of \\(10.4\\%\\) . Assuming \\(140 / 5\\) and \\(150 / 5\\) . Compared with FY3/26 ",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "df770b3c8e6ab9a9",
        "value": 100.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "term plan targets. ## Tariff Impact Fujifilm had initially disclosed a calculation of \\(140mn\\) (\\$100mn), which was not initially factored into FY3/6 guidance. The \\(140mn\\) estimate was calculated a",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "40bd1c00f93b3f65",
        "value": 40.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "revisions and supply chain changes, mgmt. has now factored in a net negative for OP of \\(6.0bn\\) (\\$40mn). Plans are to cover this with operational initiatives (healthcare \\(4.0bn\\) and \\(1.0bn\\) each",
        "provenance": {
          "page": 13
        }
      },
      {
        "num_id": "b3a170c6adf5ac4d",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "company- wide OP. Initial FY3/26 guidance is shown below. Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). B",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "63a32ddb1238298e",
        "value": 0.083,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "de OP. Initial FY3/26 guidance is shown below. Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegmen",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "94b68de234196991",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "+ ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%). Bio- CDMO EBITDA margin (ex",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "77a4defa2cf52de8",
        "value": 0.184,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%). Bio- CDMO EBITDA margin (ex- forex) expected to be in the",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "ad32c517d2b937ae",
        "value": 0.037000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "idance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%). Bio- CDMO EBITDA margin (ex- forex) expected to be in the mid- teens (low- teens in FY3/25).",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "91f8db60907ecbe8",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "cted to rise and LS Solutions to rebound slightly YoY. Electronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn).",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "8788726f2c57e8c5",
        "value": 0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "e and LS Solutions to rebound slightly YoY. Electronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guid",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "de6415797455301a",
        "value": 0.18,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semiconductor materials ¥260.0bn (+18% YoY) and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "5648f1f85434f21b",
        "value": 0.018000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Sales guidance breakdown is semiconductor materials ¥260.0bn (+18% YoY) and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0b",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "0c05092a4d55dbfa",
        "value": 0.018000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "(+18% YoY) and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sale",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "6827c13a20ac6404",
        "value": 0.032,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance ",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "0a51789dee80abed",
        "value": 0.025,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging gui",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "ee21a1a675872211",
        "value": 0.11800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0bn (- 0.4%",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "a00cf6195df3f5da",
        "value": 0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0bn (- 0.4%, +3.1% ex- forex) and OP ¥127.0bn (- ¥12.2bn Y",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "d94821afc0f92bf0",
        "value": 0.004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "n (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0bn (- 0.4%, +3.1% ex- forex) and OP ¥127.0bn (- ¥12.2bn YoY, - ¥4.2bn ex- forex, adjusted OP +¥1.3bn). 1Q s",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "1ab185bb5588def6",
        "value": 0.031,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0bn (- 0.4%, +3.1% ex- forex) and OP ¥127.0bn (- ¥12.2bn YoY, - ¥4.2bn ex- forex, adjusted OP +¥1.3bn). 1Q sales w",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "035e41113b3d5997",
        "value": 0.11199999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ") and OP ¥127.0bn (- ¥12.2bn YoY, - ¥4.2bn ex- forex, adjusted OP +¥1.3bn). 1Q sales were ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn, and adjusted profit +¥12.2bn).<",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "70ecc20026de4c29",
        "value": 0.179,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7.0bn (- ¥12.2bn YoY, - ¥4.2bn ex- forex, adjusted OP +¥1.3bn). 1Q sales were ¥145.3bn (+11.2% YoY, +17.9% ex- forex) and OP ¥41.8bn (+¥9.2bn YoY, +¥12.1bn, and adjusted profit +¥12.2bn).<｜end▁of▁sent",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "b48583a5d94c53b3",
        "value": 145.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "so, the yen is much weaker vs. the euro compared with the company's forex assumption for 2Q onward (¥145/\\\\( and ¥155/\\)). Assuming a full- year rate of ¥165/€, we estimate a ¥4.0bn addition to compan",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "3e958f5fc0115e20",
        "value": 155.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s much weaker vs. the euro compared with the company's forex assumption for 2Q onward (¥145/\\\\( and ¥155/\\)). Assuming a full- year rate of ¥165/€, we estimate a ¥4.0bn addition to company- wide OP. I",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "f63f1707b66018bd",
        "value": 165.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "the company's forex assumption for 2Q onward (¥145/\\\\( and ¥155/\\)). Assuming a full- year rate of ¥165/€, we estimate a ¥4.0bn addition to company- wide OP. Initial FY3/26 guidance is shown below. He",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "747b242469cab946",
        "value": 4.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ssumption for 2Q onward (¥145/\\\\( and ¥155/\\)). Assuming a full- year rate of ¥165/€, we estimate a ¥4.0bn addition to company- wide OP. Initial FY3/26 guidance is shown below. Healthcare FY3/26 guida",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "60df123a1555ea9f",
        "value": 1.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ition to company- wide OP. Initial FY3/26 guidance is shown below. Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥1",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "897118064a9c4401",
        "value": 86.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "uidance is shown below. Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "31773a135be14e1b",
        "value": 6.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "shown below. Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "cf1a58b5560f4d19",
        "value": 12.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ow. Healthcare FY3/26 guidance for ¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1%",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "2670f5e41c8f89fa",
        "value": 14.2,
        "unit": "¥",
        "metric_type": "currency",
        "context": "¥1.1trn (+5.0% YoY, +8.3% ex- forex) and OP ¥86.0bn (+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), ",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "da212778271a9fa2",
        "value": 700.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "(+¥6.1bn, + ¥12.1bn ex- forex, adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%). Bio- CDMO EBITDA ",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "7bbfdbb457e079b1",
        "value": 260.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": ", adjusted profit +¥14.2bn). By subsegment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%). Bio- CDMO EBITDA margin (ex- forex) expected t",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "b72dc3b45cd600f4",
        "value": 140.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "egment, guidance for medical sales ¥700.0bn (+1% YoY) Bio- CDMO ¥260.0bn (+18.4%), and LS Solutions ¥140.0bn (+3.7%). Bio- CDMO EBITDA margin (ex- forex) expected to be in the mid- teens (low- teens i",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "7d058ef851f12a83",
        "value": 10.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "(ex- forex) expected to be in the mid- teens (low- teens in FY3/25). Onetime expenses projected at ¥10.0bn (¥18.0bn). OP guidance for negative ¥16.0bn (+¥3.0bn YoY). In FY3/26, outlook for adjusted CD",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "5735ba5647ef0539",
        "value": 18.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ex) expected to be in the mid- teens (low- teens in FY3/25). Onetime expenses projected at ¥10.0bn (¥18.0bn). OP guidance for negative ¥16.0bn (+¥3.0bn YoY). In FY3/26, outlook for adjusted CDMO profi",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "e6330a8a976c3263",
        "value": 16.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s (low- teens in FY3/25). Onetime expenses projected at ¥10.0bn (¥18.0bn). OP guidance for negative ¥16.0bn (+¥3.0bn YoY). In FY3/26, outlook for adjusted CDMO profit to decline due to higher deprecia",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "3e6b0741858e5f9b",
        "value": 3.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ens in FY3/25). Onetime expenses projected at ¥10.0bn (¥18.0bn). OP guidance for negative ¥16.0bn (+¥3.0bn YoY). In FY3/26, outlook for adjusted CDMO profit to decline due to higher depreciation, whil",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "abfd89b037c5592e",
        "value": 420.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "it is expected to rise and LS Solutions to rebound slightly YoY. Electronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "9ee9e9242e9e566a",
        "value": 76.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "bound slightly YoY. Electronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semico",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "29717e64eba7aa28",
        "value": 2.9,
        "unit": "¥",
        "metric_type": "currency",
        "context": "htly YoY. Electronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semiconductor ma",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "7241fcd9f3493aac",
        "value": 6.9,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ectronics guidance for sales of ¥420.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semiconductor materials ¥260",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "39c71f4a2a4b14a8",
        "value": 6.9,
        "unit": "¥",
        "metric_type": "currency",
        "context": "0.0bn (+3.0% YoY, +6.2% ex- forex) and OP ¥76.0bn (+¥2.9bn YoY, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semiconductor materials ¥260.0bn (+18% YoY) and AF materials ¥1",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "888d69f5e0c4ec5f",
        "value": 260.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Y, +¥6.9bn ex- forex, and adjusted OP +¥6.9bn). Sales guidance breakdown is semiconductor materials ¥260.0bn (+18% YoY) and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "66c747edb54767a6",
        "value": 160.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "+¥6.9bn). Sales guidance breakdown is semiconductor materials ¥260.0bn (+18% YoY) and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "82da254e4b6dd453",
        "value": 1.22,
        "unit": "¥",
        "metric_type": "currency",
        "context": "s ¥260.0bn (+18% YoY) and AF materials ¥160.0bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "3853c7fe926fc7e3",
        "value": 79.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "bn (+1.8%). Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office sol",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "c37e28ae47e4e743",
        "value": 4.4,
        "unit": "¥",
        "metric_type": "currency",
        "context": ". Business innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥51",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "60340007b22db7a6",
        "value": 7.4,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ss innovation guidance for sales of ¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (-",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "f546f5a6868b9260",
        "value": 9.1,
        "unit": "¥",
        "metric_type": "currency",
        "context": "¥1.22trn (+1.8% YoY, +3.2% ex- forex) and OP ¥79.0bn (+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "a7080089b952343b",
        "value": 510.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "(+¥4.4bn, +¥7.4bn ex- forex, and adjusted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%).",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "0f8f0eda48dacb21",
        "value": 370.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "sted OP +¥9.1bn). Sales guidance breakdown is office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "d977e834fb58ecb6",
        "value": 340.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "office solutions ¥510.0bn (- 2.5%), business solitons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0bn (- 0.4%, +3.1% ex- forex) and OP ¥127.0bn (",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "9d01c65768543d2f",
        "value": 540.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "tons ¥370.0bn (+11.8%), and graphic communication ¥340.0bn (- 1.4%). Imaging guidance for sales of ¥540.0bn (- 0.4%, +3.1% ex- forex) and OP ¥127.0bn (- ¥12.2bn YoY, - ¥4.2bn ex- forex, adjusted OP +¥",
        "provenance": {
          "page": 15
        }
      },
      {
        "num_id": "f65b6399e141ff07",
        "value": 0.105,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>New segment</td></tr><tr><td>Sales</td><td>2,192.5</td><td>2,700.0</td><td>2,960.9</td><td>10.5%</td><td>3,150.0</td><td>3,195.8</td><td>3,195.8</td><td>3,195.8</td><td>3,280.0</td><td>3,450.",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "3f1ed0d55407a222",
        "value": 0.052000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>3,150.0</td><td>3,195.8</td><td>3,195.8</td><td>3,195.8</td><td>3,280.0</td><td>3,450.0</td><td>5.2%</td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>580.0</td><td>860.0</td><td>975.",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "7910f737b96c6a8f",
        "value": 0.18899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>580.0</td><td>860.0</td><td>975.1</td><td>18.9%</td><td>1,000.0</td><td>1,022.6</td><td>1,047.8</td><td>1,100.0</td><td>1,200.0</td><td>7.2%</",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "1012c7c391505633",
        "value": 0.07200000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>18.9%</td><td>1,000.0</td><td>1,022.6</td><td>1,047.8</td><td>1,100.0</td><td>1,200.0</td><td>7.2%</td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>569.5</td><td>720.0</td>",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "8434ff43bdb4a943",
        "value": 0.066,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td></td><td></td></tr><tr><td>Materials</td><td>569.5</td><td>720.0</td><td>690.0</td><td>6.6%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "5114c7c2449e8add",
        "value": 0.028999999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td></td></tr><tr><td>Business Innovation</td><td>757.8</td><td>820.0</td><td>826.1</td><td>2.9%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "5c6999920034a12f",
        "value": 0.18100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td><td></td><td></td></tr><tr><td>Imaging</td><td>285.2</td><td>300.0</td><td>469.7</td><td>18.1%</td><td>530.0</td><td>542.0</td><td>542.0</td><td>540.0</td><td>505.0</td><td>2.4%</td><td></t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "d2cb371667503a45",
        "value": 0.024,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>469.7</td><td>18.1%</td><td>530.0</td><td>542.0</td><td>542.0</td><td>540.0</td><td>505.0</td><td>2.4%</td><td></td><td></td><td></td><td></td></tr><tr><td>Electronics</td><td></td><td></td><td></td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "dbbf704e7f04739a",
        "value": 0.09300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>360.0</td><td></td><td>430.0</td><td>432.8</td><td>407.6</td><td>420.0</td><td>470.0</td><td>9.3%</td><td></td><td></td><td></td></tr><tr><td>Business Innovation (New)</td><td></td><td></td><td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "fffb63a3d0975d0d",
        "value": 0.033,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".0</td><td></td><td>1,190.0</td><td>1,198.5</td><td>1,198.5</td><td>1,220.0</td><td>1,275.0</td><td>3.3%</td><td></td><td></td><td></td></tr><tr><td>OP</td><td>165.5</td><td>260.0</td><td>276.7</td><t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "0f8ba91e748fa933",
        "value": 0.187,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "3%</td><td></td><td></td><td></td></tr><tr><td>OP</td><td>165.5</td><td>260.0</td><td>276.7</td><td>18.7%</td><td>315.0</td><td>330.2</td><td>330.2</td><td>331.0</td><td>360.0</td><td>9.2%</td><td></t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "143efa4a886743c8",
        "value": 0.092,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>276.7</td><td>18.7%</td><td>315.0</td><td>330.2</td><td>330.2</td><td>331.0</td><td>360.0</td><td>9.2%</td><td></td><td></td><td></td><td></td></tr><tr><td>One time cost</td><td>24.0</td><td></td><t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "f04898902b67debf",
        "value": 0.086,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>336.7</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Adjusted OPM</td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "1565e7e13f9521f4",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Adjusted OPM</td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</td><td></td><t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "68a68ac2e016f94e",
        "value": 0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td><td></td><td></td></tr><tr><td>Adjusted OPM</td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</td><td></td><td></td><td></t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "044da391846638c7",
        "value": 0.106,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td><td></td></tr><tr><td>Adjusted OPM</td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</td><td></td><td></td><td></td><td></td><td></td><td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "7f27ea1c15468bd8",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></tr><tr><td>Adjusted OPM</td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "ab16807c7289fa05",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">Adjusted OPM</td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcar",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "b8266580c9168f19",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>8.6%</td><td>10.0%</td><td>10.4%</td><td></td><td>10.6%</td><td>11.0%</td><td>11.0%</td><td>10.3%</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>55.8",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "56663f9f9dfc51dc",
        "value": 0.204,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>55.8</td><td>103.0</td><td>97.4</td><td>20.4%</td><td>80.0</td><td>77.6</td><td>79.9</td><td>83.0</td><td>140.0</td><td>12.9%</td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "c8e3f64757b82c16",
        "value": 0.129,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>97.4</td><td>20.4%</td><td>80.0</td><td>77.6</td><td>79.9</td><td>83.0</td><td>140.0</td><td>12.9%</td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>51.7</td><td>95.0</td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "f9a2e1f993fad6fc",
        "value": -0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>51.7</td><td>95.0</td><td>42.9</td><td>-6.0%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "d930ddb097f35435",
        "value": -0.012,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td><td></td></tr><tr><td>Business Innovation</td><td>73.3</td><td>82.0</td><td>70.8</td><td>-1.2%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "46d6ca781990cec5",
        "value": 0.8690000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td><td></td><td></td></tr><tr><td>Imaging</td><td>15.6</td><td>25.0</td><td>101.9</td><td>86.9%</td><td>130.0</td><td>139.2</td><td>139.2</td><td>127.0</td><td>105.0</td><td>1.0%</td><td></t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "82ff2a24869f2558",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>101.9</td><td>86.9%</td><td>130.0</td><td>139.2</td><td>139.2</td><td>127.0</td><td>105.0</td><td>1.0%</td><td></td><td></td><td></td><td></td></tr><tr><td>Electronics</td><td></td><td></td><td></td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "080cb27d487a35c1",
        "value": 0.146,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td>46.5</td><td></td><td>77.0</td><td>77.3</td><td>75.1</td><td>78.0</td><td>70.0</td><td>14.6%</td><td></td><td></td><td></td></tr><tr><td>Business Innovation (New)</td><td></td><td></td><t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "156886f79e139cd9",
        "value": 0.07200000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td>73.0</td><td></td><td>68.0</td><td>74.6</td><td>74.6</td><td>79.0</td><td>90.0</td><td>7.2%</td><td></td><td></td><td></td></tr><tr><td>Elimination</td><td>-30.9</td><td>-45.0</td><td>-36",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "edeaca99c00f4bd2",
        "value": 0.07400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>-36.3</td><td></td><td>-40.0</td><td>-38.6</td><td>-38.6</td><td>-39.0</td><td>-45.0</td><td>7.4%</td><td></td><td></td><td></td><td></td></tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "6008ed8785bc5d0c",
        "value": 0.075,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-39.0</td><td>-45.0</td><td>7.4%</td><td></td><td></td><td></td><td></td></tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td>",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "8b6e98f35d31ab6b",
        "value": 0.096,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-45.0</td><td>7.4%</td><td></td><td></td><td></td><td></td></tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "788a34a51a8a191d",
        "value": 0.09300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>7.4%</td><td></td><td></td><td></td><td></td></tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td><td></td><td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "679c6dd7d14e179f",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td></td><td></td></tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td><td></td><td></td><td></td><td></t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "2e10f8f4e675481c",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td></tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td><td></td><td></td><td></td><td></td><td></td></t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "04e6b7e6a7bb444f",
        "value": 0.10300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td>OPM</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Heal",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "f34714a6a0e57b8c",
        "value": 0.10099999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "M</td><td>7.5%</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "fbb735c6c86c5a12",
        "value": 0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>9.6%</td><td>9.3%</td><td></td><td>10.0%</td><td>10.3%</td><td>10.3%</td><td>10.1%</td><td>10.4%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>9.6%</td><td>",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "721d7b5bb0459c60",
        "value": 0.096,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0.1%</td><td>10.4%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "bbc948c7c1ed797e",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "10.4%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "cab0c9c1c4072f37",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td><td></td><td></td></tr><tr><td>Healthcare</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><td></td><td></",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "56b4f7799ff8c653",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td></td></tr><tr><td>Healthcare</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><td></td><td></td><td></td><td></td><t",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "8265ad2f63793855",
        "value": 0.076,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>Healthcare</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><td></td><td></td><td></td><td></td><td></td></tr><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "84e3b4123989b6eb",
        "value": 0.076,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>Healthcare</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Materi",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "e2f406df5a191651",
        "value": 0.075,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "re</td><td>9.6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>9",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "0ba3badf772a4d61",
        "value": 0.11699999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "6%</td><td>12.0%</td><td>10.0%</td><td></td><td>8.0%</td><td>7.6%</td><td>7.6%</td><td>7.5%</td><td>11.7%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>9.1%</td><td>1",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "8559d0277a339b7b",
        "value": 0.091,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">7.5%</td><td>11.7%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>9.1%</td><td>13.2%</td><td>6.2%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "9e6defbe40af6a1d",
        "value": 0.132,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">11.7%</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>9.1%</td><td>13.2%</td><td>6.2%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "6e2f69379facfdf5",
        "value": 0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td><td></td><td></td><td></td><td></td></tr><tr><td>Materials</td><td>9.1%</td><td>13.2%</td><td>6.2%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "8662930939e6cb02",
        "value": 0.09699999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Business Innovation</td><td>9.7%</td><td>10.0%</td><td>8.6%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "e8564776dca20064",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Business Innovation</td><td>9.7%</td><td>10.0%</td><td>8.6%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "f74fdf6ea915ae18",
        "value": 0.086,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td><td></td></tr><tr><td>Business Innovation</td><td>9.7%</td><td>10.0%</td><td>8.6%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 16
        }
      },
      {
        "num_id": "aa78a0ae09ed6593",
        "value": 0.14800000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td>20</td><td>43</td><td></td></tr><tr><td>OPM</td><td></td><td></td><td></td><td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "488dbfec1ddc0ab3",
        "value": 0.068,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>43</td><td></td></tr><tr><td>OPM</td><td></td><td></td><td></td><td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td></td></tr><tr",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "ae053cc18b80062c",
        "value": 0.14800000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td></tr><tr><td>OPM</td><td></td><td></td><td></td><td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td></td></tr><tr><td>Market C",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "a33ac9024fe00a0d",
        "value": 0.043,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td>OPM</td><td></td><td></td><td></td><td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td></td></tr><tr><td>Market Cap (6/13/2025)",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "499ad99c3cd9e38b",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "M</td><td></td><td></td><td></td><td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td></td></tr><tr><td>Market Cap (6/13/2025) ($mn)</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "ff136207d285df1c",
        "value": 0.023,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td></td></tr><tr><td>Market Cap (6/13/2025) ($mn)</td><td></td><td></td><td><",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "514f70d1724b4403",
        "value": 0.059000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td>14.8%</td><td>6.8%</td><td>14.8%</td><td>4.3%</td><td>15%</td><td></td><td>2.3%</td><td>5.9%</td><td></td></tr><tr><td>Market Cap (6/13/2025) ($mn)</td><td></td><td></td><td></td><td></td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "6f0481c77a019eac",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>1,716</td><td>7,295</td><td></td></tr><tr><td>X ray</td><td></td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "c80c681968ed6bde",
        "value": 0.13,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "6</td><td>7,295</td><td></td></tr><tr><td>X ray</td><td></td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td><",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "55977394c6b3a98b",
        "value": 0.24,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "295</td><td></td></tr><tr><td>X ray</td><td></td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "10a62360ef3042e9",
        "value": 0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>X ray</td><td></td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoro",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "afce3b4c42d853c0",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>X ray</td><td></td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "c71c2a3963391f3a",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "91f5ac10b4803313",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>570</td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "c63a7c1125b0c661",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>720</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "7e756bd9358e4014",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>5%</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "7a9c5ad7114ea4fb",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>13%</td><td>24%</td><td>25%</td><td>8%</td><td>3%</td><td>3%</td><td>2%</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "0a1b90e6e1386526",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>7%</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "8af8226124a0924a",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>15%</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "da6a2d3e00a2dc2c",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr><tr><td>X ra",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "a802d649a06631cc",
        "value": 0.35,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><td>X ray Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr><tr><td>X ray Imaging (",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "b88878b1003252b3",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Fluoroscopy</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr><tr><td>X ray Imaging (including DR)",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "4055b2c88b96fa54",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td>150</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr><tr><td>X ray Imaging (including DR)</td><td></",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "89fda899ff7ac9aa",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0</td><td>180</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr><tr><td>X ray Imaging (including DR)</td><td></td><td>200</td><td>2",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "2b209ea8d5e363f3",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "80</td><td>4%</td><td>20%</td><td>8%</td><td>35%</td><td>15%</td><td>2%</td><td></td><td>8%</td><td>12%</td><td></td></tr><tr><td>X ray Imaging (including DR)</td><td></td><td>200</td><td>240</td><td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "e4acfe6ecb68b037",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "12%</td><td></td></tr><tr><td>X ray Imaging (including DR)</td><td></td><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "28638ce6556e6a43",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td></tr><tr><td>X ray Imaging (including DR)</td><td></td><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "7de8d8317e2616f4",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><td>X ray Imaging (including DR)</td><td></td><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "2e8e90354d3ee362",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Imaging (including DR)</td><td></td><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiog",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "00460f9b07953c9a",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "cluding DR)</td><td></td><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "84ec30ff26228243",
        "value": 0.13,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "ba38d9fc27667d36",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>200</td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "360ff15734ec9563",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>240</td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td>300</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "92c0c0a718ca4b0b",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>4%</td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "070c54496445abba",
        "value": 0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>20%</td><td>12%</td><td>15%</td><td>5%</td><td>13%</td><td>4%</td><td>8%</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><td>35%</td><",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "fecdc478c8d0200e",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>7%</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "a181814dee43845c",
        "value": 0.35,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>16%</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</td></tr><tr",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "0e7ccb894607e047",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>X ray Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</td></tr><tr><td>X ray C",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "e06fff0504be8a16",
        "value": 0.32,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>X ray Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</td></tr><tr><td>X ray CT</td><td></",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "e93d06118a40dcd4",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Angiography</td><td></td><td>220</td><td>300</td><td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</td></tr><tr><td>X ray CT</td><td></td><td>520</",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "a38eddcb87bdc60f",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>300</td><td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</td></tr><tr><td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "ff429524d03931a5",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>6%</td><td>35%</td><td>15%</td><td>32%</td><td>5%</td><td></td><td></td><td></td><td>4%</td><td>9%</td></tr><tr><td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td><td>13%</td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "c681bdd6d88a6843",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td><td></td><td>4%</td><td>9%</td></tr><tr><td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td><td>13%</td><td>27%</td><td>20%</td><td></td><td></td><td></td><td></td><td>6%</t",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "e0f17591be28a20e",
        "value": 0.29,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>4%</td><td>9%</td></tr><tr><td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td><td>13%</td><td>27%</td><td>20%</td><td></td><td></td><td></td><td></td><td>6%</td></tr><tr>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "5a2d38d31af29b37",
        "value": 0.13,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>9%</td></tr><tr><td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td><td>13%</td><td>27%</td><td>20%</td><td></td><td></td><td></td><td></td><td>6%</td></tr><tr><td>MRI</td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "3ced4959365696ab",
        "value": 0.27,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></tr><tr><td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td><td>13%</td><td>27%</td><td>20%</td><td></td><td></td><td></td><td></td><td>6%</td></tr><tr><td>MRI</td><td></td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "99bfbd2f27fdbeb2",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>X ray CT</td><td></td><td>520</td><td>580</td><td>2%</td><td>29%</td><td>13%</td><td>27%</td><td>20%</td><td></td><td></td><td></td><td></td><td>6%</td></tr><tr><td>MRI</td><td></td><td>560</td><td",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "794127f639b746bd",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>2%</td><td>29%</td><td>13%</td><td>27%</td><td>20%</td><td></td><td></td><td></td><td></td><td>6%</td></tr><tr><td>MRI</td><td></td><td>560</td><td>650</td><td>3%</td><td>25%</td><td>14%</td><td>",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "e52b031e8904c3e7",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td><td></td><td></td><td>6%</td></tr><tr><td>MRI</td><td></td><td>560</td><td>650</td><td>3%</td><td>25%</td><td>14%</td><td>28%</td><td>12%</td><td></td><td></td><td></td><td></td><td>13%</",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "0b7dbb9d03f9fdd7",
        "value": 0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td><td></td><td>6%</td></tr><tr><td>MRI</td><td></td><td>560</td><td>650</td><td>3%</td><td>25%</td><td>14%</td><td>28%</td><td>12%</td><td></td><td></td><td></td><td></td><td>13%</td></tr><tr",
        "provenance": {
          "page": 17
        }
      },
      {
        "num_id": "b19f859413cf85fb",
        "value": 0.165,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>PSR</td><td>PER</td></tr><tr><td>Lonza</td><td>2024/12 Actual</td><td>6,574</td><td>1,086</td><td>16.5%</td><td>48,646</td><td>19.4</td><td>7.4</td></tr><tr><td>Samsung Biologics</td><td>2024/12 Act",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "c0276fd7759a4ffc",
        "value": 0.29,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>7.4</td></tr><tr><td>Samsung Biologics</td><td>2024/12 Actual</td><td>4,547</td><td>1,320</td><td>29.0%</td><td>52,002</td><td>28.5</td><td>11.4</td></tr><tr><td>Celltrion</td><td>2024/12 Actual</td",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "bdad0328466b82f0",
        "value": 0.171,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".5</td><td>11.4</td></tr><tr><td>Celltrion</td><td>2024/12 Actual</td><td>2,628</td><td>449</td><td>17.1%</td><td>26,881</td><td>25.7</td><td>10.2</td></tr><tr><td>Wuxi Biologics</td><td>2024/12 Actua",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "932773b15d83f162",
        "value": 0.24600000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>10.2</td></tr><tr><td>Wuxi Biologics</td><td>2024/12 Actual</td><td>2,595</td><td>637</td><td>24.6%</td><td>16,599</td><td>16.2</td><td>6.4</td></tr><tr><td>Average</td><td></td><td>4,086</td><t",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "bc9cd004fed4866d",
        "value": 0.214,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "16,599</td><td>16.2</td><td>6.4</td></tr><tr><td>Average</td><td></td><td>4,086</td><td>873</td><td>21.4%</td><td>22.5</td><td>8.9</td><td>39.4</td></tr><tr><td>Fujifilm</td><td>3/25 Actual</td><td>2,",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "78d4cbe2676c90eb",
        "value": -0.005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>8.9</td><td>39.4</td></tr><tr><td>Fujifilm</td><td>3/25 Actual</td><td>2,195</td><td>-10</td><td>-0.5%</td><td>29,030</td><td>9.9</td><td>1.2</td></tr></table> Source: Jefferies, FactSet Exhibit 10",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "88a296e44e47ef7f",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0</td><td>0.0</td><td></td><td></td></tr><tr><td>EBITDA Margin (ex one time cost)</td><td>%</td><td>15%</td><td>15%</td><td>low teen</td><td>low teen</td><td>mid teen</td><td>12%</td><td></td><td>17%<",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "cfc6d6d09e4f6378",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0</td><td></td><td></td></tr><tr><td>EBITDA Margin (ex one time cost)</td><td>%</td><td>15%</td><td>15%</td><td>low teen</td><td>low teen</td><td>mid teen</td><td>12%</td><td></td><td>17%</td></tr><tr",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "5a063a9b5cc21004",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "cost)</td><td>%</td><td>15%</td><td>15%</td><td>low teen</td><td>low teen</td><td>mid teen</td><td>12%</td><td></td><td>17%</td></tr><tr><td>One time profit/cost</td><td>¥bn</td><td>4.0</td><td>1.0</t",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "b222bbceb970e684",
        "value": 0.17,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>15%</td><td>15%</td><td>low teen</td><td>low teen</td><td>mid teen</td><td>12%</td><td></td><td>17%</td></tr><tr><td>One time profit/cost</td><td>¥bn</td><td>4.0</td><td>1.0</td><td>-18.0</td><td>",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "99c270a4ac381603",
        "value": 0.17,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-10.0</td><td>-10.0</td><td></td><td>-5.0</td></tr><tr><td>EBITDA Margin</td><td>%</td><td>17%</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "88af3c7ddadbe422",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".0</td><td>-10.0</td><td></td><td>-5.0</td></tr><tr><td>EBITDA Margin</td><td>%</td><td>17%</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><td>40%</td><",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "68040def6b56bb84",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0</td></tr><tr><td>EBITDA Margin</td><td>%</td><td>17%</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><td>40%</td></tr><tr><td>Capex (Jefferies estimate",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "aef3027d5062c40c",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<tr><td>EBITDA Margin</td><td>%</td><td>17%</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><td>40%</td></tr><tr><td>Capex (Jefferies estimates)</td><td>",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "53d36116e8afefb8",
        "value": 0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "in</td><td>%</td><td>17%</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><td>40%</td></tr><tr><td>Capex (Jefferies estimates)</td><td>¥bn</td><td>150</td",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "751f10f5ce39f7ea",
        "value": 0.17,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>17%</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><td>40%</td></tr><tr><td>Capex (Jefferies estimates)</td><td>¥bn</td><td>150</td><td>250</td",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "db2b0fce1c5fefff",
        "value": 0.4,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>15%</td><td>low single digit</td><td>2%</td><td>7%</td><td>&amp;gt;25%</td><td>17%</td><td>40%</td></tr><tr><td>Capex (Jefferies estimates)</td><td>¥bn</td><td>150</td><td>250</td><td></td><t",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "b483828ff963d8a3",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "loss</td><td>-19</td><td>-16</td><td>-19</td><td></td><td>20</td></tr><tr><td>OPM</td><td>%</td><td>10%</td><td>3%</td><td></td><td>-1%</td><td>-1%</td><td>-8%</td><td></td><td>7%</td></tr></table> So",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "0d54bbaa580ff095",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-19</td><td>-16</td><td>-19</td><td></td><td>20</td></tr><tr><td>OPM</td><td>%</td><td>10%</td><td>3%</td><td></td><td>-1%</td><td>-1%</td><td>-8%</td><td></td><td>7%</td></tr></table> Source: Jeffer",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "a3d6ef737fc57dcc",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-19</td><td></td><td>20</td></tr><tr><td>OPM</td><td>%</td><td>10%</td><td>3%</td><td></td><td>-1%</td><td>-1%</td><td>-8%</td><td></td><td>7%</td></tr></table> Source: Jefferies estimates, compa",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "5c1ab611fb234294",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td>20</td></tr><tr><td>OPM</td><td>%</td><td>10%</td><td>3%</td><td></td><td>-1%</td><td>-1%</td><td>-8%</td><td></td><td>7%</td></tr></table> Source: Jefferies estimates, company data<｜end",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "c84456e9b564ee57",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>20</td></tr><tr><td>OPM</td><td>%</td><td>10%</td><td>3%</td><td></td><td>-1%</td><td>-1%</td><td>-8%</td><td></td><td>7%</td></tr></table> Source: Jefferies estimates, company data<｜end▁of▁sentence",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "3820905172235a26",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">OPM</td><td>%</td><td>10%</td><td>3%</td><td></td><td>-1%</td><td>-1%</td><td>-8%</td><td></td><td>7%</td></tr></table> Source: Jefferies estimates, company data<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 18
        }
      },
      {
        "num_id": "9779c2d7ed5f13ef",
        "value": -0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td><",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "d4c6d234686b4d71",
        "value": -0.064,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td></td><td></td><",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "d9ece46f286b0ba1",
        "value": -0.09300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td><td></td><td></td><td></td><td></td></tr><tr><td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td></td><td></td><td></td><td></",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "14e37f4976700752",
        "value": 0.10800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td><td></td><td></td><td></td></tr><tr><td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td></td><td></td><td></td><td></td><td></td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "74dc34ff0e6f4125",
        "value": 0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td></td></tr><tr><td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "bcb4e59deea4ae97",
        "value": -0.004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "34f443eeaeb935ff",
        "value": -0.373,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>YoY</td><td>-2.0%</td><td>-6.4%</td><td>-9.3%</td><td>10.8%</td><td>10.4%</td><td>-0.4%</td><td>-37.3%</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "5f50b1eb83a99ce4",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>62.3</td><td>63.0</td><td>61.9</td><td>63.2</td><td>64.7</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "536b37327f08b41c",
        "value": 0.078,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>63.0</td><td>61.9</td><td>63.2</td><td>64.7</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "1999dffbc080ba1c",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>61.9</td><td>63.2</td><td>64.7</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "ffdc2c2251017890",
        "value": 0.228,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>63.2</td><td>64.7</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "a8d98c1b98b6dda1",
        "value": 0.231,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">64.7</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "0741bb0cb1ff3355",
        "value": 0.106,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>YoY growth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "d01feec25963baff",
        "value": 0.254,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rowth (%)</td><td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "b4be8f1586146f72",
        "value": 0.038,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>4.0%</td><td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%<",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "83e2878fbfb3afea",
        "value": 0.034,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>7.8%</td><td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%<",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "0ce43cb5fa06465c",
        "value": 0.081,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>12.0%</td><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr>",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "49875f455dc02146",
        "value": 0.107,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>22.8%</td><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr><td>AF Materi",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "d71fdf377b7bfdde",
        "value": 0.5379999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>23.1%</td><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr><td>AF Materials</td><td></",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "191d2bbc57f5cb7d",
        "value": 0.465,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>10.6%</td><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr><td>AF Materials</td><td></td><td></td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "babf65692e7892a2",
        "value": 0.125,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>25.4%</td><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr><td>AF Materials</td><td></td><td></td><td></td><td></t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "c68b54aa91df2eb5",
        "value": 0.033,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>3.8%</td><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr><td>AF Materials</td><td></td><td></td><td></td><td></td><td></td><td",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "0337c06902ddb4c7",
        "value": 0.039,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>3.4%</td><td>8.1%</td><td>10.7%</td><td>53.8%</td><td>46.5%</td><td>12.5%</td><td>3.3%</td><td>3.9%</td></tr><tr><td>AF Materials</td><td></td><td></td><td></td><td></td><td></td><td>158.7</td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "60567e7718fde8f7",
        "value": 0.212,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>70.1</td><td>78.3</td><td>104.0</td><td>0.0</td><td>90.0</td><td>88.0</td><td>85.0</td><td>21.2%</td><td>15.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "433eca53df931a6d",
        "value": 0.151,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>78.3</td><td>104.0</td><td>0.0</td><td>90.0</td><td>88.0</td><td>85.0</td><td>21.2%</td><td>15.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "657da5e051403248",
        "value": 0.192,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>104.0</td><td>0.0</td><td>90.0</td><td>88.0</td><td>85.0</td><td>21.2%</td><td>15.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "798fdb3622e6698f",
        "value": 0.055999999999999994,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>0.0</td><td>90.0</td><td>88.0</td><td>85.0</td><td>21.2%</td><td>15.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "96eedfa2bd060b38",
        "value": -0.19899999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>90.0</td><td>88.0</td><td>85.0</td><td>21.2%</td><td>15.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "0b848c704b143f2f",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".2%</td><td>15.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "fec3f84a8ce090f5",
        "value": -0.129,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "5.1%</td><td>19.2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "5b5c4ad3bbd8ac88",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".2%</td><td>5.6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "6d8d87184ffa00e0",
        "value": -0.002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "6%</td><td>-19.9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "2a234427a32c0ccd",
        "value": -0.26,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".9%</td></tr><tr><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>2",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "03557a5b46edb7d1",
        "value": 0.11699999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>YoY growth (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>26.7</td><td>26.",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "907cdae294d9a5a0",
        "value": 0.32799999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "th (%)</td><td>4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>26.7</td><td>26.5</td><td>27.0",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "ca5cb157fc160959",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">4.0%</td><td>-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>26.7</td><td>26.5</td><td>27.0</td><td>23.8<",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "2a57ae80d7f1a5e8",
        "value": -0.135,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-12.9%</td><td>11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>26.7</td><td>26.5</td><td>27.0</td><td>23.8</td><td>26.6<",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "b2aab8488c82abfc",
        "value": -0.022000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">11.0%</td><td>-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>26.7</td><td>26.5</td><td>27.0</td><td>23.8</td><td>26.6</td></tr><tr><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "51be92cddb338c0c",
        "value": -0.034,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-0.2%</td><td>-26.0%</td><td>11.7%</td><td>32.8%</td><td>0.0%</td><td>-13.5%</td><td>-2.2%</td><td>-3.4%</td><td>26.7</td><td>26.5</td><td>27.0</td><td>23.8</td><td>26.6</td></tr><tr><td>Other materi",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "bfaa434a399774d3",
        "value": 0.32799999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>100.0</td><td>80.3</td><td>78.4</td><td>0.0</td><td>76.0</td><td>78.0</td><td>82.0</td><td>32.8%</td><td>31.8%</td><td>42.9%</td><td>24.0%</td><td>-0.4%</td></tr><tr><td>YoY growth (%)</td><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "d87353371509219e",
        "value": 0.318,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>80.3</td><td>78.4</td><td>0.0</td><td>76.0</td><td>78.0</td><td>82.0</td><td>32.8%</td><td>31.8%</td><td>42.9%</td><td>24.0%</td><td>-0.4%</td></tr><tr><td>YoY growth (%)</td><td></td><td></t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "59330d5d30fb0c7f",
        "value": 0.429,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>78.4</td><td>0.0</td><td>76.0</td><td>78.0</td><td>82.0</td><td>32.8%</td><td>31.8%</td><td>42.9%</td><td>24.0%</td><td>-0.4%</td></tr><tr><td>YoY growth (%)</td><td></td><td></td><td></td><td",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "7c8750bec72eb694",
        "value": 0.24,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>0.0</td><td>76.0</td><td>78.0</td><td>82.0</td><td>32.8%</td><td>31.8%</td><td>42.9%</td><td>24.0%</td><td>-0.4%</td></tr><tr><td>YoY growth (%)</td><td></td><td></td><td></td><td></td><td></td",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "037c7171dda1a88b",
        "value": -0.004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>76.0</td><td>78.0</td><td>82.0</td><td>32.8%</td><td>31.8%</td><td>42.9%</td><td>24.0%</td><td>-0.4%</td></tr><tr><td>YoY growth (%)</td><td></td><td></td><td></td><td></td><td></td><td></td><td>",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "0058d510ee980fb1",
        "value": -0.024,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "cording media</td><td>39.0</td><td>41.9</td><td>26.3</td><td>29.9</td><td>30.0</td><td>25.0</td><td>-2.4%</td><td>0.0%</td><td>-3.1%</td><td>2.6%</td><td>5.1%</td><td>7.6%</td><td>-2.0%</td><td>-3.0%<",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "cc31f0480c198111",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>39.0</td><td>41.9</td><td>26.3</td><td>29.9</td><td>30.0</td><td>25.0</td><td>-2.4%</td><td>0.0%</td><td>-3.1%</td><td>2.6%</td><td>5.1%</td><td>7.6%</td><td>-2.0%</td><td>-3.0%</td><td>-10.4%",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "6c7233d1be4de8a4",
        "value": -0.031,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>41.9</td><td>26.3</td><td>29.9</td><td>30.0</td><td>25.0</td><td>-2.4%</td><td>0.0%</td><td>-3.1%</td><td>2.6%</td><td>5.1%</td><td>7.6%</td><td>-2.0%</td><td>-3.0%</td><td>-10.4%</td><td>-45.",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "db25f7907939a86e",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>26.3</td><td>29.9</td><td>30.0</td><td>25.0</td><td>-2.4%</td><td>0.0%</td><td>-3.1%</td><td>2.6%</td><td>5.1%</td><td>7.6%</td><td>-2.0%</td><td>-3.0%</td><td>-10.4%</td><td>-45.2%</td></tr><t",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "31d88a01f221664e",
        "value": 0.051,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>29.9</td><td>30.0</td><td>25.0</td><td>-2.4%</td><td>0.0%</td><td>-3.1%</td><td>2.6%</td><td>5.1%</td><td>7.6%</td><td>-2.0%</td><td>-3.0%</td><td>-10.4%</td><td>-45.2%</td></tr><tr><td>Electro",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "b782d880e03a0b9c",
        "value": 0.076,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>30.0</td><td>25.0</td><td>-2.4%</td><td>0.0%</td><td>-3.1%</td><td>2.6%</td><td>5.1%</td><td>7.6%</td><td>-2.0%</td><td>-3.0%</td><td>-10.4%</td><td>-45.2%</td></tr><tr><td>Electronics OP</td><",
        "provenance": {
          "page": 20
        }
      },
      {
        "num_id": "9134cd619cb9f79a",
        "value": 0.008,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "280.0</td><td>287.7</td><td>294.4</td><td>336.4</td><td>273.6</td><td></td></tr><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "1f6ff58f3b9872ed",
        "value": 0.098,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">287.7</td><td>294.4</td><td>336.4</td><td>273.6</td><td></td></tr><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "a5fbde44ac062246",
        "value": -0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>294.4</td><td>336.4</td><td>273.6</td><td></td></tr><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "e999a91d9aa487e6",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>336.4</td><td>273.6</td><td></td></tr><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "c1becc292a7ce163",
        "value": 0.035,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>273.6</td><td></td></tr><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%<",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "6d55f37fe739e289",
        "value": 0.018000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "048f1cb44a1f4d9f",
        "value": 0.051,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>YoY</td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "674fbb6c5f6aba81",
        "value": 0.002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>0.8%</td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "66cb452c14faa680",
        "value": -0.004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>9.8%</td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></td></tr><tr><t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "27146083413d1090",
        "value": 0.442,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>-1.4%</td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></td></tr><tr><td>Office Solut",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "fdd2a4e3aa44aefa",
        "value": 0.38799999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>0.0%</td><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></td></tr><tr><td>Office Solution</td><td>50",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "85495e84f9c64bb4",
        "value": 0.473,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>3.5%</td><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></td></tr><tr><td>Office Solution</td><td>507.5</td><td>55",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "b48db6db7662cdc3",
        "value": 0.49700000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>1.8%</td><td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></td></tr><tr><td>Office Solution</td><td>507.5</td><td>555.5</td><td>52",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "f924c731dda5f68a",
        "value": -0.023,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>5.1%</td><td>0.2%</td><td>-0.4%</td><td>44.2%</td><td>38.8%</td><td>47.3%</td><td>49.7%</td><td>-2.3%</td><td></td></tr><tr><td>Office Solution</td><td>507.5</td><td>555.5</td><td>524.3</td><td>52",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "686f887d7ff64894",
        "value": -0.002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-</td><td>-</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-0.2%</td><td>10.5%</td><td>-1.8%</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "d67815a45012f507",
        "value": 0.105,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-0.2%</td><td>10.5%</td><td>-1.8%</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td></",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "03a44bae91ff2b8b",
        "value": -0.018000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-0.2%</td><td>10.5%</td><td>-1.8%</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td></td><td></td><t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "ecb9195650103e70",
        "value": -0.023,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "12.3</td><td>120.0</td><td>101.0</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "06084da6a5c1ecff",
        "value": 0.185,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "20.0</td><td>101.0</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "2a6462b1417bc641",
        "value": -0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "01.0</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%<",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "b0466fdb6b5dd149",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "8f573de84fdb72f2",
        "value": 0.036000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>YoY growth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%<",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "8bd7403200999ded",
        "value": -0.009000000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>YoY growth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td>",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "b35a3bc2725f517b",
        "value": -0.035,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rowth (%)</td><td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td><td></td><td><",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "8b77f8e2b20c3769",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>-2.3%</td><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td><td></td><td></td></tr><tr><",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "e4b6fb1a4783f78f",
        "value": -0.075,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>18.5%</td><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td><td></td><td></td></tr><tr><td>Domestic</",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "8eb089762eaad811",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-2.0%</td><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td><td></td><td></td></tr><tr><td>Domestic</td><td>218.6</",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "b2021d6c47bdcce9",
        "value": 0.085,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>2.0%</td><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td><td></td><td></td></tr><tr><td>Domestic</td><td>218.6</td><td>272.1<",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "a3f6186abad391a7",
        "value": -0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>3.6%</td><td>-0.9%</td><td>-3.5%</td><td>2.0%</td><td>-7.5%</td><td>5.0%</td><td>8.5%</td><td>-4.0%</td><td></td><td></td><td></td></tr><tr><td>Domestic</td><td>218.6</td><td>272.1</td><td>230.0",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "035d9becc6b8bec8",
        "value": 0.012,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>18.2</td><td>18.7</td><td>18.5</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "13e170962b12ea3b",
        "value": 0.13,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>18.7</td><td>18.5</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "46f6331636fad8f5",
        "value": -0.135,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">18.5</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "d9a0509b72311056",
        "value": -0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "e8675d067e2273db",
        "value": -0.012,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td></tr><tr><td>YoY growth (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "2814c7605c3da34a",
        "value": -0.012,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>YoY growth (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td>",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "10a01dcb67a0f4ad",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "th (%)</td><td>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td></td><td></td>",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "0b2731eeb42f6e5d",
        "value": -0.048,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>1.2%</td><td>13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td></td><td></td><td></td></tr",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "39ff1401978cf861",
        "value": -0.059000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">13.0%</td><td>-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td></td><td></td><td></td></tr><tr><td>Produ",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "99164e42deaacd6a",
        "value": -0.147,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-13.5%</td><td>-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td></td><td></td><td></td></tr><tr><td>Production services",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "d78b93b72dbc76c4",
        "value": -0.33799999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-16.0%</td><td>-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td></td><td></td><td></td></tr><tr><td>Production services</td><td>89.7</",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "36e3d1919129cbec",
        "value": -0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-1.2%</td><td>-1.2%</td><td>0.0%</td><td>-4.8%</td><td>-5.9%</td><td>-14.7%</td><td>-33.8%</td><td>-14.0%</td><td></td><td></td><td></td></tr><tr><td>Production services</td><td>89.7</td><td>104.9</t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "888fa22761254864",
        "value": -0.07400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-</td><td>-</td><td>-</td><td>-</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "0b310d97d25174e1",
        "value": 0.17,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>-</td><td>-</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</td><td>81.1</td",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "53e3376bd356cfbb",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-</td><td></td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</td><td>81.1</td><td>77.9</td>",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "5401c1e8ba1a81d4",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td></tr><tr><td>YoY growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</td><td>81.1</td><td>77.9</td><td>101.1</td",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "b55c10d0644a42c5",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td></tr><tr><td>YoY growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</td><td>81.1</td><td>77.9</td><td>101.1</td><td>75.8</td",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "67099883c135d86b",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><tr><td>YoY growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</td><td>81.1</td><td>77.9</td><td>101.1</td><td>75.8</td><td></td><td",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "f3f856fd83570000",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "growth (%)</td><td>-7.4%</td><td>17.0%</td><td>2.0%</td><td>0.0%</td><td>2.0%</td><td>1.0%</td><td>0.0%</td><td>70.8</td><td>81.1</td><td>77.9</td><td>101.1</td><td>75.8</td><td></td><td></td><td></td",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "6319e7ab3158e1cb",
        "value": 0.035,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>256.0</td><td>282.6</td><td>330.9</td><td>370.0</td><td>328.0</td><td>340.0</td><td>340.0</td><td>3.5%</td><td>6.7%</td><td>8.8%</td><td>17.8%</td><td>7.1%</td><td></td><td></td><td></td></tr><tr><t",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "6300aa9de71d0043",
        "value": 0.067,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>282.6</td><td>330.9</td><td>370.0</td><td>328.0</td><td>340.0</td><td>340.0</td><td>3.5%</td><td>6.7%</td><td>8.8%</td><td>17.8%</td><td>7.1%</td><td></td><td></td><td></td></tr><tr><td>YoY growth ",
        "provenance": {
          "page": 21
        }
      },
      {
        "num_id": "9eb10de5841259ad",
        "value": -0.031,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0.7</td><td>126.7</td><td>169.5</td><td>115.1</td><td>145.3</td></tr><tr><td>YoY growth (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>1",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "d13571abf4f32e54",
        "value": 0.121,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "6.7</td><td>169.5</td><td>115.1</td><td>145.3</td></tr><tr><td>YoY growth (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>1",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "f380f2b4486b45d4",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9.5</td><td>115.1</td><td>145.3</td></tr><tr><td>YoY growth (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "1231c56c93ee6662",
        "value": -0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "15.1</td><td>145.3</td></tr><tr><td>YoY growth (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "3a5249d00e00ad93",
        "value": -0.14300000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "5.3</td></tr><tr><td>YoY growth (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "39666b98f7f23dfb",
        "value": 0.16899999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>YoY growth (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "5b95b8ce40d63578",
        "value": 0.231,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "th (%)</td><td>-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "ed57fc8a9e4c9ce6",
        "value": 0.145,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-3.1%</td><td>12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "0fd5f4b03022588a",
        "value": 0.154,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">12.1%</td><td>1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "d200dcfe1eed207d",
        "value": -0.004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">1.0%</td><td>-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "922be0a0a39f63c8",
        "value": 0.008,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "-14.0%</td><td>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "4932d87e5298b27d",
        "value": -0.003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-14.3%</td><td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "aed231b02facda95",
        "value": -0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>16.9%</td><td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><tr><td>Photo i",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "934c1b2e2c610cdf",
        "value": 0.242,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>23.1%</td><td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><tr><td>Photo imaging/Consume",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "58c8c3dfb1338c82",
        "value": 0.11199999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>14.5%</td><td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><tr><td>Photo imaging/Consumer Imaging</td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "aed4bf94c6d01fb0",
        "value": 0.135,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>15.4%</td><td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><tr><td>Photo imaging/Consumer Imaging</td><td>236.8</td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "201149e30a870560",
        "value": 0.138,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-0.4%</td><td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><tr><td>Photo imaging/Consumer Imaging</td><td>236.8</td><td>255.4</td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "809ec85133756f4f",
        "value": 0.11199999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>0.8%</td><td>-0.3%</td><td>-1.9%</td><td>24.2%</td><td>11.2%</td><td>13.5%</td><td>13.8%</td><td>11.2%</td></tr><tr><td>Photo imaging/Consumer Imaging</td><td>236.8</td><td>255.4</td><td>257.5</td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "1c84c616f5c5c420",
        "value": -0.051,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>74.6</td><td>77.6</td><td>110.6</td><td>65.2</td><td>77.3</td></tr><tr><td>YoY growth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "5e8a2c538d0ebcda",
        "value": 0.079,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">77.6</td><td>110.6</td><td>65.2</td><td>77.3</td></tr><tr><td>YoY growth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "5d89675383be6e1a",
        "value": 0.008,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">110.6</td><td>65.2</td><td>77.3</td></tr><tr><td>YoY growth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "8ca4c27bfd3eff92",
        "value": -0.111,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>65.2</td><td>77.3</td></tr><tr><td>YoY growth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "d06efca825047ae5",
        "value": -0.145,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "77.3</td></tr><tr><td>YoY growth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "d159a3c16316f043",
        "value": 0.11800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><td>YoY growth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "c478a275eecfcd39",
        "value": 0.21899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "wth (%)</td><td>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "a21a9c5cc25d4eef",
        "value": 0.115,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-5.1%</td><td>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "4da507bf3780f489",
        "value": 0.102,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>7.9%</td><td>0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%<",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "0b5dd38771b28562",
        "value": 0.023,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">0.8%</td><td>-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "00ce4abf1301b62a",
        "value": -0.009000000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-11.1%</td><td>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td><",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "fe6f0765f67d4009",
        "value": -0.036000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-14.5%</td><td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td></tr><tr><td>Co",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "00a853c5980f70bb",
        "value": 0.18,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>11.8%</td><td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td></tr><tr><td>Color paper</td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "ef3628f793312e51",
        "value": 0.073,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>21.9%</td><td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td></tr><tr><td>Color paper</td><td>66.3</td><",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "c2e8444636447e23",
        "value": 0.079,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>11.5%</td><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td></tr><tr><td>Color paper</td><td>66.3</td><td>63.9</td><",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "1f698820f942a597",
        "value": 0.094,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>10.2%</td><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td></tr><tr><td>Color paper</td><td>66.3</td><td>63.9</td><td>61.8</td><",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "59bb5701c3a9bfb5",
        "value": 0.036000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>2.3%</td><td>-0.9%</td><td>-3.6%</td><td>18.0%</td><td>7.3%</td><td>7.9%</td><td>9.4%</td><td>3.6%</td><td></td></tr><tr><td>Color paper</td><td>66.3</td><td>63.9</td><td>61.8</td><td>50.4</td><",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "c1b55b962c5598a8",
        "value": 0.091,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>39.6</td><td>49.5</td><td>37.1</td><td>59.2</td><td></td></tr><tr><td>YoY growth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "42b3542484d35a9f",
        "value": 0.272,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>49.5</td><td>37.1</td><td>59.2</td><td></td></tr><tr><td>YoY growth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "4ac3f58bc6ebf8e4",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>37.1</td><td>59.2</td><td></td></tr><tr><td>YoY growth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "02322d67d019e4c5",
        "value": -0.205,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>59.2</td><td></td></tr><tr><td>YoY growth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "33665c5b739cc184",
        "value": -0.054000000000000006,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>YoY growth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "d0fec57bfd7dc32c",
        "value": 0.159,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<tr><td>YoY growth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "e71a2e3678b2b0cf",
        "value": 0.331,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "owth (%)</td><td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "a40bb0bb7a7fe834",
        "value": 0.262,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>9.1%</td><td>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "7caaa974a16ba105",
        "value": 0.308,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>27.2%</td><td>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "0367d94ac415842a",
        "value": 0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>2.0%</td><td>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%</td><td>25.7%",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "074d8f099f62cf8a",
        "value": 0.003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-20.5%</td><td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%</td><td>25.7%</td><td></td",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "59e24d435dbdbe7c",
        "value": 0.002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>-5.4%</td><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%</td><td>25.7%</td><td></td></tr><tr><td",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "3b87c7a34beab2bf",
        "value": 0.456,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>15.9%</td><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%</td><td>25.7%</td><td></td></tr><tr><td>Digital came",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "222621c8832dfd9c",
        "value": 0.23399999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>33.1%</td><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%</td><td>25.7%</td><td></td></tr><tr><td>Digital camera sales (mn u",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "b733aa7b1869e34c",
        "value": 0.32,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>26.2%</td><td>30.8%</td><td>6.2%</td><td>0.3%</td><td>0.2%</td><td>45.6%</td><td>23.4%</td><td>32.0%</td><td>21.4%</td><td>25.7%</td><td></td></tr><tr><td>Digital camera sales (mn units)</td><td>",
        "provenance": {
          "page": 24
        }
      },
      {
        "num_id": "8c2ba7e868e8d7c0",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent",
        "provenance": {
          "page": 27
        }
      },
      {
        "num_id": "a48a4b57c09eaf3e",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not ",
        "provenance": {
          "page": 27
        }
      },
      {
        "num_id": "428d73069abf0aa3",
        "value": 0.6063000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>Count</td><td>Percent</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2111</td><td>60.63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "c73027c3c967da91",
        "value": 0.1753,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2111</td><td>60.63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "726c11da4fe0df15",
        "value": 0.0559,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ent</td></tr><tr><td>BUY</td><td>2111</td><td>60.63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "8f8f74f5221093aa",
        "value": 0.34840000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158<",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "8fb35d9dd58a6935",
        "value": 0.0866,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "bd65383bf489e5b1",
        "value": 0.0181,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td>",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "073fc1b7d0e3780a",
        "value": 0.0454,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "dce49416547beb99",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 28
        }
      },
      {
        "num_id": "b9235e47112e7943",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 28
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 11,
      "tables_count": 0,
      "numerical_data_count": 590,
      "passages_count": 186,
      "entities_count": 20
    }
  }
}